[{"created_at":"2016-04-05T07:26:29.000Z","possibly_sensitive":false,"text":"@EMA_News publishes report on its pilot parallel scientific advice with HTA bodies procedure. #Regulatorynews https://t.co/b7JIVyb99X","source":"Hootsuite","author_id":"845904529","lang":"en","id":"717252052657836033","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/b7JIVyb99X","expanded_url":"http://ow.ly/10iviE","display_url":"ow.ly/10iviE"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":94,"end":109,"tag":"Regulatorynews"}],"annotations":{},"cashtags":{}},"conversation_id":"717252052657836033","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-04-05T06:17:06.000Z","possibly_sensitive":false,"text":"@EMA_News -Review : #Symbioflor 2 auf dem Prüfstand #bfarm  https://t.co/h1LKrqs1rd","source":"Twitter for iPhone","author_id":"15460376","lang":"de","id":"717234590889480192","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":60,"end":83,"url":"https://t.co/h1LKrqs1rd","expanded_url":"https://www.deutsche-apotheker-zeitung.de/news/artikel/2016/04/04/symbioflor-2-auf-dem-prufstand","display_url":"deutsche-apotheker-zeitung.de/news/artikel/2…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":20,"end":31,"tag":"Symbioflor"},{"start":52,"end":58,"tag":"bfarm"}],"annotations":{},"cashtags":{}},"conversation_id":"717234590889480192","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-04-04T11:27:38.000Z","possibly_sensitive":false,"text":"@EMA_News issues positive opinion to GSK's gene therapy for ADA-SCID, Strimvelis. @CTCatapult #Regulatorynews https://t.co/qZf1KbSuq4","source":"Hootsuite","author_id":"845904529","lang":"en","id":"716950349995749376","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/qZf1KbSuq4","expanded_url":"http://ow.ly/10g1Hk","display_url":"ow.ly/10g1Hk"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":82,"end":93,"username":"CTCatapult","id":"940559888266219520"}],"hashtags":[{"start":94,"end":109,"tag":"Regulatorynews"}],"annotations":{},"cashtags":{}},"conversation_id":"716950349995749376","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-04-04T10:55:07.000Z","possibly_sensitive":false,"text":"@EMA_News grants conditional marketing authorization to daratumumab for the treatment of relapsed #MultipleMyeloma https://t.co/uhgIxvZMXL","source":"Hootsuite","author_id":"3187500729","lang":"en","id":"716942167495852032","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/uhgIxvZMXL","expanded_url":"http://bit.ly/1Rzk347","display_url":"bit.ly/1Rzk347"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":98,"end":114,"tag":"MultipleMyeloma"}],"annotations":{},"cashtags":{}},"conversation_id":"716942167495852032","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-04-04T10:34:55.000Z","possibly_sensitive":false,"text":"@EMA_News/CHMP recommendations for seven new medicines https://t.co/dSXVst9SQV #biosimilars","source":"Twitter Web Client","author_id":"71542880","lang":"en","id":"716937083059847168","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":55,"end":78,"url":"https://t.co/dSXVst9SQV","expanded_url":"http://bit.ly/1RTXCW6","display_url":"bit.ly/1RTXCW6"}],"mentions":{},"hashtags":[{"start":79,"end":91,"tag":"biosimilars"}],"annotations":{},"cashtags":{}},"conversation_id":"716937083059847168","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-04-02T21:12:33.000Z","possibly_sensitive":false,"text":"@EMA_News","source":"Twitter for Android","author_id":"381558705","lang":"und","id":"716372774827212800","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"715921314427617280","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"715921314427617280"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-04-02T01:29:53.000Z","possibly_sensitive":false,"text":"@EMA_News @amicusrx1","source":"Twitter for iPhone","author_id":"246505914","lang":"und","id":"716075146021355520","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"amicusrx1","id":"2858467579"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"715922306871259140","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"715922306871259140"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-04-01T20:37:27.000Z","possibly_sensitive":false,"text":"@EMA_News recommends seven new medicines for approval, CHMP meeting highlights April 1, news https://t.co/74T7sJsk7a https://t.co/PXLeXhBwtl","source":"Twitter for Android","author_id":"2273521479","lang":"en","id":"716001554818600961","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/74T7sJsk7a","expanded_url":"http://www.ema.europa.eu/ema/","display_url":"ema.europa.eu/ema/"},{"start":117,"end":140,"url":"https://t.co/PXLeXhBwtl","expanded_url":"https://twitter.com/Evonbr/status/716001554818600961/photo/1","display_url":"pic.twitter.com/PXLeXhBwtl"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"716001554818600961","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_716001521549316102"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-04-01T12:22:56.000Z","possibly_sensitive":false,"text":"@EMA_News finaliza su experiencia piloto de asesoramiento científico paralelo a las farmacéuticas vía @ActaSanitaria https://t.co/NGxGB8Amxd","source":"Twitter for Android","author_id":"1242516320","lang":"es","id":"715877105607839744","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/NGxGB8Amxd","expanded_url":"http://www.actasanitaria.com/la-ema-finaliza-su-experiencia-piloto-de-asesoramiento-cientifico-paralelo-las-farmaceuticas/","display_url":"actasanitaria.com/la-ema-finaliz…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":102,"end":116,"username":"ActaSanitaria","id":"507624258"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"715877105607839744","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-04-01T08:01:40.000Z","possibly_sensitive":false,"text":"@EMA_News Offers Updated Draft Guidance on Human #ClinicalTrials for #CancerDrugs https://t.co/4YAfmAbcmc","source":"Hootsuite","author_id":"164226447","lang":"en","id":"715811355236892672","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/4YAfmAbcmc","expanded_url":"http://ow.ly/ZCCm5","display_url":"ow.ly/ZCCm5"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":49,"end":64,"tag":"ClinicalTrials"},{"start":69,"end":81,"tag":"CancerDrugs"}],"annotations":{},"cashtags":{}},"conversation_id":"715811355236892672","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-29T15:02:26.000Z","possibly_sensitive":false,"text":"@EMA_News launched PRIME its new scheme that supports the development of medicines for an unmet medical need. https://t.co/oW9v9idpvK","source":"Hootsuite","author_id":"3331528055","lang":"en","id":"714830078358790144","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/oW9v9idpvK","expanded_url":"http://ow.ly/ZW3vd","display_url":"ow.ly/ZW3vd"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"714830078358790144","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-23T13:33:59.000Z","possibly_sensitive":false,"text":"@EMA_News Thought you'd be interested in the Deep Learning in Healthcare Summit London https://t.co/ks4xoq7T1c Hope you can join us!","source":"Twitter Web Client","author_id":"2307399522","lang":"en","id":"712633491758911488","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/ks4xoq7T1c","expanded_url":"https://www.re-work.co/events/deep-learning-health-london-2016","display_url":"re-work.co/events/deep-le…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":45,"end":85,"probability":0.5027,"type":"Other","normalized_text":"Deep Learning in Healthcare Summit London"}],"cashtags":{}},"conversation_id":"712633491758911488","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-21T18:45:25.000Z","possibly_sensitive":false,"text":"@EMA_News  review safety of directacting antivirals after reports of #HepatitisB reactivation: The European Medic... https://t.co/fkymTfq1sz","source":"Twitter for Android","author_id":"398080943","lang":"en","id":"711987090783756288","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/fkymTfq1sz","expanded_url":"http://bit.ly/1UySp9r","display_url":"bit.ly/1UySp9r"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":69,"end":80,"tag":"HepatitisB"}],"annotations":{},"cashtags":{}},"conversation_id":"711987090783756288","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-21T18:30:19.000Z","possibly_sensitive":false,"text":"@EMA_News elects new chair of management board  https://t.co/l8VGXqXG4G","source":"TweetDeck","author_id":"17960461","lang":"en","id":"711983293105774592","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":48,"end":71,"url":"https://t.co/l8VGXqXG4G","expanded_url":"http://www.pharmafile.com/appointment/503548/european-medicines-agency-elects-christa-wirthumer-hoche-new-chair-management-boa","display_url":"pharmafile.com/appointment/50…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"711983293105774592","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-21T08:39:20.000Z","possibly_sensitive":false,"text":"@EMA_News &amp; PR: Meeting highlights #PRAC #Pharmacovigilance Risk Assessment Committee 14-17 March 2016 more at: https://t.co/zw59ZPvcLf","source":"Twitter Web Client","author_id":"2615562036","lang":"en","id":"711834565233528833","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/zw59ZPvcLf","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/03/news_detail_002489.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":39,"end":44,"tag":"PRAC"},{"start":45,"end":63,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"conversation_id":"711834565233528833","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-18T17:31:31.000Z","possibly_sensitive":false,"text":"@EMA_News released a draft guidance for sponsors who are developing clinical trials for drugs that treat ASD. https://t.co/fhlQCh3xU2","source":"Hootsuite","author_id":"3331528055","lang":"en","id":"710881332008755200","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/fhlQCh3xU2","expanded_url":"http://ow.ly/ZmgsA","display_url":"ow.ly/ZmgsA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"710881332008755200","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-18T12:39:59.000Z","possibly_sensitive":false,"text":"Christa-Wirthumer-Hoche, Leiterin @agesnews-#Medizinmarktaufsicht, ist Vorsitzende des @EMA_News-Managment Boards https://t.co/4dpkQVPFIm","source":"Twitter Web Client","author_id":"2233494522","lang":"de","id":"710807964702130177","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/4dpkQVPFIm","expanded_url":"http://www.ots.at/presseaussendung/OTS_20160318_OTS0174/christa-wirthumer-hoche-zur-vorsitzenden-des-ema-management-board-gewaehlt-bild","display_url":"ots.at/presseaussendu…"}],"mentions":[{"start":34,"end":43,"username":"agesnews","id":"223456379"},{"start":87,"end":96,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":44,"end":65,"tag":"Medizinmarktaufsicht"}],"annotations":{},"cashtags":{}},"conversation_id":"710776792420884480","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"710776792420884480"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-17T16:56:21.000Z","possibly_sensitive":false,"text":"@EMA_News @federfarmaTweet pare la sorella gemella di #Trump !","source":"Twitter Web Client","author_id":"311074404","lang":"it","id":"710510093972979713","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":54,"end":60,"tag":"Trump"}],"annotations":{},"cashtags":{}},"conversation_id":"710478136866164736","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"710478136866164736"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-17T16:10:07.000Z","possibly_sensitive":false,"text":"@EMA_News CAT publishes minutes of Jan 2016 meeting and Feb 2016 monthly report. @CTCatapult #Regulatorynews https://t.co/gFSJX30uRB","source":"Hootsuite","author_id":"845904529","lang":"en","id":"710498459804176384","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/gFSJX30uRB","expanded_url":"http://ow.ly/ZCaIX","display_url":"ow.ly/ZCaIX"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":81,"end":92,"username":"CTCatapult","id":"940559888266219520"}],"hashtags":[{"start":93,"end":108,"tag":"Regulatorynews"}],"annotations":{},"cashtags":{}},"conversation_id":"710498459804176384","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-16T18:53:05.000Z","possibly_sensitive":false,"text":"@EMA_News issues new guidance on the publication of clinical data for medicinal products for human use. Read on: https://t.co/J9aIp5QUn1","source":"Twitter Web Client","author_id":"2968453613","lang":"en","id":"710177083755008000","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/J9aIp5QUn1","expanded_url":"http://bit.ly/1Xvdxvc","display_url":"bit.ly/1Xvdxvc"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"710177083755008000","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-16T14:05:47.000Z","possibly_sensitive":false,"text":"@EMA_News launches PRIME scheme to implement its early access regulatory toolkit. @CTCatapult #Regulatorynews https://t.co/tAdkL0zYJL","source":"Hootsuite","author_id":"845904529","lang":"en","id":"710104779247259648","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/tAdkL0zYJL","expanded_url":"http://ow.ly/Zxlkl","display_url":"ow.ly/Zxlkl"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":82,"end":93,"username":"CTCatapult","id":"940559888266219520"}],"hashtags":[{"start":94,"end":109,"tag":"Regulatorynews"}],"annotations":{},"cashtags":{}},"conversation_id":"710104779247259648","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-14T11:41:27.000Z","possibly_sensitive":false,"text":"@EMA_News will Entwicklung neuer Medikamente für bislang ungedeckten medizinischen Bedarf beschleunigen. https://t.co/x7v6li7dWi","source":"Twitter Web Client","author_id":"2473947624","lang":"de","id":"709343682206502912","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/x7v6li7dWi","expanded_url":"http://bit.ly/1RhCdCN","display_url":"bit.ly/1RhCdCN"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"709343682206502912","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-14T08:52:53.000Z","possibly_sensitive":false,"text":"@EMA_News  publica las bases para reforzar necesidades médicas no cubiertas\nhttps://t.co/5qz5Y6EelD https://t.co/p4QRz93lcX","source":"Twitter for Android","author_id":"1242516320","lang":"es","id":"709301261863141376","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/5qz5Y6EelD","expanded_url":"http://pharmaexpertise.com/ema-publica-las-bases-para-reforzar-necesidades-medicas-no-cubiertas/","display_url":"pharmaexpertise.com/ema-publica-la…"},{"start":100,"end":123,"url":"https://t.co/p4QRz93lcX","expanded_url":"https://twitter.com/PharmaExpertise/status/709301261863141376/photo/1","display_url":"pic.twitter.com/p4QRz93lcX"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"709301261863141376","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_709301252555939840"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-13T14:39:55.000Z","possibly_sensitive":false,"text":"@EMA_News On Antimicrobial Resistance, we are part of the solution: https://t.co/0tD0qTR93o Now in Spanish...later in other languages","source":"Twitter Web Client","author_id":"2801075776","lang":"en","id":"709026205731856384","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/0tD0qTR93o","expanded_url":"http://www.torrededavid.net","display_url":"torrededavid.net"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":13,"end":36,"probability":0.357,"type":"Other","normalized_text":"Antimicrobial Resistance"}],"cashtags":{}},"conversation_id":"709026205731856384","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-11T19:18:37.000Z","possibly_sensitive":false,"text":"@EMA_News to review #idelalisib following concerns over serious adverse events on ongoing #CLL #NHL clinical trials https://t.co/QfGOPxjtkz","source":"Hootsuite","author_id":"3187500729","lang":"en","id":"708371570587213825","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/QfGOPxjtkz","expanded_url":"http://bit.ly/1YH651f","display_url":"bit.ly/1YH651f"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":20,"end":31,"tag":"idelalisib"},{"start":90,"end":94,"tag":"CLL"},{"start":95,"end":99,"tag":"NHL"}],"annotations":{},"cashtags":{}},"conversation_id":"708371570587213825","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-11T11:40:27.000Z","possibly_sensitive":false,"text":"@EMA_News acelerará la aprobación de fármacos ‘prioritarios’ y para necesidades no cubiertas https://t.co/7qDY41XKdM","source":"Twitter Web Client","author_id":"785188812","lang":"es","id":"708256265491914753","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/7qDY41XKdM","expanded_url":"http://go.shr.lc/1YqIbad","display_url":"go.shr.lc/1YqIbad"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"708256265491914753","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-10T21:36:11.000Z","possibly_sensitive":false,"text":"@EMA_News initiative PRIME/PRIority MEdicines evaluate truly innovative drugs more swiftly than in the past #SharedLearning NHS @MedicineGov","source":"Twitter Web Client","author_id":"3311856665","lang":"en","id":"708043801726685184","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":128,"end":140,"username":"MedicineGov","id":"3311856665"}],"hashtags":[{"start":108,"end":123,"tag":"SharedLearning"}],"annotations":{},"cashtags":{}},"conversation_id":"708043801726685184","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-10T19:06:33.000Z","possibly_sensitive":false,"text":"@EMA_News recomienda #acalabrutinib (@AstraZenecaES) como #medicamentohuerfano en tres tipos de tumores raros https://t.co/VrCi0d89No @_SEOM","source":"Twitter Web Client","author_id":"576302294","lang":"es","id":"708006143784853504","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/VrCi0d89No","expanded_url":"http://www.lavanguardia.com/vida/20160303/40170538433/la-ema-recomienda-acalabrutinib-astrazeneca-como-medicamento-huerfano-en-tres-tipos-de-tumores-raros.html","display_url":"lavanguardia.com/vida/20160303/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":37,"end":51,"username":"AstraZenecaES","id":"2543778775"},{"start":134,"end":140,"username":"_SEOM","id":"555051765"}],"hashtags":[{"start":21,"end":35,"tag":"acalabrutinib"},{"start":58,"end":78,"tag":"medicamentohuerfano"}],"annotations":{},"cashtags":{}},"conversation_id":"708006143784853504","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-09T18:28:01.000Z","possibly_sensitive":false,"text":"@EMA_News Launches new PRIority Medicines scheme - PRIME @EACPT @BritPharmSoc @cpontesg @colemajj @garongen https://t.co/c0UCB5H5QQ","source":"TweetDeck","author_id":"27751277","lang":"en","id":"707634060882006017","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/c0UCB5H5QQ","expanded_url":"http://eacpt.blogspot.co.uk/2016/03/the-ema-launches-new-priority-medicines.html","display_url":"eacpt.blogspot.co.uk/2016/03/the-em…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":57,"end":63,"username":"EACPT","id":"234897146"},{"start":64,"end":77,"username":"BritPharmSoc","id":"33481728"},{"start":78,"end":87,"username":"cpontesg","id":"1422394500"},{"start":88,"end":97,"username":"colemajj","id":"343586203"},{"start":98,"end":107,"username":"garongen","id":"2824801005"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"707634060882006017","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-09T10:16:44.000Z","possibly_sensitive":false,"text":"@EMA_News launches new programme to fast track #meds that target unmet needs - https://t.co/1eG4N58PDN #regulatory #therapies #pharma","source":"Hootsuite","author_id":"713848298","lang":"en","id":"707510421360668672","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/1eG4N58PDN","expanded_url":"http://bit.ly/1R6YOZ1","display_url":"bit.ly/1R6YOZ1"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":47,"end":52,"tag":"meds"},{"start":103,"end":114,"tag":"regulatory"},{"start":115,"end":125,"tag":"therapies"},{"start":126,"end":133,"tag":"pharma"}],"annotations":{},"cashtags":{}},"conversation_id":"707510421360668672","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-08T23:13:30.000Z","possibly_sensitive":false,"text":"@EMA_News Esperamos que sea así y no haya problemas con tanta rapidez!!","source":"Twitter for iPad","author_id":"261573281","lang":"es","id":"707343514317803520","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"706799597126066176","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"706799597126066176"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-08T10:05:46.000Z","possibly_sensitive":false,"text":"@EMA_News Human Scientific Committees'Working PcWp &amp; HCPWP joint meeting. https://t.co/dgmJzlk2i0","source":"Twitter for Android","author_id":"2927229797","lang":"en","id":"707145275765297152","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/dgmJzlk2i0","expanded_url":"https://twitter.com/pain_europe/status/707145275765297152/photo/1","display_url":"pic.twitter.com/dgmJzlk2i0"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"707145275765297152","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_707145266919563264"]},"geo":{"place_id":"08be9e4ebe3d037d","coordinates":{"type":"Point","coordinates":[-0.0161,51.5049]}}},{"created_at":"2016-03-08T07:37:48.000Z","possibly_sensitive":false,"text":"@EMA_News launches PRIME '...a godsend for those suffering from diseases ...such as rare cancers...' https://t.co/909Sc5oSts @V_Andriukaitis","source":"Twitter Web Client","author_id":"2301430153","lang":"en","id":"707108039522983936","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/909Sc5oSts","expanded_url":"http://bit.ly/1pv5vb6","display_url":"bit.ly/1pv5vb6"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":125,"end":140,"username":"V_Andriukaitis","id":"575269517"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"707108039522983936","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-07T12:30:19.000Z","possibly_sensitive":false,"text":"@EMA_News launches PRIME scheme for priority medicines https://t.co/bgUHIEV9p6","source":"TweetDeck","author_id":"367637736","lang":"en","id":"706819265274503168","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":55,"end":78,"url":"https://t.co/bgUHIEV9p6","expanded_url":"http://www.paneuropeannetworks.com/?p=51531","display_url":"paneuropeannetworks.com/?p=51531"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"706819265274503168","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-05T13:50:23.000Z","possibly_sensitive":false,"text":"@EMA_News (RIGHT to BREATH) SDG 13&amp;11 Stop polluting cities/Wasting fuel by cars,GPS electric capsule is solution https://t.co/uXHHoXkaPp","source":"Twitter Web Client","author_id":"127923382","lang":"en","id":"706114638908301312","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":118,"end":141,"url":"https://t.co/uXHHoXkaPp","expanded_url":"https://www.facebook.com/Global-Goal-No13-A-solution-for-City-Pollution-The-Smart-City-147941658897870/","display_url":"facebook.com/Global-Goal-No…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"706114638908301312","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"166f960e289d031f","coordinates":{"coordinates":{}}}},{"created_at":"2016-03-04T17:34:19.000Z","possibly_sensitive":false,"text":"@EMA_News Recommends Extending Indications for #Afatinib | via @myESMO https://t.co/WisuyXuTfQ","source":"Twitter Web Client","author_id":"2339138737","lang":"en","id":"705808606369865728","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":71,"end":94,"url":"https://t.co/WisuyXuTfQ","expanded_url":"http://www.esmo.org/Oncology-News/EMA-Recommends-Extending-Indications-for-Afatinib#.VtnHAsoI1tc.twitter","display_url":"esmo.org/Oncology-News/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":63,"end":70,"username":"myESMO","id":"69232855"}],"hashtags":[{"start":47,"end":56,"tag":"Afatinib"}],"annotations":{},"cashtags":{}},"conversation_id":"705808606369865728","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-04T17:30:56.000Z","possibly_sensitive":false,"text":"@EMA_News Recommends Extending the Use of #Nivolumab | via @myESMO https://t.co/46Vz1w9u5D","source":"Twitter Web Client","author_id":"2339138737","lang":"en","id":"705807753974046720","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/46Vz1w9u5D","expanded_url":"http://www.esmo.org/Oncology-News/EMA-Recommends-Extending-the-Use-of-Nivolumab#.VtnFqIBEmbw.twitter","display_url":"esmo.org/Oncology-News/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":59,"end":66,"username":"myESMO","id":"69232855"}],"hashtags":[{"start":42,"end":52,"tag":"Nivolumab"}],"annotations":{},"cashtags":{}},"conversation_id":"705807753974046720","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"83f0fc2ea694eaa7","coordinates":{"coordinates":{}}}},{"created_at":"2016-03-03T15:02:38.000Z","possibly_sensitive":false,"text":"@EMA_News established a task force of EU experts to contribute to the global response to the Zika virus infection. https://t.co/d01j8PEApo","source":"Hootsuite","author_id":"3331528055","lang":"en","id":"705408044100939777","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/d01j8PEApo","expanded_url":"http://ow.ly/YZc7v","display_url":"ow.ly/YZc7v"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":38,"end":39,"probability":0.5686,"type":"Organization","normalized_text":"EU"},{"start":93,"end":96,"probability":0.5152,"type":"Place","normalized_text":"Zika"}],"cashtags":{}},"conversation_id":"705408044100939777","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-03T10:46:02.000Z","possibly_sensitive":false,"text":"@EMA_News clinical data publication policy guidance has just been published https://t.co/PbuGKfsfwq  #AllTrials","source":"Twitter Web Client","author_id":"1106659014","lang":"en","id":"705343468462329856","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/PbuGKfsfwq","expanded_url":"http://bit.ly/1p10lUf","display_url":"bit.ly/1p10lUf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":101,"end":111,"tag":"AllTrials"}],"annotations":{},"cashtags":{}},"conversation_id":"705343468462329856","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-02T15:07:53.000Z","possibly_sensitive":false,"text":"@EMA_News recommends granting a marketing authorisation for trifluridine/tipiracil https://t.co/Vw6abHu0be #ColorectalCancer #CRCSM","source":"Hootsuite","author_id":"69232855","lang":"en","id":"705046979995418624","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/Vw6abHu0be","expanded_url":"http://ow.ly/YYUnf","display_url":"ow.ly/YYUnf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":107,"end":124,"tag":"ColorectalCancer"},{"start":125,"end":131,"tag":"CRCSM"}],"annotations":{},"cashtags":{}},"conversation_id":"705046979995418624","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-02T09:57:10.000Z","possibly_sensitive":false,"text":"@EMA_News Improving patient safety through more proactive risk management #PtSafety https://t.co/ak1A4YN00J","source":"Twitter Web Client","author_id":"1249936730","lang":"en","id":"704968784604499969","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/ak1A4YN00J","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/02/news_detail_002479.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":74,"end":83,"tag":"PtSafety"}],"annotations":{},"cashtags":{}},"conversation_id":"704968784604499969","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-01T16:15:47.000Z","possibly_sensitive":false,"text":"@EMA_News confirms recommendations to minimise #risk of #brain #infection PML with Tysabri https://t.co/RPI04NYFUM","source":"Hootsuite","author_id":"454857501","lang":"en","id":"704701676842782720","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/RPI04NYFUM","expanded_url":"http://ow.ly/YSUTU","display_url":"ow.ly/YSUTU"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":47,"end":52,"tag":"risk"},{"start":56,"end":62,"tag":"brain"},{"start":63,"end":73,"tag":"infection"}],"annotations":{},"cashtags":{}},"conversation_id":"704701676842782720","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-01T14:32:46.000Z","possibly_sensitive":false,"text":"@EMA_News public consultation launched on improving #patientsafety through more proactive risk management https://t.co/Fc2W04N4Id","source":"Twitter Web Client","author_id":"216314816","lang":"en","id":"704675753045135361","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/Fc2W04N4Id","expanded_url":"http://goo.gl/SSk8cO","display_url":"goo.gl/SSk8cO"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":52,"end":66,"tag":"patientsafety"}],"annotations":{},"cashtags":{}},"conversation_id":"704675753045135361","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-03-01T11:02:13.000Z","possibly_sensitive":false,"text":"@EMA_News recommends extending indications for #idelalisib https://t.co/4cQy6PDpkz chronic lymphocytic #leukaemia #CLL","source":"Hootsuite","author_id":"69232855","lang":"en","id":"704622766394368000","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/4cQy6PDpkz","expanded_url":"http://ow.ly/YVkUS","display_url":"ow.ly/YVkUS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":47,"end":58,"tag":"idelalisib"},{"start":103,"end":113,"tag":"leukaemia"},{"start":114,"end":118,"tag":"CLL"}],"annotations":{},"cashtags":{}},"conversation_id":"704622766394368000","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-29T17:23:27.000Z","possibly_sensitive":false,"text":"@EMA_News Pls stop abuse of animals. Restrict research to human patients. \nKeep up civilisation anno 2016.","source":"Twitter Web Client","author_id":"1452235320","lang":"en","id":"704356320535777280","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"704355404243996672","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"704355404243996672"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-29T10:26:08.000Z","possibly_sensitive":false,"text":"@EMA_News recommends extending indications for #afatinib https://t.co/oqWPEstx8w #NSCLC #LCSM","source":"Hootsuite","author_id":"69232855","lang":"en","id":"704251299999703040","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/oqWPEstx8w","expanded_url":"http://ow.ly/YS1F7","display_url":"ow.ly/YS1F7"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":47,"end":56,"tag":"afatinib"},{"start":81,"end":87,"tag":"NSCLC"},{"start":88,"end":93,"tag":"LCSM"}],"annotations":{},"cashtags":{}},"conversation_id":"704251299999703040","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-29T08:35:28.000Z","possibly_sensitive":false,"text":"@EMA_News Pls RT #RareDiseaseDay2016 #Duchenne #NoTreatment #NoCure #NoWords #NoTime Our children are dying today https://t.co/9QEC2zaDMI","source":"Twitter for Android","author_id":"1238677848","lang":"en","id":"704223448650924032","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/9QEC2zaDMI","expanded_url":"https://twitter.com/joinourboys/status/704223448650924032/photo/1","display_url":"pic.twitter.com/9QEC2zaDMI"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":17,"end":36,"tag":"RareDiseaseDay2016"},{"start":37,"end":46,"tag":"Duchenne"},{"start":47,"end":59,"tag":"NoTreatment"},{"start":60,"end":67,"tag":"NoCure"},{"start":68,"end":76,"tag":"NoWords"},{"start":77,"end":84,"tag":"NoTime"}],"annotations":{},"cashtags":{}},"conversation_id":"704223448650924032","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_704223438395850752"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-26T17:00:59.000Z","possibly_sensitive":false,"text":"@EMA_News recommends extending use of #nivolumab for treatment of renal cell carcinoma and non-squamous #NSCLC https://t.co/M2HYgXMMLl","source":"Hootsuite","author_id":"69232855","lang":"en","id":"703263502551674880","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/M2HYgXMMLl","expanded_url":"http://ow.ly/YNvDQ","display_url":"ow.ly/YNvDQ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":38,"end":48,"tag":"nivolumab"},{"start":104,"end":110,"tag":"NSCLC"}],"annotations":{},"cashtags":{}},"conversation_id":"703263502551674880","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-26T16:58:18.000Z","possibly_sensitive":false,"text":"@EMA_News","source":"Twitter for iPhone","author_id":"4902261923","lang":"und","id":"703262824898895872","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"703197941251477504","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"703197941251477504"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-25T15:03:40.000Z","possibly_sensitive":false,"text":"@EMA_News and @EU_Commission introduced two safety features to help protect patients from falsified medicines. https://t.co/zRCYxl0iEJ","source":"Hootsuite","author_id":"3331528055","lang":"en","id":"702871589788983296","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/zRCYxl0iEJ","expanded_url":"http://ow.ly/Yxd3H","display_url":"ow.ly/Yxd3H"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":28,"username":"EU_Commission","id":"157981564"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"702871589788983296","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-25T14:49:03.000Z","possibly_sensitive":false,"text":"@EMA_News What will happen to you if the UK leaves the EU?","source":"Twitter Web Client","author_id":"403470749","lang":"en","id":"702867911547953153","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":41,"end":42,"probability":0.8914,"type":"Place","normalized_text":"UK"},{"start":55,"end":56,"probability":0.3508,"type":"Organization","normalized_text":"EU"}],"cashtags":{}},"conversation_id":"702867911547953153","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-22T23:02:36.000Z","possibly_sensitive":false,"text":"@EMA_News -  523 000 persons in the world could have been poisoned to death due to Propoxyphene during 1985–2011 https://t.co/qilQR3hmOO","source":"Twitter Web Client","author_id":"4158149141","lang":"en","id":"701904953099624450","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/qilQR3hmOO","expanded_url":"http://bit.ly/1PAAMUg","display_url":"bit.ly/1PAAMUg"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":83,"end":94,"probability":0.4142,"type":"Place","normalized_text":"Propoxyphene"}],"cashtags":{}},"conversation_id":"701904953099624450","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-22T23:02:07.000Z","possibly_sensitive":false,"text":"@EMA_News - People who are addicted to opioid painkillers are 40 x more likely to be addicted to heroin\" https://t.co/XQPJVPZg33","source":"Twitter Web Client","author_id":"4158149141","lang":"en","id":"701904832081346567","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/XQPJVPZg33","expanded_url":"http://bit.ly/1PJ0ZhD","display_url":"bit.ly/1PJ0ZhD"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"701904832081346567","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-22T23:01:48.000Z","possibly_sensitive":false,"text":"@EMA_News -  We got some good attention to our research on DextroPropoxyphene (Darvon &amp; Darvocet) https://t.co/TVrsBhcWz0","source":"Twitter Web Client","author_id":"4158149141","lang":"en","id":"701904754578997249","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/TVrsBhcWz0","expanded_url":"http://bit.ly/1RWoYwo","display_url":"bit.ly/1RWoYwo","status":200,"unwound_url":"http://jonassonulf.blogspot.com/2016/02/we-got-some-good-attention-to-our.html"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":59,"end":76,"probability":0.2845,"type":"Organization","normalized_text":"DextroPropoxyphene"}],"cashtags":{}},"conversation_id":"701904754578997249","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-22T23:01:23.000Z","possibly_sensitive":false,"text":"@EMA_News - The heroin epidemic in US started with Propoxyophene (Darvon &amp; Darvocet) many years ago https://t.co/PqMARrUUDO","source":"Twitter Web Client","author_id":"4158149141","lang":"en","id":"701904649411031040","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/PqMARrUUDO","expanded_url":"http://bit.ly/1Tsj72V","display_url":"bit.ly/1Tsj72V"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":35,"end":36,"probability":0.916,"type":"Place","normalized_text":"US"},{"start":51,"end":63,"probability":0.5674,"type":"Person","normalized_text":"Propoxyophene"}],"cashtags":{}},"conversation_id":"701904649411031040","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-22T14:10:58.000Z","possibly_sensitive":false,"text":"@EMA_News  https://t.co/muQYe0yVcH","source":"Twitter for iPad","author_id":"606325697","lang":"und","id":"701771163391934464","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":11,"end":34,"url":"https://t.co/muQYe0yVcH","expanded_url":"https://twitter.com/who_europe_rhn/status/701769786783637504","display_url":"twitter.com/who_europe_rhn…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"701771163391934464","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"701769786783637504"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-20T00:11:49.000Z","possibly_sensitive":false,"text":"@EMA_News https://t.co/XrH05IcDdm","source":"Twitter for iPad","author_id":"39797707","lang":"und","id":"700835211316219904","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/XrH05IcDdm","expanded_url":"https://twitter.com/joanne4142/status/700129694927216640","display_url":"twitter.com/joanne4142/sta…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"700835211316219904","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"700129694927216640"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-19T13:03:18.000Z","possibly_sensitive":false,"text":"@EMA_News sets up #Zika task force to speed vaccine work https://t.co/znrJXYDbRU","source":"Hootsuite","author_id":"164226447","lang":"en","id":"700666972795756544","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/znrJXYDbRU","expanded_url":"http://ow.ly/Ycyjq","display_url":"ow.ly/Ycyjq"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":18,"end":23,"tag":"Zika"}],"annotations":{},"cashtags":{}},"conversation_id":"700666972795756544","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-17T23:10:11.000Z","possibly_sensitive":false,"text":"@EMA_News issues new guidance for Alzheimer’s treatments. Our EU Regulatory team shares the details: https://t.co/v2voPyyXa3","source":"Twitter Web Client","author_id":"2968453613","lang":"en","id":"700094921244569600","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/v2voPyyXa3","expanded_url":"http://bit.ly/1OgwfjG","display_url":"bit.ly/1OgwfjG"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":34,"end":42,"probability":0.3097,"type":"Other","normalized_text":"Alzheimer"},{"start":62,"end":74,"probability":0.7879,"type":"Organization","normalized_text":"EU Regulatory"}],"cashtags":{}},"conversation_id":"700094921244569600","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-17T19:22:42.000Z","possibly_sensitive":false,"text":"@EMA_News ha emitido una opinión positiva sobre el uso de elotuzumab para el tratamiento del mieloma múltiple.  https://t.co/XloUOqyoKP","source":"Twitter for iPhone","author_id":"1697360292","lang":"es","id":"700037675995238400","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/XloUOqyoKP","expanded_url":"http://www.redaccionmedica.com/secciones/industria/la-ema-da-el-visto-bueno-a-elotuzumab-en-mieloma-multiple-94114","display_url":"redaccionmedica.com/secciones/indu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"700037675995238400","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-16T15:15:51.000Z","possibly_sensitive":false,"text":"@EMA_News #Resources #videos #workshops for healthcare professionals interested in learning about #EMA  https://t.co/qZ3uXL1cvZ","source":"Twitter Web Client","author_id":"59722141","lang":"en","id":"699613166632837120","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/qZ3uXL1cvZ","expanded_url":"https://twitter.com/EMA_News/status/699598906846486528","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":20,"tag":"Resources"},{"start":21,"end":28,"tag":"videos"},{"start":29,"end":39,"tag":"workshops"},{"start":98,"end":102,"tag":"EMA"}],"annotations":{},"cashtags":{}},"conversation_id":"699613166632837120","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"699598906846486528"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-16T15:05:23.000Z","possibly_sensitive":false,"text":"@EMA_News New webpages with #training for #patients - check out #EMABasics\n https://t.co/pIAEcvTp4T","source":"Twitter Web Client","author_id":"59722141","lang":"en","id":"699610532932939776","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/pIAEcvTp4T","expanded_url":"https://twitter.com/EMA_News/status/699598812952797184","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":28,"end":37,"tag":"training"},{"start":42,"end":51,"tag":"patients"},{"start":64,"end":74,"tag":"EMABasics"}],"annotations":{},"cashtags":{}},"conversation_id":"699610532932939776","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"699598812952797184"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-16T10:19:47.000Z","possibly_sensitive":false,"text":"@EMA_News COMP #patient representatives article on importance of early access - free download to read patient views https://t.co/CQy011GTjn","source":"Twitter Web Client","author_id":"59722141","lang":"en","id":"699538659679301632","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/CQy011GTjn","expanded_url":"https://twitter.com/TOPRANEWS/status/689774323398262784","display_url":"twitter.com/TOPRANEWS/stat…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":15,"end":23,"tag":"patient"}],"annotations":{},"cashtags":{}},"conversation_id":"699538659679301632","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"689774323398262784"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-15T12:07:12.000Z","possibly_sensitive":false,"text":"@EMA_News &amp;PR: Meeting highlights from #Pharmacovigilance Risk Assessment Committee PRAC 8-11 February 2016 at\nhttps://t.co/Mg5T2SJiST","source":"Twitter Web Client","author_id":"2615562036","lang":"en","id":"699203303406698497","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/Mg5T2SJiST","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/02/news_detail_002468.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":43,"end":61,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"conversation_id":"699203303406698497","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-14T16:20:42.000Z","possibly_sensitive":false,"text":"@EMA_News Please help children's mental health statistics for children overdosing https://t.co/caaJ8U3Jv0","source":"Twitter for iPhone","author_id":"361108851","lang":"en","id":"698904709835452416","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/caaJ8U3Jv0","expanded_url":"https://www.change.org/p/government-stop-children-buying-paracetamol-pain-relief?recruiter=192056486&utm_source=share_petition&utm_medium=copylinkk","display_url":"change.org/p/government-s…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"698904709835452416","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-12T20:08:14.000Z","possibly_sensitive":false,"text":"@EMA_News truly disappointing: 'stakeholder perspectives' on immune therapies- without a single patient?!!  https://t.co/GOVtMdqDhr","source":"Twitter Web Client","author_id":"810969654","lang":"en","id":"698237196336238592","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/GOVtMdqDhr","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/02/news_detail_002464.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"698237196336238592","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-12T19:59:13.000Z","possibly_sensitive":false,"text":"@EMA_News do we have a similar glossary for the EMA?","source":"Twitter Web Client","author_id":"810969654","lang":"en","id":"698234923556216832","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"698234923556216832","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-11T19:34:55.000Z","possibly_sensitive":false,"text":"@EMA_News estableció grupo de expertos europeos para contribuir a la respuesta mundial por infección virus #Zika https://t.co/2bI656e0j2","source":"Twitter Web Client","author_id":"2814885000","lang":"es","id":"697866422421188609","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/2bI656e0j2","expanded_url":"http://bit.ly/1TeDKzr","display_url":"bit.ly/1TeDKzr"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":107,"end":112,"tag":"Zika"}],"annotations":{},"cashtags":{}},"conversation_id":"697866422421188609","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-11T15:00:17.000Z","possibly_sensitive":false,"text":"@EMA_News Measures to help protect patients from falsified medicines\nhttps://t.co/UCnVyDSyrW","source":"Twitter Web Client","author_id":"2266321460","lang":"en","id":"697797307274784773","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":69,"end":92,"url":"https://t.co/UCnVyDSyrW","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/02/news_detail_002467.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"697797307274784773","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-09T15:58:57.000Z","possibly_sensitive":false,"text":"@EMA_News \"Safety features for medicines\" ! Against adverse side effects? \nBetter start phasing out animal testing.","source":"Twitter Web Client","author_id":"1452235320","lang":"en","id":"697087297267884032","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"697080164258283520","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"697080164258283520"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-06T09:48:37.000Z","possibly_sensitive":false,"text":"@EMA_News sieht keine Gefährdung durch #Xarelto @bayer - Forscher haben Zweifel @bmj_latest via @DAZheute  https://t.co/VAz2wBv6D2","source":"Twitter for iPhone","author_id":"15460376","lang":"de","id":"695906934231322624","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/VAz2wBv6D2","expanded_url":"https://www.deutsche-apotheker-zeitung.de/news/artikel/2016/02/05/ema-sieht-keine-gefahrdung-durch-rivaroxaban","display_url":"deutsche-apotheker-zeitung.de/news/artikel/2…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":48,"end":54,"username":"Bayer","id":"137319302"},{"start":80,"end":91,"username":"bmj_latest","id":"16949344"},{"start":96,"end":105,"username":"DAZheute","id":"2789645880"}],"hashtags":[{"start":39,"end":47,"tag":"Xarelto"}],"annotations":{},"cashtags":{}},"conversation_id":"695906934231322624","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-05T22:58:38.000Z","possibly_sensitive":false,"text":"@EMA_News concludes defective device in ROCKET study does not impact Xarelto's safety https://t.co/2W5FbLssiP @deb_cohen @felly500","source":"Twitter for Android","author_id":"28824136","lang":"en","id":"695743362675163137","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/2W5FbLssiP","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/02/news_detail_002465.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":110,"end":120,"username":"deb_cohen","id":"227382347"},{"start":121,"end":130,"username":"felly500","id":"250349129"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"695743362675163137","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-04T12:49:54.000Z","possibly_sensitive":false,"text":"@EMA_News @cddf_eu meeting on #challenges for the #approval of #anticancer #immunotherapeutic #drugs NOW in London https://t.co/GN0PRHwplj","source":"Twitter Web Client","author_id":"3190203975","lang":"en","id":"695227781655953409","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/GN0PRHwplj","expanded_url":"https://twitter.com/cddf_eu/status/695227781655953409/photo/1","display_url":"pic.twitter.com/GN0PRHwplj"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"cddf_eu","id":"3190203975"}],"hashtags":[{"start":30,"end":41,"tag":"challenges"},{"start":50,"end":59,"tag":"approval"},{"start":63,"end":74,"tag":"anticancer"},{"start":75,"end":93,"tag":"immunotherapeutic"},{"start":94,"end":100,"tag":"drugs"}],"annotations":[{"start":108,"end":113,"probability":0.9956,"type":"Place","normalized_text":"London"}],"cashtags":{}},"conversation_id":"695227781655953409","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_695227779944677376"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-01T10:56:32.000Z","possibly_sensitive":false,"text":"@EMA_News recommends granting a marketing authorisation for #elotuzumab   https://t.co/YuTQeKWx36 #multiple #myeloma","source":"Hootsuite","author_id":"69232855","lang":"en","id":"694112087350591489","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":74,"end":97,"url":"https://t.co/YuTQeKWx36","expanded_url":"http://ow.ly/XMQ8o","display_url":"ow.ly/XMQ8o"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":60,"end":71,"tag":"elotuzumab"},{"start":98,"end":107,"tag":"multiple"},{"start":108,"end":116,"tag":"myeloma"}],"annotations":{},"cashtags":{}},"conversation_id":"694112087350591489","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-02-01T10:15:46.000Z","possibly_sensitive":false,"text":"@EMA_News You've been quoted in my #Storify \"15th EGA Regulatory and Scientific Affaris Conference \" https://t.co/gr0gusJfA5 #EGAreg16","source":"Storify","author_id":"2315763655","lang":"en","id":"694101827290304513","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/gr0gusJfA5","expanded_url":"http://sfy.co/y1ne","display_url":"sfy.co/y1ne"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":35,"end":43,"tag":"Storify"},{"start":125,"end":134,"tag":"EGAreg16"}],"annotations":[{"start":45,"end":97,"probability":0.3019,"type":"Other","normalized_text":"15th EGA Regulatory and Scientific Affaris Conference"}],"cashtags":{}},"conversation_id":"694101827290304513","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-29T16:45:35.000Z","possibly_sensitive":false,"text":"@EMA_News adopts a positive opinion: Empliciti should be approved for in combination treatment with Rev/dex for MM https://t.co/MpRQ3sdile","source":"Twitter Web Client","author_id":"34340707","lang":"en","id":"693112767331446784","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/MpRQ3sdile","expanded_url":"http://bit.ly/1SOay26","display_url":"bit.ly/1SOay26"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":37,"end":45,"probability":0.4294,"type":"Person","normalized_text":"Empliciti"},{"start":100,"end":102,"probability":0.64,"type":"Person","normalized_text":"Rev"}],"cashtags":{}},"conversation_id":"693112767331446784","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-28T14:31:09.000Z","possibly_sensitive":false,"text":"@EMA_News It’s hard to store all my positive feelings for you. #TheNiceBot","source":"TheNiceBot","author_id":"3433099685","lang":"en","id":"692716546024673280","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":63,"end":74,"tag":"TheNiceBot"}],"annotations":{},"cashtags":{}},"conversation_id":"692716546024673280","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-28T06:46:15.000Z","possibly_sensitive":false,"text":"@EMA_News #cancer drug approval recommendations in 2015 | #pharma\nhttps://t.co/Ms9zscl5mq https://t.co/1fRueWGEiE","source":"Twitter for iPad","author_id":"633978297","lang":"en","id":"692599549186170880","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":66,"end":89,"url":"https://t.co/Ms9zscl5mq","expanded_url":"http://sms-oncology.com/blog/ema-anticancer-drug-approval-recommendations-in-2015/","display_url":"sms-oncology.com/blog/ema-antic…"},{"start":90,"end":113,"url":"https://t.co/1fRueWGEiE","expanded_url":"https://twitter.com/jagasquet/status/692599549186170880/photo/1","display_url":"pic.twitter.com/1fRueWGEiE"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":17,"tag":"cancer"},{"start":58,"end":65,"tag":"pharma"}],"annotations":{},"cashtags":{}},"conversation_id":"692599549186170880","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_692599541669961728"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-27T16:49:08.000Z","possibly_sensitive":false,"text":"@EMA_News @drreddys You've been quoted in my #Storify story \"9th EGA Pharmacovigilance Conference\" https://t.co/rK7YQItpDp #EGAphv16","source":"Storify","author_id":"2315763655","lang":"en","id":"692388884794183680","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/rK7YQItpDp","expanded_url":"http://sfy.co/a0thf","display_url":"sfy.co/a0thf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"drreddys","id":"104215142"}],"hashtags":[{"start":45,"end":53,"tag":"Storify"},{"start":123,"end":132,"tag":"EGAphv16"}],"annotations":[{"start":61,"end":96,"probability":0.4184,"type":"Other","normalized_text":"9th EGA Pharmacovigilance Conference"}],"cashtags":{}},"conversation_id":"692388884794183680","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-27T16:22:20.000Z","possibly_sensitive":false,"text":"@EMA_News connecting to the #ICCD2016 event @Europarl_EN https://t.co/nXs65QOnlH https://t.co/aXnxTpJLNK","source":"Twitter for Android","author_id":"378478769","lang":"en","id":"692382140277850112","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/nXs65QOnlH","expanded_url":"http://www.siope.eu/?p=1589","display_url":"siope.eu/?p=1589"},{"start":81,"end":104,"url":"https://t.co/aXnxTpJLNK","expanded_url":"https://twitter.com/SIOPEurope/status/692382140277850112/photo/1","display_url":"pic.twitter.com/aXnxTpJLNK"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":44,"end":56,"username":"Europarl_EN","id":"36329597"}],"hashtags":[{"start":28,"end":37,"tag":"ICCD2016"}],"annotations":{},"cashtags":{}},"conversation_id":"692382140277850112","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_692382130899390465"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-27T11:14:21.000Z","possibly_sensitive":false,"text":"@EMA_News ha autorizado 19 biosimilares de 9 sustancias activas y 11 compañías https://t.co/KiH7dfH8BY","source":"TweetDeck","author_id":"152983899","lang":"es","id":"692304633855885312","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/KiH7dfH8BY","expanded_url":"http://pmfarma.es/noticias/22175-ema-ha-autorizado-19-biosimilares-de-9-sustancias-activas-y-11-companias.html?utm_source=twitter&utm_medium=manual","display_url":"pmfarma.es/noticias/22175…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"692304633855885312","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-26T13:35:42.000Z","possibly_sensitive":false,"text":"@EMA_News adaptive pathways represent a solid way to collect real data #access2med","source":"Twitter Web Client","author_id":"784869524","lang":"en","id":"691977817333108736","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":71,"end":82,"tag":"access2med"}],"annotations":{},"cashtags":{}},"conversation_id":"691977817333108736","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-21T19:18:33.000Z","possibly_sensitive":false,"text":"@EMA_News Committee for Advanced Therapies (CAT)\nhttps://t.co/lcbeFKMKhr","source":"Twitter Web Client","author_id":"2266321460","lang":"en","id":"690252158843949057","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":49,"end":72,"url":"https://t.co/lcbeFKMKhr","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2016/01/WC500200040.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"690252158843949057","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-21T16:02:37.000Z","possibly_sensitive":false,"text":"@EMA_News Approves 93 New #Drugs in 2015\nhttps://t.co/oAAD9MZhEJ https://t.co/kF6K4qkdPu","source":"Twitter Web Client","author_id":"23111717","lang":"en","id":"690202849792430081","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":41,"end":64,"url":"https://t.co/oAAD9MZhEJ","expanded_url":"http://www.pharmpro.com/news/2016/01/ema-approves-93-new-drugs-2015","display_url":"pharmpro.com/news/2016/01/e…"},{"start":65,"end":88,"url":"https://t.co/kF6K4qkdPu","expanded_url":"https://twitter.com/PharmProEditor/status/690202849792430081/photo/1","display_url":"pic.twitter.com/kF6K4qkdPu"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":26,"end":32,"tag":"Drugs"}],"annotations":{},"cashtags":{}},"conversation_id":"690202849792430081","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_690202849356201984"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-21T10:24:12.000Z","possibly_sensitive":false,"text":"@EMA_News @shireplc for non-English languages SPC links from #Cinryze page go to Nimvastid SPCs instead https://t.co/aGqPBLGlij - fix please","source":"Hootsuite","author_id":"2902360799","lang":"en","id":"690117684315447297","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/aGqPBLGlij","expanded_url":"http://ow.ly/XlT3E","display_url":"ow.ly/XlT3E"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":61,"end":69,"tag":"Cinryze"}],"annotations":[{"start":81,"end":94,"probability":0.4634,"type":"Person","normalized_text":"Nimvastid SPCs"}],"cashtags":{}},"conversation_id":"690117684315447297","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-21T07:20:47.000Z","possibly_sensitive":false,"text":"@EMA_News thanks for the reply. much appreciated!","source":"Twitter Web Client","author_id":"2539867801","lang":"en","id":"690071526050258944","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"689740857898090496","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"689843705310744576"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-20T09:26:49.000Z","possibly_sensitive":false,"text":"@EMA_News It has been more than a week that the trial with Bial drug was halted. Why is there no official statement from EMA?","source":"Twitter Web Client","author_id":"2539867801","lang":"en","id":"689740857898090496","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":59,"end":62,"probability":0.8388,"type":"Person","normalized_text":"Bial"}],"cashtags":{}},"conversation_id":"689740857898090496","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-19T19:31:55.000Z","possibly_sensitive":false,"text":"@EMA_News  and HMA  adopt a single strategy for the European medicines regulatory network. https://t.co/Um7dkr77Ii","source":"Hootsuite","author_id":"3331528055","lang":"en","id":"689530745522634753","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/Um7dkr77Ii","expanded_url":"http://ow.ly/X6H6F","display_url":"ow.ly/X6H6F"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":15,"end":17,"probability":0.5361,"type":"Organization","normalized_text":"HMA"}],"cashtags":{}},"conversation_id":"689530745522634753","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-18T15:10:42.000Z","possibly_sensitive":false,"text":"@EMA_News medirá el impacto de la #farmacovigilancia https://t.co/SXk9rPO576 vía @redaccionmedica https://t.co/ccHrYNzcvT","source":"Hootsuite","author_id":"600871466","lang":"es","id":"689102623211937792","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":53,"end":76,"url":"https://t.co/SXk9rPO576","expanded_url":"http://go.shr.lc/1SrMXUN","display_url":"go.shr.lc/1SrMXUN"},{"start":98,"end":121,"url":"https://t.co/ccHrYNzcvT","expanded_url":"https://twitter.com/coftenerife/status/689102623211937792/photo/1","display_url":"pic.twitter.com/ccHrYNzcvT"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":81,"end":97,"username":"redaccionmedica","id":"229001251"}],"hashtags":[{"start":34,"end":52,"tag":"farmacovigilancia"}],"annotations":{},"cashtags":{}},"conversation_id":"689102623211937792","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_689102622264029184"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-18T14:40:39.000Z","possibly_sensitive":false,"text":"@EMA_News aprueba una ‘Estrategia de medición dl impacto de las actividades de farmacovigilancia’ https://t.co/qsErC4TBum vía @ActaSanitaria","source":"Hootsuite","author_id":"814609195","lang":"es","id":"689095057648005120","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/qsErC4TBum","expanded_url":"http://ow.ly/Xb3Bi","display_url":"ow.ly/Xb3Bi"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":140,"username":"ActaSanitaria","id":"507624258"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"689095057648005120","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-18T13:18:01.000Z","possibly_sensitive":false,"text":"@EMA_News :transparency on clinical trials is needed now, not in 2018... https://t.co/JOW6xHs9V4 https://t.co/weCprMcK3Z","source":"Twitter Web Client","author_id":"2977862386","lang":"en","id":"689074264885071872","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/JOW6xHs9V4","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000629.jsp&mid=WC0b01ac05808768df","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":97,"end":120,"url":"https://t.co/weCprMcK3Z","expanded_url":"https://twitter.com/Mains_Propres/status/689074264885071872/photo/1","display_url":"pic.twitter.com/weCprMcK3Z"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"689074264885071872","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_689074264008454144"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-15T21:15:03.000Z","possibly_sensitive":false,"text":"@EMA_News: opening clinical trial #data. Speech by Hans-Georg Eichle https://t.co/1p3JsQ1Pav","source":"Clarabridge Engage","author_id":"84582815","lang":"en","id":"688107150543986688","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":69,"end":92,"url":"https://t.co/1p3JsQ1Pav","expanded_url":"http://bit.ly/1PgCIvR","display_url":"bit.ly/1PgCIvR"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":34,"end":39,"tag":"data"}],"annotations":[{"start":51,"end":67,"probability":0.5804,"type":"Person","normalized_text":"Hans-Georg Eichle"}],"cashtags":{}},"conversation_id":"688107150543986688","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-15T14:56:11.000Z","possibly_sensitive":false,"text":"@EMA_News &amp;PR: Meeting highlights from #Pharmacovigilance Risk Assessment Committee #PRAC 11-14Jan 2016 see more @ https://t.co/vZDBs92Eo5","source":"Twitter Web Client","author_id":"2615562036","lang":"en","id":"688011803587121154","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":119,"end":142,"url":"https://t.co/vZDBs92Eo5","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/01/news_detail_002457.jsp&mid=WC0b01ac058004d5c1b","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":43,"end":61,"tag":"Pharmacovigilance"},{"start":88,"end":93,"tag":"PRAC"}],"annotations":{},"cashtags":{}},"conversation_id":"688011803587121154","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-14T13:16:02.000Z","possibly_sensitive":false,"text":"@EMA_News Leichtes Plus bei Neuzulassungen in Europa #Panobinostat #Blinatumomab https://t.co/Xgvt8r2R96 https://t.co/K6uJQIe2FF","source":"Twitter Web Client","author_id":"2789645880","lang":"de","id":"687624213893615617","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/Xgvt8r2R96","expanded_url":"https://www.deutsche-apotheker-zeitung.de/news/artikel/2016/01/14/leichte-steigerung-der-neuzulassungen-in-europa","display_url":"deutsche-apotheker-zeitung.de/news/artikel/2…"},{"start":105,"end":128,"url":"https://t.co/K6uJQIe2FF","expanded_url":"https://twitter.com/DAZheute/status/687624213893615617/photo/1","display_url":"pic.twitter.com/K6uJQIe2FF"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":53,"end":66,"tag":"Panobinostat"},{"start":67,"end":80,"tag":"Blinatumomab"}],"annotations":{},"cashtags":{}},"conversation_id":"687624213893615617","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_687624211838451713"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-14T12:15:07.000Z","possibly_sensitive":false,"text":"@EMA_News recomendó autorización de 93 medicamentos en 2015 https://t.co/TpiqrYoHda","source":"TweetDeck","author_id":"152983899","lang":"es","id":"687608884912111616","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":60,"end":83,"url":"https://t.co/TpiqrYoHda","expanded_url":"http://pmfarma.es/noticias/22101-ema-recomendo-autorizacion-de-93-medicamentos-en-2015.html?utm_source=twitter&utm_medium=manual","display_url":"pmfarma.es/noticias/22101…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"687608884912111616","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-13T08:36:11.000Z","possibly_sensitive":false,"text":"@EMA_News Great","source":"Twitter for Android","author_id":"1598215428","lang":"en","id":"687191397678465024","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"686855957318610944","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"686855957318610944"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-13T03:23:05.000Z","possibly_sensitive":false,"text":"@EMA_News can you do something for the pharmacy sector here in Italy?There are only a few pharmacies because of backwards rules","source":"Twitter Web Client","author_id":"4120768395","lang":"en","id":"687112604951678977","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":63,"end":67,"probability":0.996,"type":"Place","normalized_text":"Italy"}],"cashtags":{}},"conversation_id":"677856203733639172","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"677856203733639172"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-12T20:15:15.000Z","possibly_sensitive":false,"text":"@EMA_News is there any way to easily link to all the EMA's EPARs?","source":"Twuffer","author_id":"906554365","lang":"en","id":"687004936702304257","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"687004936702304257","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-12T15:25:25.000Z","possibly_sensitive":false,"text":"@EMA_News advice on use of colistin in animals to be updated #AMR https://t.co/TlMutIaFnw","source":"Twitter for iPhone","author_id":"283292925","lang":"en","id":"686931999408394240","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":66,"end":89,"url":"https://t.co/TlMutIaFnw","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/01/news_detail_002455.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":61,"end":65,"tag":"AMR"}],"annotations":{},"cashtags":{}},"conversation_id":"686931999408394240","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-10T12:59:55.000Z","possibly_sensitive":false,"text":"@EMA_News We have first hand experience that these toxic materials inside the human body are causing #EssureProblems https://t.co/XdMCvPcOnZ","source":"Twitter Web Client","author_id":"2854357211","lang":"en","id":"686170604677033984","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":6,"quote_count":0},"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/XdMCvPcOnZ","expanded_url":"https://twitter.com/StopEssureFIN/status/686170604677033984/photo/1","display_url":"pic.twitter.com/XdMCvPcOnZ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":101,"end":116,"tag":"EssureProblems"}],"annotations":{},"cashtags":{}},"conversation_id":"686170604677033984","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_686170603758469120"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-08T20:40:06.000Z","possibly_sensitive":false,"text":"@EMA_News Hello from Finland. We are suffering from the #Essure device. We would really like to see the #EU to take a stand on this matter.","source":"Twitter Web Client","author_id":"2854357211","lang":"en","id":"685561639643574272","public_metrics":{"retweet_count":29,"reply_count":1,"like_count":11,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":56,"end":63,"tag":"Essure"},{"start":104,"end":107,"tag":"EU"}],"annotations":[{"start":21,"end":27,"probability":0.9813,"type":"Place","normalized_text":"Finland"}],"cashtags":{}},"conversation_id":"685561639643574272","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-08T01:45:42.000Z","possibly_sensitive":false,"text":"@EMA_News https://t.co/LeH1RBZvfe","source":"Twitter for iPhone","author_id":"1392823914","lang":"und","id":"685276159920238592","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/LeH1RBZvfe","expanded_url":"http://www.pajamadaze.com/blog/trial-by-fire-a-film-about-crpsrsd-by-charles-mattocks","display_url":"pajamadaze.com/blog/trial-by-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"685276159920238592","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-04T13:00:25.000Z","possibly_sensitive":false,"text":"@EMA_News recomana el primer medicament oncolític per al tractament del #melanoma https://t.co/Q9AqTOzB8K #GeCoFarma","source":"TweetDeck","author_id":"110394456","lang":"ca","id":"683996403102695424","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/Q9AqTOzB8K","expanded_url":"http://goo.gl/e3Sl0K","display_url":"goo.gl/e3Sl0K"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":72,"end":81,"tag":"melanoma"},{"start":106,"end":116,"tag":"GeCoFarma"}],"annotations":{},"cashtags":{}},"conversation_id":"683996403102695424","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2016-01-04T12:58:01.000Z","possibly_sensitive":false,"text":"@EMA_News recommends use of TKV, eGFR and Age for #ADPKD #trials enrichment https://t.co/1HrWyTGujk","source":"Twitter Web Client","author_id":"3021456359","lang":"en","id":"683995798804258816","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/1HrWyTGujk","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2015/11/WC500196569.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":50,"end":56,"tag":"ADPKD"},{"start":57,"end":64,"tag":"trials"}],"annotations":{},"cashtags":{}},"conversation_id":"683995798804258816","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-25T11:05:54.000Z","possibly_sensitive":false,"text":"@ema_news since you’re into Health I thought u might like https://t.co/jezWELFuw1 it tracks our nation’s weight gain over xmasỊ RT","source":"Google Addon","author_id":"21073709","lang":"en","id":"680343705425948672","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":58,"end":81,"url":"https://t.co/jezWELFuw1","expanded_url":"http://www.jinglebellies.co.uk","display_url":"jinglebellies.co.uk"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"680343705425948672","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-21T15:34:05.000Z","possibly_sensitive":false,"text":"@EMA_News Director Guido Rasi EMA continues commitment to #patients_needs &amp; thanks all for their hard work in 2015 https://t.co/PzU5t14shR","source":"Twitter Web Client","author_id":"59722141","lang":"en","id":"678961644677046272","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":119,"end":142,"url":"https://t.co/PzU5t14shR","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/12/news_detail_002453.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":58,"end":73,"tag":"patients_needs"}],"annotations":[{"start":19,"end":32,"probability":0.5709,"type":"Person","normalized_text":"Guido Rasi EMA"}],"cashtags":{}},"conversation_id":"678961644677046272","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-21T08:29:24.000Z","possibly_sensitive":false,"text":"@EMA_News: Neun Arzneimittel erhalten ein positives Votum https://t.co/MU5JnKcZAS","source":"Twitter for iPhone","author_id":"2789645880","lang":"de","id":"678854771080568832","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":58,"end":81,"url":"https://t.co/MU5JnKcZAS","expanded_url":"https://www.deutsche-apotheker-zeitung.de/news/artikel/2015/12/18/neun-arzneimittel-erhalten-ein-positives-votum","display_url":"deutsche-apotheker-zeitung.de/news/artikel/2…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"678854771080568832","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-18T18:50:13.000Z","possibly_sensitive":false,"text":"@EMA_News Fast-Tracks New Oral Treatment For #NSCLC\nhttps://t.co/lJ47y1FqtL https://t.co/W6hRxvL5Xf","source":"Twitter Web Client","author_id":"23111717","lang":"en","id":"677923841495203840","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":52,"end":75,"url":"https://t.co/lJ47y1FqtL","expanded_url":"http://www.pharmpro.com/news/2015/12/ema-fast-tracks-new-oral-treatment-non-small-cell-lung-cancer","display_url":"pharmpro.com/news/2015/12/e…"},{"start":76,"end":99,"url":"https://t.co/W6hRxvL5Xf","expanded_url":"https://twitter.com/PharmProEditor/status/677923841495203840/photo/1","display_url":"pic.twitter.com/W6hRxvL5Xf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":45,"end":51,"tag":"NSCLC"}],"annotations":{},"cashtags":{}},"conversation_id":"677923841495203840","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_677923840291430400"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-18T13:08:43.000Z","possibly_sensitive":false,"text":"@EMA_News gives 1st ever positive opinion for accelerated, conditional approval; Agency committed to patient access https://t.co/9OS1ceD8WH","source":"Twitter for iPhone","author_id":"4339652302","lang":"en","id":"677837900638248960","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/9OS1ceD8WH","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2015/12/WC500199049.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"677837900638248960","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-18T09:15:28.000Z","possibly_sensitive":false,"text":"@EMA_News outlines 5-year vision https://t.co/yjXaWhHXN1","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"677779201982906368","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":33,"end":56,"url":"https://t.co/yjXaWhHXN1","expanded_url":"http://ow.ly/W1JUw","display_url":"ow.ly/W1JUw"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"677779201982906368","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-16T08:32:10.000Z","possibly_sensitive":false,"text":"@EMA_News  #EMWA #medicalwriting #clinicaltrial EMWA's regulatory Special Interest Groups (SIGs). Learn more:https://t.co/IGf6s9hpKf","source":"Twitter Web Client","author_id":"2407513628","lang":"en","id":"677043527470198784","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/IGf6s9hpKf","expanded_url":"http://www.emwa.org/Documents/What%20are%20EMWA%20SIGs-16dec15.pdf","display_url":"emwa.org/Documents/What…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":11,"end":16,"tag":"EMWA"},{"start":17,"end":32,"tag":"medicalwriting"},{"start":33,"end":47,"tag":"clinicaltrial"}],"annotations":{},"cashtags":{}},"conversation_id":"677043527470198784","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-15T09:02:05.000Z","possibly_sensitive":false,"text":"@EMA_News Offers Guidance on Applying for the Adaptive Pathways Pilot https://t.co/mIUUKEHca2","source":"Hootsuite","author_id":"164226447","lang":"en","id":"676688667918864385","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":70,"end":93,"url":"https://t.co/mIUUKEHca2","expanded_url":"http://ow.ly/VHZQl","display_url":"ow.ly/VHZQl"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"676688667918864385","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-11T09:54:05.000Z","possibly_sensitive":false,"text":"@EMA_News Exec Director Guido Rasi says #patient_involvement is one of 5 building blocks for addressing challenges https://t.co/ZqlhyezwzX","source":"Twitter Web Client","author_id":"59722141","lang":"en","id":"675252201351225345","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/ZqlhyezwzX","expanded_url":"https://twitter.com/EMA_News/status/674627963334352898","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":40,"end":60,"tag":"patient_involvement"}],"annotations":[{"start":24,"end":33,"probability":0.6059,"type":"Person","normalized_text":"Guido Rasi"}],"cashtags":{}},"conversation_id":"675252201351225345","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"674627963334352898"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-11T09:50:06.000Z","possibly_sensitive":false,"text":"@EMA_News #EMWA #medicalwriting #clinicaltrial EMWA to launch Regulatory Public Disclosure Special Interest Group: https://t.co/isXuPHYtm7","source":"Twitter Web Client","author_id":"2407513628","lang":"en","id":"675251202926452737","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/isXuPHYtm7","expanded_url":"http://www.emwa.org/Documents/EMWA%20RPD%20SIG-announcement-11dec15.pdf","display_url":"emwa.org/Documents/EMWA…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"EMWA"},{"start":16,"end":31,"tag":"medicalwriting"},{"start":32,"end":46,"tag":"clinicaltrial"}],"annotations":{},"cashtags":{}},"conversation_id":"675251202926452737","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-11T02:17:10.000Z","possibly_sensitive":false,"text":"@EMA_News priorities: R&amp;D for meds addressing public health needs; transparency; patient involvement; best use of data; global ref authority","source":"Twitter for iPhone","author_id":"122131645","lang":"en","id":"675137217086545920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"675137217086545920","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-10T21:38:50.000Z","possibly_sensitive":false,"text":"@EMA_News Director Says Smarter #Regulation Can Lead to Lower Drug Prices\nhttps://t.co/YvmJPKBpDL https://t.co/X4hHLxI3NG","source":"Twitter Web Client","author_id":"23111717","lang":"en","id":"675067172901789696","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":74,"end":97,"url":"https://t.co/YvmJPKBpDL","expanded_url":"http://www.pharmpro.com/news/2015/12/ema-director-says-smarter-regulation-can-lead-lower-drug-prices","display_url":"pharmpro.com/news/2015/12/e…"},{"start":98,"end":121,"url":"https://t.co/X4hHLxI3NG","expanded_url":"https://twitter.com/PharmProEditor/status/675067172901789696/photo/1","display_url":"pic.twitter.com/X4hHLxI3NG"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":32,"end":43,"tag":"Regulation"}],"annotations":{},"cashtags":{}},"conversation_id":"675067172901789696","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_675067172222312448"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-10T14:35:04.000Z","possibly_sensitive":false,"text":"@EMA_News Automate Recruiting. Simplify Job Search. https://t.co/cg75e3Ngm6 @HireTeamMate #hireme #jobfairy","source":"Twitter Web Client","author_id":"60416537","lang":"en","id":"674960526330322945","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":52,"end":75,"url":"https://t.co/cg75e3Ngm6","expanded_url":"https://bit.ly/hireteammate","display_url":"bit.ly/hireteammate"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":76,"end":89,"username":"HireTeamMate","id":"2916980271"}],"hashtags":[{"start":90,"end":97,"tag":"hireme"},{"start":98,"end":107,"tag":"jobfairy"}],"annotations":{},"cashtags":{}},"conversation_id":"671649130746404864","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"671649130746404864"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-09T15:39:45.000Z","possibly_sensitive":false,"text":"@EMA_News prima conferenza di Guido Rasi, impegno per contribuire ad abbassare costo #farmaci","source":"Twitter Web Client","author_id":"408478366","lang":"it","id":"674614416470614016","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":85,"end":93,"tag":"farmaci"}],"annotations":{},"cashtags":{}},"conversation_id":"674614416470614016","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-08T10:48:51.000Z","possibly_sensitive":false,"text":"@EMA_news @roche PLEASE post references re original data on mycophenolate &amp; quoted \"45-49% spontaneous abortion\". https://t.co/KKPRUQAu0Z","source":"Mobile Web (M2)","author_id":"70248716","lang":"en","id":"674178821193641984","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":118,"end":141,"url":"https://t.co/KKPRUQAu0Z","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/10/news_detail_002418.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":16,"username":"Roche","id":"20815041"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"674178821193641984","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-04T16:08:13.000Z","possibly_sensitive":false,"text":"@EMA_news Investigating Validity of Clinical Trial Led by FDA Commissioner Nominee | RAPS https://t.co/vZqCYoALVg","source":"Twitter Web Client","author_id":"1106659014","lang":"en","id":"672809642758692864","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/vZqCYoALVg","expanded_url":"https://shar.es/1c9W3E","display_url":"shar.es/1c9W3E"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":58,"end":60,"probability":0.8296,"type":"Organization","normalized_text":"FDA"}],"cashtags":{}},"conversation_id":"672809642758692864","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-04T15:04:43.000Z","possibly_sensitive":false,"text":"@EMA_News &amp; PR: Meeting highlights from #Pharmacovigilance Risk Assessment Committee (PRAC) 30 Nov -03 Dec more at: \nhttps://t.co/VFWBOQgX2f","source":"Twitter Web Client","author_id":"2615562036","lang":"en","id":"672793661025947648","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":121,"end":144,"url":"https://t.co/VFWBOQgX2f","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/12/news_detail_002442.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":44,"end":62,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"conversation_id":"672793661025947648","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-03T11:27:55.000Z","possibly_sensitive":false,"text":"@EMA_News  approva Elocta per il trattamento preventivo dell’emofilia A - Doctor33 https://t.co/0UAg8AC6qe\"","source":"Twitter for Android","author_id":"368821278","lang":"it","id":"672376712735432704","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/0UAg8AC6qe","expanded_url":"http://fb.me/7GDMv6yOf","display_url":"fb.me/7GDMv6yOf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"672376712735432704","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-01T11:41:43.000Z","possibly_sensitive":false,"text":"@EMA_News Latest Agenda for Monday's promising workshop: Demonstrating significant benefit of #orphan medicine...\n\nhttps://t.co/wNO4QiAQ5k","source":"Twitter for iPhone","author_id":"3819195808","lang":"en","id":"671655412727435264","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/wNO4QiAQ5k","expanded_url":"http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500193185","display_url":"ema.europa.eu/ema/pages/incl…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":94,"end":101,"tag":"orphan"}],"annotations":{},"cashtags":{}},"conversation_id":"671655412727435264","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-12-01T08:41:43.000Z","possibly_sensitive":false,"text":"@EMA_News adopts new guidance on Adaptive Pathways, read our #LifeScience #alert https://t.co/mv3l6YsOMM","source":"TweetDeck","author_id":"3003467715","lang":"en","id":"671610112038019072","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/mv3l6YsOMM","expanded_url":"http://bit.ly/1lUiZva","display_url":"bit.ly/1lUiZva"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":61,"end":73,"tag":"LifeScience"},{"start":74,"end":80,"tag":"alert"}],"annotations":[{"start":33,"end":49,"probability":0.5135,"type":"Organization","normalized_text":"Adaptive Pathways"}],"cashtags":{}},"conversation_id":"671610112038019072","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-30T14:14:48.000Z","possibly_sensitive":false,"text":"@EMA_News releases guidance on methods used in for post-authorisation efficacy studies. #RegulatoryNews https://t.co/7MmSzqcu7v","source":"Hootsuite","author_id":"845904529","lang":"en","id":"671331550089371648","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/7MmSzqcu7v","expanded_url":"http://ow.ly/VgwHf","display_url":"ow.ly/VgwHf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":88,"end":103,"tag":"RegulatoryNews"}],"annotations":{},"cashtags":{}},"conversation_id":"671331550089371648","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-28T13:43:39.000Z","possibly_sensitive":false,"text":"@EMA_News Reunión Nov2015 #CHMP recomienda 10 nuevos medicam, 1 opinión negat Insulina, 3 ext indicac y rev vac #VPH https://t.co/2JvGn0njwm","source":"Twitter Web Client","author_id":"2364065293","lang":"es","id":"670598933094211585","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/2JvGn0njwm","expanded_url":"http://bit.ly/1Ykig4m","display_url":"bit.ly/1Ykig4m"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":26,"end":31,"tag":"CHMP"},{"start":112,"end":116,"tag":"VPH"}],"annotations":{},"cashtags":{}},"conversation_id":"670598933094211585","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-26T17:05:43.000Z","possibly_sensitive":false,"text":"@EMA_News You can track orphan designations through to approval via our new #RegulatoryInsights app! https://t.co/ULjaqOKHrz","source":"Twitter for iPhone","author_id":"3819195808","lang":"en","id":"669925007733202948","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/ULjaqOKHrz","expanded_url":"https://twitter.com/ConciseIntelli/status/669925007733202948/photo/1","display_url":"pic.twitter.com/ULjaqOKHrz"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":76,"end":95,"tag":"RegulatoryInsights"}],"annotations":{},"cashtags":{}},"conversation_id":"669922137671602176","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"669922137671602176"}],"attachments":{"media_keys":["3_669925003102523393"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-26T14:55:24.000Z","possibly_sensitive":false,"text":"@EMA_News  interesting learning opportunities for patients in general and @pain_europe members with Eupati @eupatients and Eurodis.","source":"Twitter for iPad","author_id":"2927229797","lang":"en","id":"669892212881285120","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":74,"end":86,"username":"pain_europe","id":"2927229797"},{"start":107,"end":118,"username":"eupatients","id":"465674067"}],"hashtags":{},"annotations":[{"start":100,"end":105,"probability":0.3333,"type":"Person","normalized_text":"Eupati"}],"cashtags":{}},"conversation_id":"669892212881285120","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-25T17:04:26.000Z","possibly_sensitive":false,"text":"@EMA_News issues positive opinion backing orphan drug designation for avelumab https://t.co/qXFUhkF8rO","source":"Twitter Web Client","author_id":"71542880","lang":"en","id":"669562297396932608","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/qXFUhkF8rO","expanded_url":"http://www.thepharmaletter.com/article/ema-issues-positive-opinion-backing-orphan-drug-designation-for-avelumab","display_url":"thepharmaletter.com/article/ema-is…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"669562297396932608","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-24T14:51:55.000Z","possibly_sensitive":false,"text":"@EMA_News publishes new guidance on clinical data requirements for medicinal product authorisation. #RegulatoryNews https://t.co/ZC6QkpmMup","source":"Hootsuite","author_id":"845904529","lang":"en","id":"669166563744980992","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/ZC6QkpmMup","expanded_url":"http://ow.ly/V1isI","display_url":"ow.ly/V1isI"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":100,"end":115,"tag":"RegulatoryNews"}],"annotations":{},"cashtags":{}},"conversation_id":"669166563744980992","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-23T09:02:11.000Z","possibly_sensitive":false,"text":"@EMA_News European Medicines Agency finds no link between HPV vaccine and abnormal symptoms https://t.co/vCmwHe3q26","source":"Hootsuite","author_id":"164226447","lang":"en","id":"668716161169797120","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/vCmwHe3q26","expanded_url":"http://ow.ly/UHDDn","display_url":"ow.ly/UHDDn"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"668716161169797120","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-22T13:02:18.000Z","possibly_sensitive":false,"text":"@EMA_News Issues Draft Guidance on Post-Authorization Efficacy Studies https://t.co/kyBrWxXDk6","source":"Hootsuite","author_id":"164226447","lang":"en","id":"668414199769513985","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":71,"end":94,"url":"https://t.co/kyBrWxXDk6","expanded_url":"http://ow.ly/UHDDu","display_url":"ow.ly/UHDDu"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"668414199769513985","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-21T10:46:46.000Z","possibly_sensitive":false,"text":"@EMA_News accorde son feu vert à un biosimilaire d'Enbrel® (etanercept, anti-TNF) https://t.co/i39o0PFp8W #rhumatologie","source":"Twitter Web Client","author_id":"2826292747","lang":"fr","id":"668017705681842176","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/i39o0PFp8W","expanded_url":"http://www.fiercepharma.com/story/biogen-and-samsungs-enbrel-biosimilar-wins-ema-nod-eu-approval/2015-11-20","display_url":"fiercepharma.com/story/biogen-a…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":106,"end":119,"tag":"rhumatologie"}],"annotations":{},"cashtags":{}},"conversation_id":"668017705681842176","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-20T15:10:25.000Z","possibly_sensitive":false,"text":"@EMA_News This is disappointing as I wanted to apply for this vacancy... now I don't trust this agency anymore.","source":"Twitter Web Client","author_id":"1443849613","lang":"en","id":"667721664994680832","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"667654304510144513","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"667654304510144513"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-20T13:02:50.000Z","possibly_sensitive":false,"text":"@EMA_News European Medicines Agency signs four-year deal for AdisInsight https://t.co/bg7fqcQoNf","source":"Hootsuite","author_id":"164226447","lang":"en","id":"667689560005066752","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/bg7fqcQoNf","expanded_url":"http://ow.ly/UHDDs","display_url":"ow.ly/UHDDs"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":10,"end":34,"probability":0.5822,"type":"Organization","normalized_text":"European Medicines Agency"}],"cashtags":{}},"conversation_id":"667689560005066752","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-20T11:58:26.000Z","possibly_sensitive":false,"text":"@EMA_News Maybe if you show me statistics on temporary workers from inside and outside the agency, I will trust the system again...&lt;3 Europe","source":"Twitter for Android","author_id":"2354848216","lang":"en","id":"667673353176686592","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":134,"end":139,"probability":0.8162,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"conversation_id":"667654304510144513","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"667663472805720064"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-20T11:26:37.000Z","possibly_sensitive":false,"text":"@EMA_News My interview with HRpartner was supposed to b 30' and it lasted 5', and was totally pointless...I know how things work, not a fool","source":"Twitter for Android","author_id":"2354848216","lang":"en","id":"667665345713479680","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":28,"end":36,"probability":0.8227,"type":"Person","normalized_text":"HRpartner"}],"cashtags":{}},"conversation_id":"667654304510144513","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"667663472805720064"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-20T11:25:05.000Z","possibly_sensitive":false,"text":"@EMA_News One thing is that u advertise 1 job, cause it's a public agency and you are obliged, other thing is that u aren't biased.","source":"Twitter for Android","author_id":"2354848216","lang":"en","id":"667664959938166785","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"667654304510144513","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"667663472805720064"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-20T11:22:15.000Z","possibly_sensitive":false,"text":"@EMA_News Yes,that's why in the job agency they told me BEFORE going that the vacancy was going to b covered by a former trainee 90% prob.","source":"Twitter for Android","author_id":"2354848216","lang":"en","id":"667664245434241024","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"667654304510144513","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"667663472805720064"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-20T10:47:52.000Z","possibly_sensitive":false,"text":"@EMA_News Just to \"maybe\" hire a former trainee, does it worth to go there for an interview? Really? #nepotism","source":"Twitter for Android","author_id":"2354848216","lang":"en","id":"667655594086649857","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":101,"end":110,"tag":"nepotism"}],"annotations":{},"cashtags":{}},"conversation_id":"667654304510144513","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"667654304510144513"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-19T18:24:09.000Z","possibly_sensitive":false,"text":"@EMA_News #webinar Manage #pharma R&amp;D through #tech &amp; #OpEx tools. November 24th, 1pm EST. #register https://t.co/O7IxGSN4RS","source":"Twitter Web Client","author_id":"32553138","lang":"en","id":"667408034071728129","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/O7IxGSN4RS","expanded_url":"http://bit.ly/1MuHrsA","display_url":"bit.ly/1MuHrsA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":18,"tag":"webinar"},{"start":26,"end":33,"tag":"pharma"},{"start":50,"end":55,"tag":"tech"},{"start":62,"end":67,"tag":"OpEx"},{"start":99,"end":108,"tag":"register"}],"annotations":{},"cashtags":{}},"conversation_id":"667408034071728129","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-19T03:47:30.000Z","possibly_sensitive":false,"text":"@EMA_News 17 is amazing and great evidence of 141/2000. Great to see a new MAA in CF also, a bright future for European patients","source":"Twitter for iPhone","author_id":"3819195808","lang":"en","id":"667187417913364480","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"667049679159500800","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"667049679159500800"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-16T11:22:31.000Z","possibly_sensitive":false,"text":"@EMA_News video of EMWA-AMWA CORE Ref Q&amp;A The Hague, 06 Nov 15: https://t.co/bmyca9xoMo","source":"Twitter Web Client","author_id":"2407513628","lang":"ht","id":"666214761219170304","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/bmyca9xoMo","expanded_url":"https://vimeo.com/145279503","display_url":"vimeo.com/145279503"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"666214761219170304","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-12T15:23:46.000Z","possibly_sensitive":false,"text":"@EMA_News' proposed PRIME pathway could offer \"back door\" transparency into Breakthrough, @US_FDA's John Jenkins says #BPCongress2015","source":"Twitter for iPhone","author_id":"77863231","lang":"en","id":"664825921950609408","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":90,"end":97,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":118,"end":133,"tag":"BPCongress2015"}],"annotations":[{"start":100,"end":111,"probability":0.9946,"type":"Person","normalized_text":"John Jenkins"}],"cashtags":{}},"conversation_id":"664825921950609408","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"01fbe706f872cb32","coordinates":{"coordinates":{}}}},{"created_at":"2015-11-12T11:47:21.000Z","possibly_sensitive":false,"text":"@EMA_News: Miglioramento della segnalazione elettronica delle sospette reazioni avverse\nhttps://t.co/VmMed6gVLn https://t.co/woDDcNwBiQ","source":"Twitter Web Client","author_id":"1879728746","lang":"it","id":"664771460167266304","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/VmMed6gVLn","expanded_url":"http://www.socialfarma.it/informazione/news-dal-web/6615-ema-miglioramento-della-segnalazione-elettronica-delle-sospette-reazioni-avverse-per-una-migliore-protezione-della-salute","display_url":"socialfarma.it/informazione/n…"},{"start":112,"end":135,"url":"https://t.co/woDDcNwBiQ","expanded_url":"https://twitter.com/SocialfarmaWeb/status/664771460167266304/photo/1","display_url":"pic.twitter.com/woDDcNwBiQ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"664771460167266304","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_664771455888977920"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-12T05:08:48.000Z","possibly_sensitive":false,"text":"@EMA_News ATM for Medicine like Bank ATM ??? Save Environment/Reduce Drug Addiction&amp; Price of Medicine by 50%• https://t.co/htxrBEEh1h","source":"Twitter Web Client","author_id":"127923382","lang":"en","id":"664671159561023489","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/htxrBEEh1h","expanded_url":"http://lnkd.in/bB9bbsf","display_url":"lnkd.in/bB9bbsf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"664671159561023489","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"166f960e289d031f","coordinates":{"coordinates":{}}}},{"created_at":"2015-11-11T13:44:11.000Z","possibly_sensitive":false,"text":"@EMA_News Chief Medical Officer  shares his views about #ctdata and #alltrials with @el_pais https://t.co/gQZNggsQRw","source":"Twitter Web Client","author_id":"9307672","lang":"en","id":"664438472594321408","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/gQZNggsQRw","expanded_url":"http://elpais.com/elpais/2015/11/04/ciencia/1446636289_541618.html","display_url":"elpais.com/elpais/2015/11…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":84,"end":92,"username":"el_pais","id":"7996082"}],"hashtags":[{"start":56,"end":63,"tag":"ctdata"},{"start":68,"end":78,"tag":"alltrials"}],"annotations":{},"cashtags":{}},"conversation_id":"664438472594321408","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-10T17:31:14.000Z","possibly_sensitive":false,"text":"@EMA_News Public consultation on #PRIME-scheme to optimise development of medicines &amp; facilitate patients’ access  https://t.co/uSmAwroQOd","source":"Twitter Web Client","author_id":"3062275577","lang":"en","id":"664133225191710721","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":119,"end":142,"url":"https://t.co/uSmAwroQOd","expanded_url":"http://bit.ly/1WdwK38","display_url":"bit.ly/1WdwK38"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":33,"end":39,"tag":"PRIME"}],"annotations":{},"cashtags":{}},"conversation_id":"664133225191710721","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-10T14:36:20.000Z","possibly_sensitive":false,"text":"@EMA_News report on #adaptivepathways will be published in Spring 2016 says  @EU_Health DG Prats Monné @EventsPOLITICO #AHCS15","source":"Twitter Web Client","author_id":"1106659014","lang":"fr","id":"664089210350141441","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":77,"end":87,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":20,"end":37,"tag":"adaptivepathways"},{"start":119,"end":126,"tag":"AHCS15"}],"annotations":{},"cashtags":{}},"conversation_id":"664089210350141441","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-04T11:49:50.000Z","possibly_sensitive":false,"text":"@EMA_News We'd love to get #StepJockey in your Canary Wharf office. It could benefit the health of your staff: https://t.co/v7bjHxXFW6","source":"Twitter Web Client","author_id":"378445071","lang":"en","id":"661872980620926976","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/v7bjHxXFW6","expanded_url":"https://www.stepjockey.com/video","display_url":"stepjockey.com/video"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":27,"end":38,"tag":"StepJockey"}],"annotations":[{"start":47,"end":58,"probability":0.3946,"type":"Place","normalized_text":"Canary Wharf"}],"cashtags":{}},"conversation_id":"661872980620926976","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-11-02T18:05:59.000Z","possibly_sensitive":false,"text":"@EMA_News Releases Pharmacovigilance Program Update https://t.co/E4wgjfXhT1","source":"Hootsuite","author_id":"115496754","lang":"en","id":"661242865805344768","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":52,"end":75,"url":"https://t.co/E4wgjfXhT1","expanded_url":"http://ht.ly/TUhMh","display_url":"ht.ly/TUhMh"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"661242865805344768","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-30T15:10:06.000Z","possibly_sensitive":false,"text":"@EMA_News issues positive opinion to Amgen’s advanced therapy, Imlygic™ (T-Vec). Read the full article here: https://t.co/Y1dumMDFyG","source":"Hootsuite","author_id":"845904529","lang":"en","id":"660111442247593984","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/Y1dumMDFyG","expanded_url":"http://ow.ly/U2PA2","display_url":"ow.ly/U2PA2"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":37,"end":41,"probability":0.5409,"type":"Organization","normalized_text":"Amgen"}],"cashtags":{}},"conversation_id":"660111442247593984","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-26T11:27:47.000Z","possibly_sensitive":false,"text":"@EMA_News invites feedback on PRIME – a new scheme to optimise development of priority medicines, facilitate patient access #pharma #safety","source":"Twitter Web Client","author_id":"459335626","lang":"en","id":"658605943391965184","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":124,"end":131,"tag":"pharma"},{"start":132,"end":139,"tag":"safety"}],"annotations":{},"cashtags":{}},"conversation_id":"658605943391965184","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-23T16:25:06.000Z","possibly_sensitive":false,"text":"@EMA_News October CHMP Minutes Highlights https://t.co/HdHAL5jCB8","source":"Twitter for iPhone","author_id":"1171477128","lang":"en","id":"657593600268746752","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":42,"end":65,"url":"https://t.co/HdHAL5jCB8","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/10/news_detail_002416.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"657593600268746752","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-22T17:56:22.000Z","possibly_sensitive":false,"text":"@EMA_News When do you publish the table highlighting decisions?","source":"Twitter Web Client","author_id":"2171489356","lang":"en","id":"657254181171015680","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"654983042080067584","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"654983042080067584"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-15T16:03:01.000Z","possibly_sensitive":false,"text":"@EMA_News #MelanieCarr concludes the third EMA - EuropaBio Information Day saying that focus must stay on patients http://t.co/UYfALGEgjq","source":"Twitter for iPhone","author_id":"66323649","lang":"en","id":"654688938678841344","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/UYfALGEgjq","expanded_url":"https://twitter.com/mgargesi/status/654688938678841344/photo/1","display_url":"pic.twitter.com/UYfALGEgjq"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":22,"tag":"MelanieCarr"}],"annotations":[{"start":43,"end":73,"probability":0.5402,"type":"Other","normalized_text":"EMA - EuropaBio Information Day"}],"cashtags":{}},"conversation_id":"654688938678841344","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_654688930487386112"]},"geo":{"place_id":"08be9e4ebe3d037d","coordinates":{"coordinates":{}}}},{"created_at":"2015-10-15T11:35:16.000Z","possibly_sensitive":false,"text":"@EMA_News &amp; @EuropaBio are addressing EU regulatory changes &amp; policy dvltpts in #healthcare #biotechnology in London http://t.co/7gUK7zzLiT","source":"Hootsuite","author_id":"745020536","lang":"en","id":"654621558657388544","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":[{"start":125,"end":147,"url":"http://t.co/7gUK7zzLiT","expanded_url":"http://ow.ly/TqkZz","display_url":"ow.ly/TqkZz"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":26,"username":"EuropaBio","id":"19642657"}],"hashtags":[{"start":88,"end":99,"tag":"healthcare"},{"start":100,"end":114,"tag":"biotechnology"}],"annotations":[{"start":38,"end":39,"probability":0.6349,"type":"Organization","normalized_text":"EU"},{"start":110,"end":115,"probability":0.9933,"type":"Place","normalized_text":"London"}],"cashtags":{}},"conversation_id":"654621558657388544","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-15T09:24:13.000Z","possibly_sensitive":false,"text":"@EMA_News #GuidoRasi @ EMA - @EuropaBio: need 4 strong EU regulatory network 2 ensure sustainability &amp; quality http://t.co/okN3jmSYJB","source":"Twitter for iPhone","author_id":"66323649","lang":"en","id":"654588580455673857","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/okN3jmSYJB","expanded_url":"https://twitter.com/mgargesi/status/654588580455673857/photo/1","display_url":"pic.twitter.com/okN3jmSYJB"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":29,"end":39,"username":"EuropaBio","id":"19642657"}],"hashtags":[{"start":10,"end":20,"tag":"GuidoRasi"}],"annotations":{},"cashtags":{}},"conversation_id":"654588580455673857","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_654588575481221121"]},"geo":{"place_id":"08be9e4ebe3d037d","coordinates":{"coordinates":{}}}},{"created_at":"2015-10-14T14:31:55.000Z","possibly_sensitive":false,"text":"@EMA_News: Tell @pfizer &amp; @tevapharm to clean up #pharma #pollution from antibiotic supply chains! http://t.co/vmO2Hublya #CPhIWW","source":"Twitter Web Client","author_id":"320432933","lang":"en","id":"654303624672210945","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/vmO2Hublya","expanded_url":"http://bit.ly/1LL3zot","display_url":"bit.ly/1LL3zot"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":23,"username":"pfizer","id":"56488059"},{"start":30,"end":40,"username":"tevapharm","id":"121551238"}],"hashtags":[{"start":53,"end":60,"tag":"pharma"},{"start":61,"end":71,"tag":"pollution"},{"start":126,"end":133,"tag":"CPhIWW"}],"annotations":{},"cashtags":{}},"conversation_id":"654303624672210945","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-14T09:38:35.000Z","possibly_sensitive":false,"text":"@EMA_News Pres V. Costigliole presents philosophy: better informed doctors means better patient care #PrecisionMedicine @EU_Health","source":"Twitter Web Client","author_id":"111253056","lang":"en","id":"654229805366423552","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":120,"end":130,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":101,"end":119,"tag":"PrecisionMedicine"}],"annotations":[{"start":10,"end":28,"probability":0.7728,"type":"Person","normalized_text":"Pres V. Costigliole"}],"cashtags":{}},"conversation_id":"654229805366423552","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-13T10:42:29.000Z","possibly_sensitive":false,"text":"@EMA_News EMA launches pilot project to make better use of patient registry data on #medicines in #clinical use http://t.co/3Ii6wSX8FE","source":"Twitter Web Client","author_id":"2848173730","lang":"en","id":"653883500857266176","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/3Ii6wSX8FE","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/10/news_detail_002413.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":84,"end":94,"tag":"medicines"},{"start":98,"end":107,"tag":"clinical"}],"annotations":[{"start":10,"end":12,"probability":0.5445,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"conversation_id":"653883500857266176","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-12T14:09:33.000Z","possibly_sensitive":false,"text":"@EMA_News Fergus Sweeney describing the complexity of the future Clinical Trials portal and database @TOPRANEWS http://t.co/74sDrC8TUy","source":"Twitter for iPhone","author_id":"2876403948","lang":"en","id":"653573222689058816","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/74sDrC8TUy","expanded_url":"https://twitter.com/sinieskola/status/653573222689058816/photo/1","display_url":"pic.twitter.com/74sDrC8TUy"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":101,"end":111,"username":"TOPRANEWS","id":"26739900"}],"hashtags":{},"annotations":[{"start":10,"end":23,"probability":0.9264,"type":"Person","normalized_text":"Fergus Sweeney"}],"cashtags":{}},"conversation_id":"653573222689058816","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_653573205286887424"]},"geo":{"place_id":"3078869807f9dd36","coordinates":{"coordinates":{}}}},{"created_at":"2015-10-10T11:18:25.000Z","possibly_sensitive":false,"text":"@EMA_News Very relevant topic, could you post the link to the broadcast, please?","source":"Twitter Web Client","author_id":"810969654","lang":"en","id":"652805380351860737","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"652128712545181696","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"652128712545181696"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-09T10:02:21.000Z","possibly_sensitive":false,"text":"@EMA_News recommends granting marketing authorisation for Cinacalcet Mylan http://t.co/uoXfVgCGSZ #parathyroid #carcinoma @_rarecancer","source":"Hootsuite","author_id":"69232855","lang":"en","id":"652423846151213056","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/uoXfVgCGSZ","expanded_url":"http://ow.ly/TcGWn","display_url":"ow.ly/TcGWn","status":200,"unwound_url":"https://www.esmo.org/oncology-news/archive/european-medicines-agency-recommends-granting-marketing-authorisation-for-cinacalcet-mylan"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":122,"end":134,"username":"_rarecancer","id":"2301430153"}],"hashtags":[{"start":98,"end":110,"tag":"parathyroid"},{"start":111,"end":121,"tag":"carcinoma"}],"annotations":{},"cashtags":{}},"conversation_id":"652423846151213056","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-07T11:02:11.000Z","possibly_sensitive":false,"text":"@EMA_News #ITsystems will be temporarily unavailable from Friday 30th October to Tuesday 3rd November 2015 http://t.co/SXxORNGjD9","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"651714128009109504","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/SXxORNGjD9","expanded_url":"http://ow.ly/T55tj","display_url":"ow.ly/T55tj"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":20,"tag":"ITsystems"}],"annotations":{},"cashtags":{}},"conversation_id":"651714128009109504","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-07T10:30:21.000Z","possibly_sensitive":false,"text":"@EMA_News recs granting marketing authorisation for carfilzomib  #multiple #myeloma http://t.co/6KaMI8SwGh","source":"Hootsuite","author_id":"69232855","lang":"en","id":"651706120826953729","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/6KaMI8SwGh","expanded_url":"http://ow.ly/T6QwR","display_url":"ow.ly/T6QwR"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":65,"end":74,"tag":"multiple"},{"start":75,"end":83,"tag":"myeloma"}],"annotations":{},"cashtags":{}},"conversation_id":"651706120826953729","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-07T09:05:07.000Z","possibly_sensitive":false,"text":"@EMA_News recs granting marketing authorisation for blinatumomab for Philadelphia chrom-neg ALL http://t.co/p81MhX4rXz","source":"Hootsuite","author_id":"69232855","lang":"en","id":"651684668480319488","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/p81MhX4rXz","expanded_url":"http://ow.ly/T6PFS","display_url":"ow.ly/T6PFS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":69,"end":80,"probability":0.9584,"type":"Place","normalized_text":"Philadelphia"}],"cashtags":{}},"conversation_id":"651684668480319488","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-05T17:27:34.000Z","possibly_sensitive":false,"text":"@EMA_News https://t.co/RRSlcB1jy2","source":"Twitter for iPhone","author_id":"318608545","lang":"und","id":"651086340566720512","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/RRSlcB1jy2","expanded_url":"https://www.change.org/p/petitioning-for-the-right-to-carry-a-minimum-of-two-auto-injector-adrenaline-pens","display_url":"change.org/p/petitioning-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"651086340566720512","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-05T12:17:25.000Z","possibly_sensitive":false,"text":"@EMA_News Hans Eichler: Is the   RCT &amp; 1 drug for 1 condition the right approach? #PersonalizedMedicine #cochranevienna","source":"Twitter for iPhone","author_id":"141869566","lang":"en","id":"651008288360919040","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":86,"end":107,"tag":"PersonalizedMedicine"},{"start":108,"end":123,"tag":"cochranevienna"}],"annotations":[{"start":10,"end":21,"probability":0.9758,"type":"Person","normalized_text":"Hans Eichler"}],"cashtags":{}},"conversation_id":"651008288360919040","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-05T12:08:29.000Z","possibly_sensitive":false,"text":"@EMA_News - Hans Eichler: Uptill now only the top &amp; bottom done &amp; everything in the middle missed.  #cochranevienna http://t.co/YCkSTYTpwJ","source":"Twitter for iPhone","author_id":"141869566","lang":"en","id":"651006040956399616","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":124,"end":146,"url":"http://t.co/YCkSTYTpwJ","expanded_url":"https://twitter.com/TShealthpolicy/status/651006040956399616/photo/1","display_url":"pic.twitter.com/YCkSTYTpwJ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":108,"end":123,"tag":"cochranevienna"}],"annotations":[{"start":12,"end":23,"probability":0.968,"type":"Person","normalized_text":"Hans Eichler"}],"cashtags":{}},"conversation_id":"651006040956399616","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_651006031150059520"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-01T12:43:20.000Z","possibly_sensitive":false,"text":"@EMA_News Guido Rasi nominated as Executive Director of the European Medicines Agency http://t.co/M0blKEuxzQ","source":"Twitter Web Client","author_id":"146448525","lang":"en","id":"649565256440774656","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/M0blKEuxzQ","expanded_url":"http://bit.ly/1GkfRMF","display_url":"bit.ly/1GkfRMF"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":10,"end":19,"probability":0.9878,"type":"Person","normalized_text":"Guido Rasi"},{"start":60,"end":84,"probability":0.3637,"type":"Organization","normalized_text":"European Medicines Agency"}],"cashtags":{}},"conversation_id":"649565256440774656","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-10-01T09:20:46.000Z","possibly_sensitive":false,"text":"@EMA_News Read EMWA Qs to EMA re. impact of EU gen court ruling of 1 Sep 15 on EMA Policy 0700: http://t.co/OsbrTkfcUr","source":"Twitter Web Client","author_id":"2407513628","lang":"en","id":"649514282066014208","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/OsbrTkfcUr","expanded_url":"http://www.emwa.org/Documents/News/EU%20Ruling%20impact.pdf","display_url":"emwa.org/Documents/News…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"649514282066014208","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-30T15:48:54.000Z","possibly_sensitive":false,"text":"@EMA_News Draft Guidance seeks to speed new #antibiotics development - http://t.co/m1WnaWdJas @RAPSorg #regulatoryaffairs #pharma","source":"Hootsuite","author_id":"713848298","lang":"en","id":"649249570300559360","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/m1WnaWdJas","expanded_url":"http://bit.ly/1LOYf1K","display_url":"bit.ly/1LOYf1K"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":94,"end":102,"username":"RAPSorg","id":"111425542"}],"hashtags":[{"start":44,"end":56,"tag":"antibiotics"},{"start":103,"end":121,"tag":"regulatoryaffairs"},{"start":122,"end":129,"tag":"pharma"}],"annotations":{},"cashtags":{}},"conversation_id":"649249570300559360","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-30T15:03:12.000Z","possibly_sensitive":false,"text":"@EMA_News is your website down? I can't get it to load","source":"Twitter Web Client","author_id":"190310284","lang":"en","id":"649238070152294400","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"649238070152294400","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-30T13:06:59.000Z","possibly_sensitive":false,"text":"@EMA_News would be great to help have more information on the process of getting TDF/FTC approved for a prevention indication in Europe.","source":"Twitter Web Client","author_id":"17732964","lang":"en","id":"649208821072662528","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":129,"end":134,"probability":0.9907,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"conversation_id":"649208821072662528","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-30T13:06:16.000Z","possibly_sensitive":false,"text":"@EMA_News New WHO guidelines on ARVs and PrEP.http://t.co/NE22wtEnGm","source":"Twitter Web Client","author_id":"17732964","lang":"en","id":"649208640801492993","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/NE22wtEnGm","expanded_url":"http://who.int/mediacentre/news/releases/2015/hiv-treat-all-recommendation/en/","display_url":"who.int/mediacentre/ne…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"649208640801492993","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-29T13:55:26.000Z","possibly_sensitive":false,"text":"@EMA_News @EFPIA @FIP_IPS Thomas Lönngren received FIP André Bédat award: Pharmacist who has made significant international contributions!","source":"Twitter for iPhone","author_id":"2876403948","lang":"ca","id":"648858624924753920","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":16,"username":"EFPIA","id":"52084584"},{"start":17,"end":25,"username":"FIP_IPS","id":"2279021066"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"648858624924753920","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"b7d3c12268abd20e","coordinates":{"coordinates":{}}}},{"created_at":"2015-09-29T11:15:21.000Z","possibly_sensitive":false,"text":"@EMA_News recomienda ampliar la indicación de 'Vidaza' @Celgene para mayores de 65 años con #leucemia mieloide aguda http://t.co/zqYJM0Laa1","source":"Hootsuite","author_id":"1410756721","lang":"es","id":"648818338706141185","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/zqYJM0Laa1","expanded_url":"http://ow.ly/SME6x","display_url":"ow.ly/SME6x"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":55,"end":63,"username":"celgene","id":"1350978062125588490"}],"hashtags":[{"start":92,"end":101,"tag":"leucemia"}],"annotations":[{"start":47,"end":52,"probability":0.3471,"type":"Organization","normalized_text":"Vidaza"}],"cashtags":{}},"conversation_id":"648818338706141185","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-25T14:13:40.000Z","possibly_sensitive":false,"text":"@EMA_News recommends licensing of orkambi for ppl with common mutation of CF &amp; extension of Kalydeco to u-6s &amp; R117H #Orkambi #Kalydeco","source":"Twitter for Android","author_id":"396639152","lang":"en","id":"647413665168277504","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":125,"end":133,"tag":"Orkambi"},{"start":134,"end":143,"tag":"Kalydeco"}],"annotations":{},"cashtags":{}},"conversation_id":"647413665168277504","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-25T13:09:33.000Z","possibly_sensitive":false,"text":"@EMA_News recommends licensing of Orkambi for over-12s with common form of CF &amp; extension of Kalydeo to U-6s &amp; R117Hs @cftrust reaction soon","source":"Twitter Web Client","author_id":"23132770","lang":"en","id":"647397526878965760","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":134,"username":"cftrust","id":"21299778"}],"hashtags":{},"annotations":[{"start":93,"end":116,"probability":0.2255,"type":"Product","normalized_text":"Kalydeo to U-6s & R117Hs"}],"cashtags":{}},"conversation_id":"647397526878965760","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"1c37515518593fe3","coordinates":{"coordinates":{}}}},{"created_at":"2015-09-25T12:35:22.000Z","possibly_sensitive":false,"text":"@EMA_News recommends licensing of orkambi for ppl with common mutation of CF &amp; extension of Kalydeco to u-6s &amp; R117H @cftrust statement soon","source":"Twitter for Windows Phone","author_id":"23132770","lang":"en","id":"647388925758152704","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":125,"end":133,"username":"cftrust","id":"21299778"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"647388925758152704","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-23T08:12:43.000Z","possibly_sensitive":false,"text":"@EMA_News: \"innovative information\" to be censored from release clinical trial data. @EUombudsman: what´s trade secret today is not tomorrow","source":"TweetDeck","author_id":"18483956","lang":"en","id":"646598053638602752","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":85,"end":97,"username":"EUombudsman","id":"873777758"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"646598053638602752","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-22T16:35:47.000Z","possibly_sensitive":false,"text":"@EMA_News to join selected applicant consortium for IMI 2 Call 5 topic on patients &amp; medicines risks &amp; benefits http://t.co/nN5UYdAv8h","source":"Twitter Web Client","author_id":"153741027","lang":"en","id":"646362266988879873","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/nN5UYdAv8h","expanded_url":"http://bit.ly/IMI2Call5-1","display_url":"bit.ly/IMI2Call5-1"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"646362266988879873","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-22T11:17:35.000Z","possibly_sensitive":false,"text":"@EMA_News close to finalizing guidance on redacting commercially confidential info in clinical reports http://t.co/c5X7QgqkA3 #transparency","source":"Twitter Web Client","author_id":"459335626","lang":"en","id":"646282186467995652","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/c5X7QgqkA3","expanded_url":"http://bit.ly/1YyBZ1b","display_url":"bit.ly/1YyBZ1b"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":126,"end":139,"tag":"transparency"}],"annotations":{},"cashtags":{}},"conversation_id":"646282186467995652","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-22T09:52:59.000Z","possibly_sensitive":false,"text":"@EMA_News @EU_Health @WHO step up cooperation to better protect global public health with new agreement http://t.co/yqiByeOTqD","source":"iOS","author_id":"113148426","lang":"en","id":"646260898626203648","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/yqiByeOTqD","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/09/news_detail_002396.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":21,"end":25,"username":"WHO","id":"14499829"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"646260898626203648","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-21T09:29:21.000Z","possibly_sensitive":false,"text":"@EMA_News organizza un workshop sul beneficio dei #farmaciorfani @Aifa_ufficiale http://t.co/H1ktxRkCMe http://t.co/Lu4VFnfeQ7","source":"Twitter Web Client","author_id":"1879728746","lang":"it","id":"645892562545438720","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/H1ktxRkCMe","expanded_url":"http://www.socialfarma.it/informazione/news-dal-web/6318-ema-organizza-workshop-sull%E2%80%99approccio-da-seguire-per-dimostrare-il-beneficio-significativo-dei-nuovi-farmaci-orfani-rispetto-ai-medicinali-gi%C3%A0-esistenti","display_url":"socialfarma.it/informazione/n…"},{"start":104,"end":126,"url":"http://t.co/Lu4VFnfeQ7","expanded_url":"https://twitter.com/SocialfarmaWeb/status/645892562545438720/photo/1","display_url":"pic.twitter.com/Lu4VFnfeQ7"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":65,"end":80,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":50,"end":64,"tag":"farmaciorfani"}],"annotations":{},"cashtags":{}},"conversation_id":"645892562545438720","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_645892558778793984"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-17T10:24:45.000Z","possibly_sensitive":false,"text":"@EMA_News approval #translarna in EU @NICEcomms @ActionDuchenne @alljoinjack @HarrisonsFund @BushbyKate @MDUK_News http://t.co/fq5T96zves","source":"Twitter for Android","author_id":"153054732","lang":"fr","id":"644456953461276672","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/fq5T96zves","expanded_url":"https://twitter.com/nickcatlin/status/644456953461276672/photo/1","display_url":"pic.twitter.com/fq5T96zves"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":37,"end":47,"username":"NICEComms","id":"85555796"},{"start":48,"end":63,"username":"ActionDuchenne","id":"94312025"},{"start":64,"end":76,"username":"alljoinjack","id":"554667907"},{"start":77,"end":91,"username":"HarrisonsFund","id":"360154668"},{"start":92,"end":103,"username":"BushbyKate","id":"1216228962"},{"start":104,"end":114,"username":"MDUK_News","id":"17389502"}],"hashtags":[{"start":19,"end":30,"tag":"translarna"}],"annotations":{},"cashtags":{}},"conversation_id":"644456953461276672","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_644456946536464384"]},"geo":{"place_id":"26b0db32cfda0432","coordinates":{"coordinates":{}}}},{"created_at":"2015-09-15T02:47:51.000Z","possibly_sensitive":false,"text":"@EMA_News When do you inform a MAH about PRAC outcome ? Right after the meeting or later ?","source":"Twitter for iPhone","author_id":"2830257207","lang":"en","id":"643617193637347328","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"643617193637347328","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-11T12:47:18.000Z","possibly_sensitive":false,"text":"@EMA_News Hi Guys, we would love to discuss the potential of getting you involved in the national government apprenticeship program #IT #GOV","source":"Twitter Web Client","author_id":"3456044903","lang":"en","id":"642318498497228800","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":132,"end":135,"tag":"IT"},{"start":136,"end":140,"tag":"GOV"}],"annotations":{},"cashtags":{}},"conversation_id":"642318498497228800","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-11T09:29:51.000Z","possibly_sensitive":false,"text":"@EMA_News great, many thanks. So we should hear the outcome in October then.","source":"Twitter for iPhone","author_id":"3437733083","lang":"en","id":"642268807390732288","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"642083335293042688","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"642258567362412544"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-11T06:57:04.000Z","possibly_sensitive":false,"text":"@EMA_News -- US regulators accept ‘chip in a pill’ application - http://t.co/4U9vwMrOOZ","source":"Twitter for Android","author_id":"49319956","lang":"en","id":"642230361607565312","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/4U9vwMrOOZ","expanded_url":"http://www.ft.com/cms/s/0/decece84-57b1-11e5-a28b-50226830d644.html","display_url":"ft.com/cms/s/0/decece…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":13,"end":14,"probability":0.6614,"type":"Place","normalized_text":"US"}],"cashtags":{}},"conversation_id":"642230361607565312","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-10T16:38:40.000Z","possibly_sensitive":false,"text":"@EMA_News found today utterly fascinating.","source":"Twitter for iPhone","author_id":"44080641","lang":"en","id":"642014338031747072","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"641985632626167808","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"642006985169354752"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-09T06:30:51.000Z","possibly_sensitive":false,"text":"@EMA_News organises a workshop to clarify concept &amp; demonstration of benefit of new #OrphanMedicines http://t.co/PW55574lxA #biotech4life","source":"Hootsuite","author_id":"19642657","lang":"en","id":"641498986411610112","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/PW55574lxA","expanded_url":"http://ow.ly/RUSOs","display_url":"ow.ly/RUSOs"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":88,"end":104,"tag":"OrphanMedicines"},{"start":128,"end":141,"tag":"biotech4life"}],"annotations":{},"cashtags":{}},"conversation_id":"641498986411610112","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-05T11:03:40.000Z","possibly_sensitive":false,"text":"@EMA_News Grants Marketing Authorization for Kanuma™ for Patients of All Ages with Lysosomal Acid Lipase Deficiency https://t.co/UiePgODOGC","source":"Twitter for iPhone","author_id":"576302294","lang":"en","id":"640118090714476545","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/UiePgODOGC","expanded_url":"https://shar.es/1vAulk","display_url":"shar.es/1vAulk"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"640118090714476545","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-04T21:34:40.000Z","possibly_sensitive":false,"text":"@EMA_News workshop to clarify concept and demonstration of benefit of new #orphanmedicines over existing treatments http://t.co/5NsFbvtsEO","source":"Twitter for iPhone","author_id":"576302294","lang":"en","id":"639914500452429824","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/5NsFbvtsEO","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/09/news_detail_002390.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":74,"end":90,"tag":"orphanmedicines"}],"annotations":{},"cashtags":{}},"conversation_id":"639914500452429824","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-09-04T15:49:24.000Z","possibly_sensitive":false,"text":"@EMA_News approves @NovartisPharma new skin cancer drug #Odomzo http://t.co/VnYpls4LuD","source":"TweetDeck","author_id":"33832891","lang":"en","id":"639827608998420481","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/VnYpls4LuD","expanded_url":"http://www.tumorijournal.com/notizie/eu-approves-novartis--new-skin-cancer-drug","display_url":"tumorijournal.com/notizie/eu-app…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":56,"end":63,"tag":"Odomzo"}],"annotations":{},"cashtags":{}},"conversation_id":"639827608998420481","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-31T14:32:04.000Z","possibly_sensitive":false,"text":"@EMA_News validates @Pfizer’s application to market Ibrance for #breastcancer. http://t.co/dcR9k0xOqp @PharmaTimes","source":"Hootsuite","author_id":"55586971","lang":"en","id":"638358597332783105","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/dcR9k0xOqp","expanded_url":"http://bit.ly/1NI2Gf1","display_url":"bit.ly/1NI2Gf1"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":20,"end":27,"username":"pfizer","id":"56488059"},{"start":102,"end":114,"username":"PharmaTimes","id":"52354784"}],"hashtags":[{"start":64,"end":77,"tag":"breastcancer"}],"annotations":{},"cashtags":{}},"conversation_id":"638358597332783105","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-31T12:32:29.000Z","possibly_sensitive":false,"text":"@EMA_News  https://t.co/xjvKMrmkXM","source":"Twitter for Android","author_id":"164835748","lang":"und","id":"638328502832529409","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":11,"end":34,"url":"https://t.co/xjvKMrmkXM","expanded_url":"https://twitter.com/nsiriwardena/status/638327257287819264","display_url":"twitter.com/nsiriwardena/s…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"638328502832529409","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"638327257287819264"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-27T12:17:20.000Z","possibly_sensitive":false,"text":"@EMA_News #GLP15 &amp; clinical laboratory symposium on 30 Sept 15 http://t.co/JPQq6S7WGP a unique opp 2 hear/learn from the regulator- pls RT","source":"Hootsuite","author_id":"330993102","lang":"en","id":"636875138768740352","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/JPQq6S7WGP","expanded_url":"http://ow.ly/QUnuY","display_url":"ow.ly/QUnuY"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":16,"tag":"GLP15"}],"annotations":{},"cashtags":{}},"conversation_id":"636875138768740352","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-27T10:08:14.000Z","possibly_sensitive":false,"text":"@EMA_News consultation seeking views: how to assess risk of human #antibiotic resistance from use of drugs in farming http://t.co/xS4jFzUZo8","source":"Twitter Web Client","author_id":"526576312","lang":"en","id":"636842649811554304","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/xS4jFzUZo8","expanded_url":"http://bit.ly/1JxyZHy","display_url":"bit.ly/1JxyZHy"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":66,"end":77,"tag":"antibiotic"}],"annotations":{},"cashtags":{}},"conversation_id":"636842649811554304","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-26T12:29:08.000Z","possibly_sensitive":false,"text":"@EMA_News publishes reader-friendly information on herbal medicines http://t.co/ePcJ2axZF3","source":"Twitter Web Client","author_id":"1106659014","lang":"en","id":"636515722315874304","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/ePcJ2axZF3","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002385.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"636515722315874304","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-25T07:26:06.000Z","possibly_sensitive":false,"text":"@EMA_News hi trying to contact the press office re interview on RTE radio news this morning I am on hannah.parkes@rte.ie","source":"Twitter Web Client","author_id":"955002667","lang":"en","id":"636077071756881920","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":64,"end":72,"probability":0.4507,"type":"Organization","normalized_text":"RTE radio"}],"cashtags":{}},"conversation_id":"636077071756881920","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-24T11:02:35.000Z","possibly_sensitive":false,"text":"@EMA_News releases updated guidance on #GoodClinicalPractice for consultation http://t.co/GUAfq6bZkA http://t.co/cEcpKpy4uQ","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"635769164691603456","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/GUAfq6bZkA","expanded_url":"http://ow.ly/Rh78o","display_url":"ow.ly/Rh78o"},{"start":101,"end":123,"url":"http://t.co/cEcpKpy4uQ","expanded_url":"https://twitter.com/WALregulatory/status/635769164691603456/photo/1","display_url":"pic.twitter.com/cEcpKpy4uQ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":39,"end":60,"tag":"GoodClinicalPractice"}],"annotations":{},"cashtags":{}},"conversation_id":"635769164691603456","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_635769164439920640"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-24T08:36:34.000Z","possibly_sensitive":false,"text":"@EMA_News thank you!","source":"TweetDeck","author_id":"173111183","lang":"en","id":"635732416821391360","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"634988759759589376","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"635731963333214208"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-22T07:21:32.000Z","possibly_sensitive":false,"text":"@EMA_News Is this (https://t.co/h9vw7ZxDhV) info on suspended medicines accurate? I cannot find any info on your website","source":"Twitter Web Client","author_id":"173111183","lang":"en","id":"634988759759589376","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":19,"end":42,"url":"https://t.co/h9vw7ZxDhV","expanded_url":"https://www.scribd.com/fullscreen/272710089?access_key=key-RlEYmXGopnw6pE2CBQ3v&allow_share=true&escape=false&view_mode=scroll","display_url":"scribd.com/fullscreen/272…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"634988759759589376","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-20T10:06:16.000Z","possibly_sensitive":false,"text":"@EMA_News new @EuropaBio article on #biosimilar product #label - http://t.co/Ch2TJW2yMZ","source":"Twitter Web Client","author_id":"445603487","lang":"en","id":"634305442525614080","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/Ch2TJW2yMZ","expanded_url":"http://bit.ly/1Nn2brL","display_url":"bit.ly/1Nn2brL"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":24,"username":"EuropaBio","id":"19642657"}],"hashtags":[{"start":36,"end":47,"tag":"biosimilar"},{"start":56,"end":62,"tag":"label"}],"annotations":{},"cashtags":{}},"conversation_id":"634305442525614080","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-15T23:33:01.000Z","possibly_sensitive":false,"text":"@EMA_News approves @GSK ’s Malaria vaccine http://t.co/rkQT43oOZ7","source":"Buffer","author_id":"22080808","lang":"en","id":"632696524414320640","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":43,"end":65,"url":"http://t.co/rkQT43oOZ7","expanded_url":"http://buff.ly/1MYjIoY","display_url":"buff.ly/1MYjIoY"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":19,"end":23,"username":"GSK","id":"5383942"}],"hashtags":{},"annotations":[{"start":27,"end":33,"probability":0.5582,"type":"Other","normalized_text":"Malaria"}],"cashtags":{}},"conversation_id":"632696524414320640","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-14T11:25:24.000Z","possibly_sensitive":false,"text":"@EMA_News supports use of #IT services for #medicineregulation http://t.co/ihJCQ5pAU9 http://t.co/L4ZiHAtpgh","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"632151027295371264","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/ihJCQ5pAU9","expanded_url":"http://ow.ly/QRuOH","display_url":"ow.ly/QRuOH"},{"start":86,"end":108,"url":"http://t.co/L4ZiHAtpgh","expanded_url":"https://twitter.com/WALregulatory/status/632151027295371264/photo/1","display_url":"pic.twitter.com/L4ZiHAtpgh"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":26,"end":29,"tag":"IT"},{"start":43,"end":62,"tag":"medicineregulation"}],"annotations":{},"cashtags":{}},"conversation_id":"632151027295371264","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_632151027039490048"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-14T08:05:58.000Z","possibly_sensitive":false,"text":"@EMA_News Revised guidelines on fast track routes for medicines that address unmet medical needs http://t.co/9hRlq5Q3Z3","source":"TweetDeck","author_id":"1229834264","lang":"en","id":"632100838148833280","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/9hRlq5Q3Z3","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002381.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"632100838148833280","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-14T03:46:07.000Z","possibly_sensitive":false,"text":"@EMA_News http://t.co/ClI3tc73dn #CRPS\n@CMattocks1 \nhttp://t.co/Cs6u10TlO4","source":"Twitter for Android","author_id":"77625634","lang":"und","id":"632035443677130752","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":10,"end":32,"url":"http://t.co/ClI3tc73dn","expanded_url":"http://www.hcplive.com/medical-news/plasma-exchange-may-be-effective-treatment-for-crps-patients","display_url":"hcplive.com/medical-news/p…"},{"start":52,"end":74,"url":"http://t.co/Cs6u10TlO4","expanded_url":"http://TrialByFireMovie.com","display_url":"TrialByFireMovie.com"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":39,"end":50,"username":"CMattocks1","id":"22139847"}],"hashtags":[{"start":33,"end":38,"tag":"CRPS"}],"annotations":{},"cashtags":{}},"conversation_id":"632035443677130752","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"3df4f427b5a60fea","coordinates":{"coordinates":{}}}},{"created_at":"2015-08-12T08:58:52.000Z","possibly_sensitive":false,"text":"@EMA_News endorses the EU Telematics Strategy &amp; Implementation roadmap. More IT for better #medicine #regulation http://t.co/95rSOvuOuP","source":"Twitter Web Client","author_id":"216314816","lang":"en","id":"631389374538760193","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/95rSOvuOuP","expanded_url":"http://bit.ly/1N2sYt2","display_url":"bit.ly/1N2sYt2"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":95,"end":104,"tag":"medicine"},{"start":105,"end":116,"tag":"regulation"}],"annotations":[{"start":23,"end":35,"probability":0.7423,"type":"Organization","normalized_text":"EU Telematics"}],"cashtags":{}},"conversation_id":"631389374538760193","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-10T08:50:15.000Z","possibly_sensitive":false,"text":"@EMA_News @EduardGToledano conste que hasta que no se lo pregunté en su web ponían que del 3 al 6 había reunión!","source":"Twitter Web Client","author_id":"77272175","lang":"es","id":"630662431572930560","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"EduardGToledano","id":"1177260435021684736"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"629645855881068544","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"629654626036531200"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-07T13:36:56.000Z","possibly_sensitive":false,"text":"@EMA_News there are no agenda neither highlights of August meeting","source":"Twitter for iPhone","author_id":"77272175","lang":"en","id":"629647413633019904","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"629645855881068544","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"629645855881068544"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-07T06:28:24.000Z","possibly_sensitive":false,"text":"@EMA_News Our badge helps people with hidden disabilities. Come visit us @askformyseat http://t.co/aG7lilP17I","source":"Twitter Web Client","author_id":"3377258171","lang":"en","id":"629539569524953089","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/aG7lilP17I","expanded_url":"http://bit.ly/1GnGGOL","display_url":"bit.ly/1GnGGOL"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":73,"end":86,"username":"askformyseat","id":"3377258171"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"629539569524953089","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-06T08:42:08.000Z","possibly_sensitive":false,"text":"@EMA_News  Regulators and industry tackle dose-finding issues http://t.co/WCbADvTPWD at EMA Workshop http://t.co/n59TBDbAwP","source":"Twitter Web Client","author_id":"2194335170","lang":"en","id":"629210835857088512","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/WCbADvTPWD","expanded_url":"http://rdcu.be/dACW","display_url":"rdcu.be/dACW"},{"start":101,"end":123,"url":"http://t.co/n59TBDbAwP","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Report/2015/04/WC500185864.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":88,"end":99,"probability":0.6317,"type":"Organization","normalized_text":"EMA Workshop"}],"cashtags":{}},"conversation_id":"629210835857088512","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-05T11:31:29.000Z","possibly_sensitive":false,"text":"@EMA_News to publish public-friendly information on #herbalmedicines http://t.co/r9Sc4KhErr http://t.co/WNtkpbPtOF","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"628891068487106560","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/r9Sc4KhErr","expanded_url":"http://ow.ly/QvYjy","display_url":"ow.ly/QvYjy"},{"start":92,"end":114,"url":"http://t.co/WNtkpbPtOF","expanded_url":"https://twitter.com/WALregulatory/status/628891068487106560/photo/1","display_url":"pic.twitter.com/WNtkpbPtOF"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":52,"end":68,"tag":"herbalmedicines"}],"annotations":{},"cashtags":{}},"conversation_id":"628891068487106560","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_628891068071739392"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-04T13:37:29.000Z","possibly_sensitive":false,"text":"@EMA_News sorry,  but we already tried yesterday using form without result! NOOS SRL MR ANDREA SAPORI","source":"Twitter for Android","author_id":"71639666","lang":"en","id":"628560388083335168","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":88,"end":100,"probability":0.5175,"type":"Person","normalized_text":"ANDREA SAPORI"}],"cashtags":{}},"conversation_id":"628544032717807616","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"628550124562722816"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-04T13:00:27.000Z","possibly_sensitive":false,"text":"@EMA_News has revised the list of class waivers for the paediatric investigation plan. Find out more http://t.co/trO4Ry5sg5  #regaffairs","source":"Twitter Web Client","author_id":"26739900","lang":"en","id":"628551069619064834","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/trO4Ry5sg5","expanded_url":"http://bit.ly/1INpcmz","display_url":"bit.ly/1INpcmz"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":125,"end":136,"tag":"regaffairs"}],"annotations":{},"cashtags":{}},"conversation_id":"628551069619064834","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-04T12:32:29.000Z","possibly_sensitive":false,"text":"@EMA_News Hi, we need your VAT number because not present in your invoice to Noos Srl (Italy). Please send it as soon as possible! Thanks","source":"Twitter Web Client","author_id":"71639666","lang":"en","id":"628544032717807616","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":77,"end":84,"probability":0.4391,"type":"Organization","normalized_text":"Noos Srl"},{"start":87,"end":91,"probability":0.7485,"type":"Place","normalized_text":"Italy"}],"cashtags":{}},"conversation_id":"628544032717807616","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-04T10:24:45.000Z","possibly_sensitive":false,"text":"@EMA_News -  #EMA will be making the use of the XML delivery file mandatory from 1 Sept for all PSUR submissions see  http://t.co/YpFRKUoND9","source":"Twitter Web Client","author_id":"2615562036","lang":"en","id":"628511885642612736","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/YpFRKUoND9","expanded_url":"http://esubmission.ema.europa.eu/psur/psur_repository.htm","display_url":"esubmission.ema.europa.eu/psur/psur_repo…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":13,"end":17,"tag":"EMA"}],"annotations":{},"cashtags":{}},"conversation_id":"628511885642612736","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-08-04T04:34:04.000Z","possibly_sensitive":false,"text":"@EMA_News Prof. Bruno Miguel Nogueira Sepodes , Chair COMP at National Regulatory Conference 2015, Malaysia","source":"Twitter for iPhone","author_id":"246343802","lang":"pt","id":"628423634856472576","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":10,"end":36,"probability":0.6673,"type":"Person","normalized_text":"Prof. Bruno Miguel Nogueira"},{"start":99,"end":106,"probability":0.6455,"type":"Place","normalized_text":"Malaysia"}],"cashtags":{}},"conversation_id":"628423634856472576","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"77def60fb9166b95","coordinates":{"coordinates":{}}}},{"created_at":"2015-08-03T18:10:58.000Z","possibly_sensitive":false,"text":"@EMA_News they were and thanks@","source":"Twitter for iPhone","author_id":"108597502","lang":"en","id":"628266824044515328","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"627134711438143489","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"628171713163960320"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-31T18:23:59.000Z","possibly_sensitive":false,"text":"Hi @EMA_News sent you a press query several days ago. No response. Can you look into it? Thanks","source":"Twitter for iPhone","author_id":"108597502","lang":"en","id":"627182936538894336","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"627134711438143489","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"627134711438143489"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-31T09:51:07.000Z","possibly_sensitive":false,"text":"@EMA_News thanks, I just wondered if they explained *why* they did that? They also applied for the 3 indications and the rest is identical","source":"Hootsuite","author_id":"2902360799","lang":"en","id":"627053871999938560","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"626745452830965760","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"627053117528481792"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-30T13:25:34.000Z","possibly_sensitive":false,"text":"@EMA_News what's the difference between Pregabalin Sandoz (3 indications) and Pregabalin Sandoz GmbH (2 indications)? http://t.co/0P2k3Si93u","source":"Twitter Web Client","author_id":"2902360799","lang":"en","id":"626745452830965760","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/0P2k3Si93u","expanded_url":"http://ow.ly/QgYZX","display_url":"ow.ly/QgYZX"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":40,"end":56,"probability":0.4893,"type":"Person","normalized_text":"Pregabalin Sandoz"},{"start":78,"end":99,"probability":0.232,"type":"Organization","normalized_text":"Pregabalin Sandoz GmbH"}],"cashtags":{}},"conversation_id":"626745452830965760","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-29T16:52:46.000Z","possibly_sensitive":false,"text":"@EMA_News Thanks for the retweets!","source":"Twitter Web Client","author_id":"2528303509","lang":"en","id":"626435206241775616","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"626435206241775616","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-28T13:05:39.000Z","possibly_sensitive":false,"text":"@EMA_News grants accelerated approval for #elotuzumab read more here: http://t.co/GxSZ9jS3LU #myeloma","source":"Twitter Web Client","author_id":"281593336","lang":"en","id":"626015664919171072","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/GxSZ9jS3LU","expanded_url":"http://www.myeloma.org.uk/blog/news/ema-grants-accelerated-approval-for-elotuzumab/","display_url":"myeloma.org.uk/blog/news/ema-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":42,"end":53,"tag":"elotuzumab"},{"start":93,"end":101,"tag":"myeloma"}],"annotations":{},"cashtags":{}},"conversation_id":"626015664919171072","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-28T10:05:49.000Z","possibly_sensitive":false,"text":"“@EMA_News:report for #Pregabalin Zentiva,  for #epilepsy #anxiety disorder: http://t.co/6XdGrCLvhA” be alert for suicide &amp; Psych ADR risks!","source":"Twitter for iPad","author_id":"205270115","lang":"en","id":"625970407984775168","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/6XdGrCLvhA","expanded_url":"http://bit.ly/1KuX2wL","display_url":"bit.ly/1KuX2wL"}],"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":22,"end":33,"tag":"Pregabalin"},{"start":48,"end":57,"tag":"epilepsy"},{"start":58,"end":66,"tag":"anxiety"}],"annotations":{},"cashtags":{}},"conversation_id":"625945532272410624","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"625945532272410624"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-28T09:59:12.000Z","possibly_sensitive":false,"text":"@EMA_News launches consultation on fast track routes 4 #medicines addressing unmet medical needs  http://t.co/WtnvoXd5X2  @EuropaBio","source":"Twitter Web Client","author_id":"3251574099","lang":"en","id":"625968742082736129","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/WtnvoXd5X2","expanded_url":"http://goo.gl/l7o2Ho","display_url":"goo.gl/l7o2Ho"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":122,"end":132,"username":"EuropaBio","id":"19642657"}],"hashtags":[{"start":55,"end":65,"tag":"medicines"}],"annotations":{},"cashtags":{}},"conversation_id":"625968742082736129","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-27T22:49:17.000Z","possibly_sensitive":false,"text":"@ema_news Cytotoxicity, immune suppression, and anxiety/depression from use of steroids.","source":"Right Relevance","author_id":"22981419","lang":"en","id":"625800151081226240","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"625800151081226240","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-27T20:04:37.000Z","possibly_sensitive":false,"text":"@EMA_News grants accelerated acceptance for filing of #Empliciti (#elotuzumab) for #multiplemyeloma http://t.co/4Q1Ih23Ixv @bmsnews","source":"Twitter for iPad","author_id":"633978297","lang":"en","id":"625758710678298624","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/4Q1Ih23Ixv","expanded_url":"http://bit.ly/1S70Kkr","display_url":"bit.ly/1S70Kkr"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":123,"end":131,"username":"bmsnews","id":"34010976"}],"hashtags":[{"start":54,"end":64,"tag":"Empliciti"},{"start":66,"end":77,"tag":"elotuzumab"},{"start":83,"end":99,"tag":"multiplemyeloma"}],"annotations":{},"cashtags":{}},"conversation_id":"625758710678298624","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-27T12:09:47.000Z","possibly_sensitive":false,"text":"@EMA_News grants accelerated MAA for #empliciti #elotuzumab for #multiplemyeloma\n@bmsnews @abbvie #SLAMF7 \nhttp://t.co/8dWVdgJSFB","source":"Twitter Web Client","author_id":"1149776131","lang":"en","id":"625639217591398400","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/8dWVdgJSFB","expanded_url":"http://bit.ly/1LNs7un","display_url":"bit.ly/1LNs7un"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":81,"end":89,"username":"bmsnews","id":"34010976"},{"start":90,"end":97,"username":"abbvie","id":"531892451"}],"hashtags":[{"start":37,"end":47,"tag":"empliciti"},{"start":48,"end":59,"tag":"elotuzumab"},{"start":64,"end":80,"tag":"multiplemyeloma"},{"start":98,"end":105,"tag":"SLAMF7"}],"annotations":{},"cashtags":{}},"conversation_id":"625639217591398400","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-27T07:28:24.000Z","possibly_sensitive":false,"text":"@EMA_News empfiehlt Malaria-Impfstoff:  http://t.co/tIdPA6gFF5","source":"Twitter Web Client","author_id":"2974854213","lang":"de","id":"625568401730224129","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":40,"end":62,"url":"http://t.co/tIdPA6gFF5","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002376.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"625568401730224129","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-25T00:18:31.000Z","possibly_sensitive":false,"text":"“@EMA_News: First #malaria #vaccine receives positive scientific opinion from EMA: http://t.co/IixWgZkePb” What a historic day! Great news!","source":"Twitter for iPad","author_id":"1942349545","lang":"en","id":"624735442944942080","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/IixWgZkePb","expanded_url":"http://bit.ly/1elljqI","display_url":"bit.ly/1elljqI"}],"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":18,"end":26,"tag":"malaria"},{"start":27,"end":35,"tag":"vaccine"}],"annotations":{},"cashtags":{}},"conversation_id":"624496841774788608","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"624496841774788608"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-24T20:31:04.000Z","possibly_sensitive":false,"text":"@EMA_News recomienda nueva terapia de Sanofi que consigue la reducción media del colesterol de lipoproteínas de baja densidad","source":"Hootsuite","author_id":"1058935662","lang":"es","id":"624678204305973248","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":38,"end":43,"probability":0.5305,"type":"Organization","normalized_text":"Sanofi"}],"cashtags":{}},"conversation_id":"624678204305973248","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-24T19:11:54.000Z","possibly_sensitive":false,"text":"@EMA_News emite opinión positiva sobre tratamiento de Sanofi que disminuye los niveles de colesterol que provocan hipercolesterolemia","source":"Twitter Web Client","author_id":"1058935662","lang":"es","id":"624658282204917760","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":54,"end":59,"probability":0.6236,"type":"Organization","normalized_text":"Sanofi"}],"cashtags":{}},"conversation_id":"624658282204917760","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-24T16:07:57.000Z","possibly_sensitive":false,"text":"@EMA_News gave positive view on world's 1st #malaria vaccine; @WHO to consider the use of it in #Africa. #goodnews! https://t.co/LSCtWPCKsq","source":"Twitter for iPhone","author_id":"223969008","lang":"en","id":"624611988354641920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/LSCtWPCKsq","expanded_url":"https://twitter.com/bbcbreaking/status/624444955084374016","display_url":"twitter.com/bbcbreaking/st…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":62,"end":66,"username":"WHO","id":"14499829"}],"hashtags":[{"start":44,"end":52,"tag":"malaria"},{"start":96,"end":103,"tag":"Africa"},{"start":105,"end":114,"tag":"goodnews"}],"annotations":{},"cashtags":{}},"conversation_id":"624611988354641920","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"624444955084374016"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-24T11:58:15.000Z","possibly_sensitive":false,"text":"@EMA_News @SanofiPolska http://t.co/psRZhHtMaV","source":"Twitter Web Client","author_id":"49072383","lang":"und","id":"624549148600233984","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":24,"end":46,"url":"http://t.co/psRZhHtMaV","expanded_url":"http://trafisz.com/p/voWXvo6HxegTGnW304zzh1w0Wbq7WOP3lfXw0L1TxyihhH5rbg","display_url":"trafisz.com/p/voWXvo6HxegT…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"SanofiPolska","id":"2289646178"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"624496841774788608","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"624496841774788608"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-24T11:01:29.000Z","possibly_sensitive":false,"text":"@soysolisu @EMA_News\nMagnifica noticia","source":"Twitter for Android","author_id":"299504092","lang":"pt","id":"624534861806706688","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":10,"username":"soysolisu","id":"155705184"},{"start":11,"end":20,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"624496841774788608","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"624496841774788608"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-24T10:58:31.000Z","possibly_sensitive":false,"text":"@EMA_News gibt grünes Licht für #Malaria-Mittel von @GSK;  Zulassung steht bevor; Tübinger an Studie beteiligt; mehr: http://t.co/cLjhDNGsFT","source":"Twitter Web Client","author_id":"19646980","lang":"de","id":"624534116428611584","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/cLjhDNGsFT","expanded_url":"http://goo.gl/vmqzqo","display_url":"goo.gl/vmqzqo"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":52,"end":56,"username":"GSK","id":"5383942"}],"hashtags":[{"start":32,"end":40,"tag":"Malaria"}],"annotations":{},"cashtags":{}},"conversation_id":"624534116428611584","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-24T09:52:42.000Z","possibly_sensitive":false,"text":"@EMA_News en chans för en rejäl hälsoförbättring i världen!","source":"Twitter for iPhone","author_id":"26791880","lang":"sv","id":"624517553679933440","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"624496841774788608","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"624496841774788608"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-24T08:35:44.000Z","possibly_sensitive":false,"text":"“@EMA_News: First #malaria #vaccine receives positive scientific opinion from EMA: http://t.co/vLjZgQQgKl” gran noticia!","source":"Twitter for iPad","author_id":"364716671","lang":"en","id":"624498186732879872","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/vLjZgQQgKl","expanded_url":"http://bit.ly/1elljqI","display_url":"bit.ly/1elljqI"}],"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":18,"end":26,"tag":"malaria"},{"start":27,"end":35,"tag":"vaccine"}],"annotations":{},"cashtags":{}},"conversation_id":"624496841774788608","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"624496841774788608"}],"attachments":{"media_keys":{}},"geo":{"place_id":"dd5ca53bdb47a1cb","coordinates":{"coordinates":{}}}},{"created_at":"2015-07-24T08:34:34.000Z","possibly_sensitive":false,"text":"@EMA_News stimulates #pharma to develop more #medicines for children @EuropaBio http://t.co/Co3UR1xmTw","source":"Twitter Web Client","author_id":"3251574099","lang":"en","id":"624497890287878144","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/Co3UR1xmTw","expanded_url":"http://goo.gl/rcBdEA","display_url":"goo.gl/rcBdEA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":69,"end":79,"username":"EuropaBio","id":"19642657"}],"hashtags":[{"start":21,"end":28,"tag":"pharma"},{"start":45,"end":55,"tag":"medicines"}],"annotations":{},"cashtags":{}},"conversation_id":"624497890287878144","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-23T19:43:58.000Z","possibly_sensitive":false,"text":"@EMA_News Announces sweeping revisions to pediatric investigation plan (PIP) class waivers, read about it here - http://t.co/Y6vyWhnmQv","source":"Twitter Web Client","author_id":"1195040281","lang":"en","id":"624303961487577088","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/Y6vyWhnmQv","expanded_url":"http://ow.ly/Q0wkR","display_url":"ow.ly/Q0wkR"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"624303961487577088","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-23T16:32:09.000Z","possibly_sensitive":false,"text":"@EMA_News, @EU_Health &amp; Swiss regulators agreed to share non-public info on safety, quality, efficacy of #medicines http://t.co/bnwBVojhX7","source":"Hootsuite","author_id":"19642657","lang":"en","id":"624255691117752320","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/bnwBVojhX7","expanded_url":"http://ow.ly/PYxcC","display_url":"ow.ly/PYxcC"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":21,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":109,"end":119,"tag":"medicines"}],"annotations":{},"cashtags":{}},"conversation_id":"624255691117752320","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-21T14:48:24.000Z","possibly_sensitive":false,"text":"@EMA_News y @US_FDA apuestan por introducir al #paciente en la aprobación de #fármacos\nhttp://t.co/KMoKxvXX9Q","source":"Twitter Web Client","author_id":"1242516320","lang":"es","id":"623504807559589888","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/KMoKxvXX9Q","expanded_url":"http://pharmaexpertise.com/ema-y-fda-apuestan-por-introducir-al-paciente-en-la-aprobacion-de-farmacos/","display_url":"pharmaexpertise.com/ema-y-fda-apue…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":47,"end":56,"tag":"paciente"},{"start":77,"end":86,"tag":"fármacos"}],"annotations":{},"cashtags":{}},"conversation_id":"623504807559589888","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-20T09:03:01.000Z","possibly_sensitive":false,"text":"@EMA_News Follow me for #HIV &amp; #Hepatitis #Features #News #Blog #Polls #Resources #Videos #Infographics #Subscribe http://t.co/4jnI9xWS4R","source":"Twitter for iPhone","author_id":"2416339741","lang":"en","id":"623055500926689280","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":119,"end":141,"url":"http://t.co/4jnI9xWS4R","expanded_url":"http://www.design-redefined.co.uk","display_url":"design-redefined.co.uk"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":24,"end":28,"tag":"HIV"},{"start":35,"end":45,"tag":"Hepatitis"},{"start":46,"end":55,"tag":"Features"},{"start":56,"end":61,"tag":"News"},{"start":62,"end":67,"tag":"Blog"},{"start":68,"end":74,"tag":"Polls"},{"start":75,"end":85,"tag":"Resources"},{"start":86,"end":93,"tag":"Videos"},{"start":94,"end":107,"tag":"Infographics"},{"start":108,"end":118,"tag":"Subscribe"}],"annotations":{},"cashtags":{}},"conversation_id":"623055500926689280","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"4c56154e1c99a7d7","coordinates":{"coordinates":{}}}},{"created_at":"2015-07-20T07:50:28.000Z","possibly_sensitive":false,"text":"@EMA_News @EuropaBio @onlineherbalist @ddeforce @biolink_us @SorayaLemaire @MartinGantzhorn @NovateurBio thanks for the RT and FAVs!","source":"TweetDeck","author_id":"2917826331","lang":"en","id":"623037242848772097","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EuropaBio","id":"19642657"},{"start":21,"end":37,"username":"onlineherbalist","id":"20833203"},{"start":38,"end":47,"username":"ddeforce","id":"126329620"},{"start":60,"end":74,"username":"SorayaLemaire","id":"583632144"},{"start":75,"end":91,"username":"MartinGantzhorn","id":"1894697492"},{"start":92,"end":104,"username":"NovateurBio","id":"3220814930"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"623037242848772097","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-17T10:12:25.000Z","possibly_sensitive":false,"text":"18:11 07/17 Learn Spanish With Rocket Spanish http://t.co/sVNbhFFDA8 @EMA_News @patientexpert It is only in Spanish but this infographic ...","source":"Moviestrap","author_id":"111591706","lang":"en","id":"621985801753079808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/sVNbhFFDA8","expanded_url":"http://cloudservermarket.com/Learn-Spanish-With-Rocket-Spanish.jsp","display_url":"cloudservermarket.com/Learn-Spanish-…"}],"mentions":[{"start":69,"end":78,"username":"EMA_News","id":"116716199"},{"start":79,"end":93,"username":"PatientExpert","id":"1371958822676348932"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"621703473537642496","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"621985620949344256"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-16T23:49:36.000Z","possibly_sensitive":false,"text":"@EMA_News y @US_FDA apuestan por introducir al paciente en el proceso de aprobación de fármacos @TalentsPharma http://t.co/HLwfuGKh4i","source":"Twitter Web Client","author_id":"127018012","lang":"es","id":"621829062613434368","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/HLwfuGKh4i","expanded_url":"http://pharmatalents.es/Noticias/detalle/2939","display_url":"pharmatalents.es/Noticias/detal…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"},{"start":96,"end":110,"username":"TalentsPharma","id":"821464826"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"621829062613434368","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-16T09:17:52.000Z","possibly_sensitive":false,"text":"@EMA_News y @US_FDA apuestan por introducir al #paciente en el proceso de aprobación de #fármacos - http://t.co/WB3QYxAkqC @redaccionmedica","source":"Twitter Web Client","author_id":"2282014590","lang":"es","id":"621609682914967552","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/WB3QYxAkqC","expanded_url":"http://go.shr.lc/1I3raNf","display_url":"go.shr.lc/1I3raNf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"},{"start":123,"end":139,"username":"redaccionmedica","id":"229001251"}],"hashtags":[{"start":47,"end":56,"tag":"paciente"},{"start":88,"end":97,"tag":"fármacos"}],"annotations":{},"cashtags":{}},"conversation_id":"621609682914967552","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-16T08:49:54.000Z","possibly_sensitive":false,"text":"@EMA_News y @US_FDA apuestan por introducir al paciente en el proceso de aprobación de fármacos @TalentsPharma http://t.co/7UdysrECHt","source":"Twitter Web Client","author_id":"20530352","lang":"es","id":"621602645460054016","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/7UdysrECHt","expanded_url":"http://pharmatalents.es/Noticias/detalle/2939","display_url":"pharmatalents.es/Noticias/detal…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"},{"start":96,"end":110,"username":"TalentsPharma","id":"821464826"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"621602645460054016","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-16T08:44:42.000Z","possibly_sensitive":false,"text":"@EMA_News y @US_FDA apuestan por introducir al paciente en el proceso de aprobación de fármacos @TalentsPharma http://t.co/H9hYzATwUA","source":"Mobile Web","author_id":"438473748","lang":"es","id":"621601336661024768","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/H9hYzATwUA","expanded_url":"http://pharmatalents.es/Noticias/detalle/2939","display_url":"pharmatalents.es/Noticias/detal…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"},{"start":96,"end":110,"username":"TalentsPharma","id":"821464826"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"621601336661024768","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-16T08:42:31.000Z","possibly_sensitive":false,"text":"@EMA_News y @US_FDA apuestan por introducir al paciente en el proceso de aprobación de fármacos @TalentsPharma http://t.co/T7M0r5Wowe","source":"OS X","author_id":"2184430467","lang":"es","id":"621600787878252544","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/T7M0r5Wowe","expanded_url":"http://www.pharmatalents.es/Noticias/detalle/2939","display_url":"pharmatalents.es/Noticias/detal…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"},{"start":96,"end":110,"username":"TalentsPharma","id":"821464826"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"621600787878252544","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-16T08:34:31.000Z","possibly_sensitive":false,"text":"@EMA_News y @US_FDA apuestan por introducir al #paciente en el proceso de aprobación de fármacos http://t.co/xCzsbAhYvi","source":"Twitter Web Client","author_id":"270051623","lang":"es","id":"621598775207981056","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/xCzsbAhYvi","expanded_url":"http://go.shr.lc/1I3raNf","display_url":"go.shr.lc/1I3raNf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":47,"end":56,"tag":"paciente"}],"annotations":{},"cashtags":{}},"conversation_id":"621598775207981056","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-15T16:32:39.000Z","possibly_sensitive":false,"text":"@EMA_News is recruiting a Scientific Officer, Inspections and Human Medicines Pharmacovigilance http://t.co/7wcqyw30RO","source":"Hootsuite","author_id":"19642657","lang":"en","id":"621356714777018368","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/7wcqyw30RO","expanded_url":"http://ow.ly/PDnbR","display_url":"ow.ly/PDnbR"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"621356714777018368","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-15T12:59:24.000Z","possibly_sensitive":false,"text":"@EMA_News reinforced its collaboration with @US_FDA and @EU_Commission to advance medicine development and evaluation http://t.co/YJcgX9VKI1","source":"Tweetbot for iΟS","author_id":"2834291205","lang":"en","id":"621303047952728064","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/YJcgX9VKI1","expanded_url":"http://bit.ly/1M8cqiP","display_url":"bit.ly/1M8cqiP"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":44,"end":51,"username":"US_FDA","id":"208120290"},{"start":56,"end":70,"username":"EU_Commission","id":"157981564"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"621303047952728064","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-15T12:14:01.000Z","possibly_sensitive":false,"text":"When will sustainability become a priority? “@EMA_News: We've reinforced our collaboration with @US_FDA http://t.co/3Pl2t6dBCy”","source":"Twitter for iPad","author_id":"3312924448","lang":"en","id":"621291627672432640","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/3Pl2t6dBCy","expanded_url":"http://bit.ly/1M8cqiP","display_url":"bit.ly/1M8cqiP"}],"mentions":[{"start":45,"end":54,"username":"EMA_News","id":"116716199"},{"start":96,"end":103,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"621238037322854400","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"621238037322854400"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-14T11:32:02.000Z","possibly_sensitive":false,"text":"@EMA_News starts to publish outcomes of single assessments of #PSURs http://t.co/fk0FeY5D8U http://t.co/8DzSM5fBrF","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"620918673620996097","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/fk0FeY5D8U","expanded_url":"http://ow.ly/Pwp17","display_url":"ow.ly/Pwp17"},{"start":92,"end":114,"url":"http://t.co/8DzSM5fBrF","expanded_url":"https://twitter.com/WALregulatory/status/620918673620996097/photo/1","display_url":"pic.twitter.com/8DzSM5fBrF"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":62,"end":68,"tag":"PSURs"}],"annotations":{},"cashtags":{}},"conversation_id":"620918673620996097","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_620918673134325760"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-13T21:05:02.000Z","possibly_sensitive":false,"text":"@EMA_News Is this patient leaflet acceptable??  The font must be sub 6 http://t.co/5f8saCDsNp","source":"Twitter for Android","author_id":"40549442","lang":"en","id":"620700485679476736","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/5f8saCDsNp","expanded_url":"https://twitter.com/JAHCave/status/620700485679476736/photo/1","display_url":"pic.twitter.com/5f8saCDsNp"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"620700485679476736","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_620700478041653248"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-13T18:47:34.000Z","possibly_sensitive":false,"text":"@EMA_News As usual. HVP vaccine. Harms are \"possible\" (you need to demonstrate a causal connection).","source":"Twitter Web Client","author_id":"833942719","lang":"en","id":"620665889692741632","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"620665889692741632","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-13T18:47:06.000Z","possibly_sensitive":false,"text":"@EMA_News As usual. HVP vaccine. Benefits are \"evident\" (you need not to demonstrate a causal connection)","source":"Twitter Web Client","author_id":"833942719","lang":"en","id":"620665772831047680","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"620665772831047680","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-13T11:01:57.000Z","possibly_sensitive":false,"text":"@EMA_News started a review of human papillomavirus HPV vaccines #Gardasil &amp; #Cervarix to further clarify their safety http://t.co/VmE98KrrN4","source":"Twitter Web Client","author_id":"1106659014","lang":"en","id":"620548716315955200","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/VmE98KrrN4","expanded_url":"http://bit.ly/1HpJM8K","display_url":"bit.ly/1HpJM8K"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":64,"end":73,"tag":"Gardasil"},{"start":80,"end":89,"tag":"Cervarix"}],"annotations":{},"cashtags":{}},"conversation_id":"620548716315955200","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-10T15:31:37.000Z","possibly_sensitive":false,"text":"@EMA_News Follow me for #HIV &amp; #Hepatitis #Features #News #Blog #Polls #Resources #Videos #Infographics #Subscribe http://t.co/4jnI9xWS4R","source":"Twitter for iPhone","author_id":"2416339741","lang":"en","id":"619529416264298497","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":119,"end":141,"url":"http://t.co/4jnI9xWS4R","expanded_url":"http://www.design-redefined.co.uk","display_url":"design-redefined.co.uk"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":24,"end":28,"tag":"HIV"},{"start":35,"end":45,"tag":"Hepatitis"},{"start":46,"end":55,"tag":"Features"},{"start":56,"end":61,"tag":"News"},{"start":62,"end":67,"tag":"Blog"},{"start":68,"end":74,"tag":"Polls"},{"start":75,"end":85,"tag":"Resources"},{"start":86,"end":93,"tag":"Videos"},{"start":94,"end":107,"tag":"Infographics"},{"start":108,"end":118,"tag":"Subscribe"}],"annotations":{},"cashtags":{}},"conversation_id":"619529416264298497","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"4c56154e1c99a7d7","coordinates":{"coordinates":{}}}},{"created_at":"2015-07-10T13:57:31.000Z","possibly_sensitive":false,"text":"@Tweet_Ha  June 2015 Newsletter from the Polish Medicines Agency contains only a list of registered medicines products in June. @EMA_News","source":"Twitter for iPhone","author_id":"556679074","lang":"en","id":"619505734250819584","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"Tweet_Ha","id":"254489074"},{"start":128,"end":137,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":41,"end":63,"probability":0.6967,"type":"Organization","normalized_text":"Polish Medicines Agency"}],"cashtags":{}},"conversation_id":"619488216501063685","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"619500942401138688"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-10T12:53:22.000Z","possibly_sensitive":false,"text":"@EMA_News would you please translate what’s important to English.","source":"Tweetbot for iΟS","author_id":"254489074","lang":"en","id":"619489591268020224","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"619488216501063685","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"619488216501063685"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-10T07:39:52.000Z","possibly_sensitive":false,"text":"The highlights from this week's #pharmacovigilance committee (PRAC) meeting will now be out on Monday, not today.","source":"Twitter Web Client","author_id":"116716199","lang":"en","id":"619410697328455680","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":{},"mentions":{},"hashtags":[{"start":32,"end":50,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"conversation_id":"616921102925885440","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"616921102925885440"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-09T13:01:51.000Z","possibly_sensitive":false,"text":"@EMA_News publishes outcomes of single assessments of PSURs for active substances of nationally authorised medicines: http://t.co/FiXmmqcSHh","source":"Twitter Web Client","author_id":"1576993495","lang":"en","id":"619129336277409792","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/FiXmmqcSHh","expanded_url":"http://www.zva.gov.lv//?rel=2364&setlang=en","display_url":"zva.gov.lv//?rel=2364&set…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":54,"end":58,"probability":0.4191,"type":"Organization","normalized_text":"PSURs"}],"cashtags":{}},"conversation_id":"619129336277409792","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"1d73626cc863c69f","coordinates":{"coordinates":{}}}},{"created_at":"2015-07-08T14:12:41.000Z","possibly_sensitive":false,"text":"@EMA_News","source":"Twitter for Android","author_id":"1008463328","lang":"und","id":"618784776384700416","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"618715649486028800","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"618715649486028800"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-08T13:57:11.000Z","possibly_sensitive":false,"text":"@EMA_News informs about changes in the submission of marketing authorisation documentation. Read more: http://t.co/PdHXy5qt8v","source":"Twitter Web Client","author_id":"1576993495","lang":"en","id":"618780876361605120","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/PdHXy5qt8v","expanded_url":"http://www.zva.gov.lv/?id=&sa=&top=&large=0&rel=2353","display_url":"zva.gov.lv/?id=&sa=&top=&…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"618780876361605120","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"1d73626cc863c69f","coordinates":{"coordinates":{}}}},{"created_at":"2015-07-08T13:56:11.000Z","possibly_sensitive":false,"text":"@EMA_News informē par izmaiņām zāļu reģistrēšanas pieteikumu iesniegšanā. Vairāk: http://t.co/jVjT5l8BXB","source":"Twitter Web Client","author_id":"1576993495","lang":"lv","id":"618780621939343361","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/jVjT5l8BXB","expanded_url":"http://www.zva.gov.lv/?id=&sa=&top=&large=0&rel=2351","display_url":"zva.gov.lv/?id=&sa=&top=&…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"618780621939343361","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"1d73626cc863c69f","coordinates":{"coordinates":{}}}},{"created_at":"2015-07-07T09:45:24.000Z","possibly_sensitive":false,"text":"@EMA_News rec. granting a marketing authorisation for Docetaxel Hospira UK Ltd http://t.co/iiMj4sXYZX #BCSM #LCSM #PCSM #HNCSM","source":"Hootsuite","author_id":"69232855","lang":"en","id":"618355124247900160","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/iiMj4sXYZX","expanded_url":"http://ow.ly/PgQ8v","display_url":"ow.ly/PgQ8v"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":102,"end":107,"tag":"BCSM"},{"start":108,"end":113,"tag":"LCSM"},{"start":114,"end":119,"tag":"PCSM"},{"start":120,"end":126,"tag":"HNCSM"}],"annotations":{},"cashtags":{}},"conversation_id":"618355124247900160","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-04T08:01:44.000Z","possibly_sensitive":false,"text":"@EMA_News has recommended for approval ten new medicines, including treatments for cancer and rare diseases. http://t.co/DOVIEDCtLg","source":"Hootsuite","author_id":"164226447","lang":"en","id":"617241872227024896","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/DOVIEDCtLg","expanded_url":"http://ow.ly/P2rYU","display_url":"ow.ly/P2rYU"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"617241872227024896","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-02T10:42:27.000Z","possibly_sensitive":false,"text":"@EMA_News - Better training tools recommended to support patients using adrenaline auto-injectors http://t.co/UlJLzSuBgl","source":"Twitter Web Client","author_id":"164835748","lang":"en","id":"616557539661103104","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/UlJLzSuBgl","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/06/news_detail_002351.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"616557539661103104","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-07-01T13:46:31.000Z","possibly_sensitive":false,"text":"@EMA_News Guido Rasi: \"early dialogue &amp; long term evidence generation are two key pillars to improve #accesstomedicines \" @TheProgressives","source":"Twitter for Android","author_id":"1106659014","lang":"en","id":"616241475584663552","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":142,"username":"TheProgressives","id":"19287037"}],"hashtags":[{"start":105,"end":123,"tag":"accesstomedicines"}],"annotations":[{"start":10,"end":19,"probability":0.9737,"type":"Person","normalized_text":"Guido Rasi"}],"cashtags":{}},"conversation_id":"616241475584663552","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-30T14:07:50.000Z","possibly_sensitive":false,"text":"@EMA_News aggiorna i modelli RCP, Fogli Illustrativi e etichettatura  nell’UE @Aifa_ufficiale http://t.co/36H47FfSra","source":"Twitter Web Client","author_id":"179536654","lang":"it","id":"615884451994861568","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/36H47FfSra","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/l%E2%80%99ema-aggiorna-i-modelli-la-presentazione-dei-riassunti-delle-caratteristiche-del-prodotto-f","display_url":"agenziafarmaco.gov.it/it/content/l%E…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":78,"end":93,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"615884451994861568","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-24T16:29:45.000Z","possibly_sensitive":false,"text":"@EMA_News Lack of Speed Kills-Lack of Interoperability Kills\n\nhttps://t.co/U9DetfyQcJ","source":"Twitter for iPhone","author_id":"1093893686","lang":"en","id":"613745837512986624","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":62,"end":85,"url":"https://t.co/U9DetfyQcJ","expanded_url":"https://www.linkedin.com/pulse/lack-speed-kills-lack-interoperability-kills-howard-green-md","display_url":"linkedin.com/pulse/lack-spe…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"613745837512986624","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-23T15:26:26.000Z","possibly_sensitive":false,"text":"#Consultation ending on #guideline on use of minimal residue disease as endpoint in chronic #lymphocytic #leukaemia: http://t.co/UJQByEklpG","source":"Twitter for iPhone","author_id":"116716199","lang":"en","id":"613367516597981184","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/UJQByEklpG","expanded_url":"http://bit.ly/12VvzR9","display_url":"bit.ly/12VvzR9"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":24,"end":34,"tag":"guideline"},{"start":92,"end":104,"tag":"lymphocytic"},{"start":105,"end":115,"tag":"leukaemia"}],"annotations":{},"cashtags":{}},"conversation_id":"613234215338033152","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"613234215338033152"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-23T15:25:58.000Z","possibly_sensitive":false,"text":"#Consultation ending on #guideline on chemical &amp; pharmaceutical #quality documentation on investigational medicines: http://t.co/83JkQL9tCU","source":"Twitter for iPhone","author_id":"116716199","lang":"en","id":"613367397769191425","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/83JkQL9tCU","expanded_url":"http://bit.ly/1De9Vqy","display_url":"bit.ly/1De9Vqy"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":24,"end":34,"tag":"guideline"},{"start":68,"end":76,"tag":"quality"}],"annotations":{},"cashtags":{}},"conversation_id":"613237358956269568","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"613237358956269568"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-23T15:25:19.000Z","possibly_sensitive":false,"text":"#Consultation ending on Q&amp;A on #guideline on #environmental #risk assessment of medicinal products for human use: http://t.co/ymiy0WXM9g","source":"Twitter for iPhone","author_id":"116716199","lang":"en","id":"613367236586262528","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/ymiy0WXM9g","expanded_url":"http://bit.ly/1FdoCcs","display_url":"bit.ly/1FdoCcs"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":35,"end":45,"tag":"guideline"},{"start":49,"end":63,"tag":"environmental"},{"start":64,"end":69,"tag":"risk"}],"annotations":{},"cashtags":{}},"conversation_id":"613239224268136448","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"613239224268136448"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-23T15:24:41.000Z","possibly_sensitive":false,"text":"#Consultation ending on #EU #medicines agencies network strategy to 2020 - working together to improve #health: http://t.co/fq7hPGqIos","source":"Twitter for iPhone","author_id":"116716199","lang":"en","id":"613367075566944256","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/fq7hPGqIos","expanded_url":"http://bit.ly/1JRuD3w","display_url":"bit.ly/1JRuD3w"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":24,"end":27,"tag":"EU"},{"start":28,"end":38,"tag":"medicines"},{"start":103,"end":110,"tag":"health"}],"annotations":{},"cashtags":{}},"conversation_id":"613240022343528448","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"613240022343528448"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-23T15:23:49.000Z","possibly_sensitive":false,"text":"#Consultation ending on #guideline on clinical investigation of #medicines to treat #axial #spondyloarthritis: http://t.co/83EDby9CF5","source":"Twitter for iPhone","author_id":"116716199","lang":"en","id":"613366858717265920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/83EDby9CF5","expanded_url":"http://bit.ly/1Dp8yXH","display_url":"bit.ly/1Dp8yXH"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":24,"end":34,"tag":"guideline"},{"start":64,"end":74,"tag":"medicines"},{"start":84,"end":90,"tag":"axial"},{"start":91,"end":109,"tag":"spondyloarthritis"}],"annotations":{},"cashtags":{}},"conversation_id":"613240875355910144","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"613240875355910144"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-22T20:19:37.000Z","possibly_sensitive":false,"text":"@EMA_News CYSTICFIBROSIS.WaitingApproval EMA for ORKAMBI!1stmed VERTEXstops Cf F508del.People is DYING.No more time. http://t.co/ibzgwGJhHy","source":"Twitter Web Client","author_id":"2789795314","lang":"en","id":"613078909924573184","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/ibzgwGJhHy","expanded_url":"http://www.aprobacioncurafq.blogspot.com.es","display_url":"aprobacioncurafq.blogspot.com.es"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"613078909924573184","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-21T13:13:50.000Z","possibly_sensitive":false,"text":"@EMA_News #H7N9 https://t.co/Cdh8Q1jyx0","source":"Twitter for Android","author_id":"1579596458","lang":"und","id":"612609372426932229","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":16,"end":39,"url":"https://t.co/Cdh8Q1jyx0","expanded_url":"https://twitter.com/FluTrackers/status/612306299624267776","display_url":"twitter.com/FluTrackers/st…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"H7N9"}],"annotations":{},"cashtags":{}},"conversation_id":"612609372426932229","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"612306299624267776"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-19T14:02:02.000Z","possibly_sensitive":false,"text":"@EMA_News solicits input on clinical trial database http://t.co/rNF9e570TR","source":"Twitter Web Client","author_id":"85504867","lang":"en","id":"611896726706745344","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/rNF9e570TR","expanded_url":"http://www.pearlirb.com/ema-wants-stakeholders-opinions-for-clinical-trials-database","display_url":"pearlirb.com/ema-wants-stak…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"611896726706745344","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-17T08:31:03.000Z","possibly_sensitive":false,"text":"@EMA_News gives green light for use of #centralrepository for #PSURs across the EU http://t.co/b0Xpcba4KB http://t.co/WmYINFTU2E","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"611088655998951424","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/b0Xpcba4KB","expanded_url":"http://ow.ly/OnUNw","display_url":"ow.ly/OnUNw"},{"start":106,"end":128,"url":"http://t.co/WmYINFTU2E","expanded_url":"https://twitter.com/WALregulatory/status/611088655998951424/photo/1","display_url":"pic.twitter.com/WmYINFTU2E"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":39,"end":57,"tag":"centralrepository"},{"start":62,"end":68,"tag":"PSURs"}],"annotations":{},"cashtags":{}},"conversation_id":"611088655998951424","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_611088655432577024"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-17T07:31:34.000Z","possibly_sensitive":false,"text":"@EMA_News @Chemogroup @oliviapita @Rinnakkaislaake @tesselmellema @ichange_coach  @Brand_NewHealth Thanks for the RT! Good morning!","source":"TweetDeck","author_id":"2315763655","lang":"en","id":"611073687312289792","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":22,"end":33,"username":"oliviapita","id":"93911107"},{"start":34,"end":50,"username":"Rinnakkaislaake","id":"2354554735"},{"start":51,"end":65,"username":"tesselmellema","id":"471815116"},{"start":66,"end":80,"username":"ichange_coach","id":"2859294735"},{"start":82,"end":98,"username":"Brand_NewHealth","id":"1341966104"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"611073687312289792","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-15T22:11:52.000Z","possibly_sensitive":false,"text":"@EMA_News central repository for safety reports - 1 year to go before mandatory use http://t.co/AKh64HZEY7","source":"Twitter for Android","author_id":"3320529515","lang":"en","id":"610570445092483073","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/AKh64HZEY7","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/06/news_detail_002346.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"610570445092483073","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-15T15:14:15.000Z","possibly_sensitive":false,"text":"@EMA_News You've been quoted in \"Data sharing, disruptive innovation and breakthrough meds mulled at DIA 2015\" http://t.co/6V259GFx0O","source":"Storify","author_id":"18800238","lang":"en","id":"610465347339161601","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/6V259GFx0O","expanded_url":"http://sfy.co/g0jbd","display_url":"sfy.co/g0jbd"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"610465347339161601","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:59:51.000Z","possibly_sensitive":false,"text":"@EMA_News recognise the need to translate results of #clinicaltrials into a language understood by patients and the public #EULAR2015","source":"Twitter Web Client","author_id":"51132524","lang":"en","id":"609344362292584448","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":53,"end":68,"tag":"clinicaltrials"},{"start":123,"end":133,"tag":"EULAR2015"}],"annotations":{},"cashtags":{}},"conversation_id":"609344362292584448","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:56:34.000Z","possibly_sensitive":false,"text":"@EMA_NEws Pilot initiative involving patients in #CHMP during oral explanations preceding decision-making #EULAR2015","source":"Twitter Web Client","author_id":"51132524","lang":"en","id":"609343533212958720","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":49,"end":54,"tag":"CHMP"},{"start":106,"end":116,"tag":"EULAR2015"}],"annotations":{},"cashtags":{}},"conversation_id":"609343533212958720","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"16385645","lang":"en","id":"609342303560314880","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342303560314880","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"103042994","lang":"en","id":"609342303434489857","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342303434489857","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"103042107","lang":"en","id":"609342303342170112","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342303342170112","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"55266192","lang":"en","id":"609342303312875520","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342303312875520","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"45659360","lang":"en","id":"609342303220555776","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342303220555776","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"463359285","lang":"en","id":"609342303187021824","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342303187021824","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"103023746","lang":"en","id":"609342303166050304","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342303166050304","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"63533499","lang":"en","id":"609342303103139840","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342303103139840","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"103022269","lang":"en","id":"609342303019216896","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342303019216896","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"27461078","lang":"en","id":"609342302964707328","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342302964707328","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"463364325","lang":"en","id":"609342302931173376","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342302931173376","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:51:40.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Sprout Social","author_id":"16892009","lang":"en","id":"609342302746587137","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609342302746587137","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T12:50:26.000Z","possibly_sensitive":false,"text":"@EMA_News #European Medicines Agency Reports 101 cases of diabetic ketoacidosis with SGLT2 inhibitors for type 2 diabetes; starts review","source":"Mobile Web (M2)","author_id":"402968367","lang":"en","id":"609341991827152897","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"European"}],"annotations":{},"cashtags":{}},"conversation_id":"609341991827152897","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-12T03:17:15.000Z","possibly_sensitive":false,"text":"@EMA_News Celebrity Chef  @CMattocks1 #CRPS  Documentary trailer http://t.co/Cs6u10TlO4  Please partner   http://t.co/JYJ57ZnaLx","source":"Twitter for Android","author_id":"77625634","lang":"en","id":"609197747434958848","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/Cs6u10TlO4","expanded_url":"http://TrialByFireMovie.com","display_url":"TrialByFireMovie.com"},{"start":106,"end":128,"url":"http://t.co/JYJ57ZnaLx","expanded_url":"http://dt.gofund.me/trialbyfire","display_url":"dt.gofund.me/trialbyfire"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":26,"end":37,"username":"CMattocks1","id":"22139847"}],"hashtags":[{"start":38,"end":43,"tag":"CRPS"}],"annotations":{},"cashtags":{}},"conversation_id":"609197747434958848","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-11T10:21:57.000Z","possibly_sensitive":false,"text":"@EMA_News reflects on #advancedtherapy #classification #thisisbiotech #biotech4life @EuropaBio https://t.co/JjBIlx8xRQ","source":"LinkedIn","author_id":"3293090771","lang":"en","id":"608942236932308992","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/JjBIlx8xRQ","expanded_url":"https://lnkd.in/e8eAWnd","display_url":"lnkd.in/e8eAWnd"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":84,"end":94,"username":"EuropaBio","id":"19642657"}],"hashtags":[{"start":22,"end":38,"tag":"advancedtherapy"},{"start":39,"end":54,"tag":"classification"},{"start":55,"end":69,"tag":"thisisbiotech"},{"start":70,"end":83,"tag":"biotech4life"}],"annotations":{},"cashtags":{}},"conversation_id":"608942236932308992","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-10T13:28:21.000Z","possibly_sensitive":false,"text":"@EMA_News a VOCES enU.E Justicia Gobierno España ESTAFA a una EMPRENDEDORA y a la COMISION EUROPEA \nhttp://t.co/q0LlCWOhD6","source":"Twitter for iPhone","author_id":"761781776","lang":"es","id":"608626759492337664","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/q0LlCWOhD6","expanded_url":"http://youtu.be/w6_xTAaQvLo","display_url":"youtu.be/w6_xTAaQvLo"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":42,"end":47,"probability":0.3696,"type":"Place","normalized_text":"España"},{"start":82,"end":97,"probability":0.441,"type":"Organization","normalized_text":"COMISION EUROPEA"}],"cashtags":{}},"conversation_id":"608626759492337664","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-09T16:31:18.000Z","possibly_sensitive":false,"text":"@EMA_News reflects on how products are classified as advanced therapy medicinal products (#ATMPs) http://t.co/MTltr6RAve #pharma","source":"Hootsuite","author_id":"19642657","lang":"en","id":"608310411172134913","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/MTltr6RAve","expanded_url":"http://ow.ly/O40ee","display_url":"ow.ly/O40ee"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":90,"end":96,"tag":"ATMPs"},{"start":121,"end":128,"tag":"pharma"}],"annotations":{},"cashtags":{}},"conversation_id":"608310411172134913","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-09T16:30:13.000Z","possibly_sensitive":false,"text":"@EMA_News to hold webinar on 24 June to update stakeholders on policy on publication of clinical data http://t.co/20vjpFfWqJ","source":"Twitter Web Client","author_id":"523248351","lang":"en","id":"608310137825148930","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/20vjpFfWqJ","expanded_url":"http://bit.ly/1eZOf8w","display_url":"bit.ly/1eZOf8w"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"608310137825148930","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-09T13:30:44.000Z","possibly_sensitive":false,"text":"@EMA_News EMA Webinar on 24 June on implementation of EMA policy on publication of clinical data. Register at http://t.co/UXeaLkljIg","source":"Twitter Web Client","author_id":"2194335170","lang":"en","id":"608264968904036352","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/UXeaLkljIg","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/06/news_detail_002343.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":54,"end":56,"probability":0.4684,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"conversation_id":"608264968904036352","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-09T09:30:20.000Z","possibly_sensitive":false,"text":"@EMA_News getting ready for the publication of clinical data http://t.co/Mg9GgcYWxE","source":"Twitter Web Client","author_id":"1106659014","lang":"en","id":"608204471689183233","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/Mg9GgcYWxE","expanded_url":"http://bit.ly/1eZOf8w","display_url":"bit.ly/1eZOf8w"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"608204471689183233","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-09T09:28:04.000Z","possibly_sensitive":false,"text":"@EMA_News getting ready for the publication of clinical data http://t.co/V8XnEoxv7f","source":"Twitter Web Client","author_id":"1106659014","lang":"en","id":"608203899426775040","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/V8XnEoxv7f","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/06/news_detail_002343.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"608203899426775040","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-08T09:11:26.000Z","possibly_sensitive":false,"text":"@EMA_News released dedicated webpage for ISO IDMP. Our Reg Information Director @munnire1 will attend next meeting. http://t.co/mr8uZVEgOm","source":"Twitter Web Client","author_id":"717962540","lang":"en","id":"607837325566087168","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/mr8uZVEgOm","expanded_url":"http://goo.gl/w8m9Wo","display_url":"goo.gl/w8m9Wo"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":80,"end":89,"username":"munnire1","id":"954200790"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"607837325566087168","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-04T14:03:01.000Z","possibly_sensitive":false,"text":"@EMA_News updates its recommendations for 2015/16 #seasonalflu vaccine composition http://t.co/u37WcolQG3 http://t.co/4zm3Du1csW","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"606461152898478080","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/u37WcolQG3","expanded_url":"http://ow.ly/NHu7M","display_url":"ow.ly/NHu7M"},{"start":106,"end":128,"url":"http://t.co/4zm3Du1csW","expanded_url":"https://twitter.com/WALregulatory/status/606461152898478080/photo/1","display_url":"pic.twitter.com/4zm3Du1csW"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":50,"end":62,"tag":"seasonalflu"}],"annotations":{},"cashtags":{}},"conversation_id":"606461152898478080","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_606461152197931008"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-04T12:01:34.000Z","possibly_sensitive":false,"text":"@EMA_News, @myESMO &amp; RCE joint workshop: #chordoma as model for #rarecancers @ChordomaFDN @casali_pg @BettinaRyll http://t.co/uGIzlJUPiI","source":"Twitter Web Client","author_id":"2301430153","lang":"en","id":"606430592281001984","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/uGIzlJUPiI","expanded_url":"http://bit.ly/1KbOnha","display_url":"bit.ly/1KbOnha"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":18,"username":"myESMO","id":"69232855"},{"start":81,"end":93,"username":"ChordomaFDN","id":"44783529"},{"start":94,"end":104,"username":"casali_pg","id":"470919035"},{"start":105,"end":117,"username":"BettinaRyll","id":"810969654"}],"hashtags":[{"start":45,"end":54,"tag":"chordoma"},{"start":68,"end":80,"tag":"rarecancers"}],"annotations":{},"cashtags":{}},"conversation_id":"606430592281001984","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-04T11:28:57.000Z","possibly_sensitive":false,"text":"@EMA_News committed to support @_rarecancer stakeholders in vital innovation for #rarecancer patients http://t.co/UXVmXxushR","source":"Twitter Web Client","author_id":"416095845","lang":"en","id":"606422380978831360","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/UXVmXxushR","expanded_url":"http://bit.ly/1KbOnha","display_url":"bit.ly/1KbOnha"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":31,"end":43,"username":"_rarecancer","id":"2301430153"}],"hashtags":[{"start":81,"end":92,"tag":"rarecancer"}],"annotations":{},"cashtags":{}},"conversation_id":"606422380978831360","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-04T11:24:55.000Z","possibly_sensitive":false,"text":"@EMA_News @MyESMO @_rarecancer joint workshop focuses on #rarecancers and #chordoma http://t.co/SXSpgARtCA","source":"Twitter Web Client","author_id":"416095845","lang":"en","id":"606421367626600448","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/SXSpgARtCA","expanded_url":"http://www.news-medical.net/news/20150604/EMA-ESMO-and-RCE-joint-workshop-focuses-on-rare-cancers-and-chordoma.aspx","display_url":"news-medical.net/news/20150604/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"myESMO","id":"69232855"},{"start":18,"end":30,"username":"_rarecancer","id":"2301430153"}],"hashtags":[{"start":57,"end":69,"tag":"rarecancers"},{"start":74,"end":83,"tag":"chordoma"}],"annotations":{},"cashtags":{}},"conversation_id":"606421367626600448","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-04T09:37:54.000Z","possibly_sensitive":false,"text":"@EMA_News  https://t.co/omhi3tYB5n","source":"Twitter for iPhone","author_id":"59722141","lang":"und","id":"606394437015609344","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":11,"end":34,"url":"https://t.co/omhi3tYB5n","expanded_url":"https://twitter.com/virginiehivert/status/606371846318116864","display_url":"twitter.com/virginiehivert…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"606394437015609344","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"606371846318116864"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-03T14:49:05.000Z","possibly_sensitive":false,"text":"@Fly2Belgium @EMA_News only limited protection expected against H3N2 viruses that drifted. They were the dominant ones in many countries.","source":"TweetDeck","author_id":"204752573","lang":"en","id":"606110358672142337","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":12,"username":"Fly2Belgium","id":"2827969954"},{"start":13,"end":22,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"606023767383543808","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"606033683770961920"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-03T13:15:58.000Z","possibly_sensitive":false,"text":"@EMA_News #medicalliterature monitoring service goes live in July http://t.co/Vy9FwOIt7e http://t.co/MiYNEh32iN","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"606086927721365504","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/Vy9FwOIt7e","expanded_url":"http://ow.ly/NHtMy","display_url":"ow.ly/NHtMy"},{"start":89,"end":111,"url":"http://t.co/MiYNEh32iN","expanded_url":"https://twitter.com/WALregulatory/status/606086927721365504/photo/1","display_url":"pic.twitter.com/MiYNEh32iN"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":28,"tag":"medicalliterature"}],"annotations":{},"cashtags":{}},"conversation_id":"606086927721365504","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_606086927385653249"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-02T11:01:59.000Z","possibly_sensitive":false,"text":"@EMA_News workshop aims to explore new ways of tackling #antimicrobialresistance http://t.co/a07LOl4tAD http://t.co/dRKDTDmWz2","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"605690822101770241","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/a07LOl4tAD","expanded_url":"http://ow.ly/NHqi4","display_url":"ow.ly/NHqi4"},{"start":104,"end":126,"url":"http://t.co/dRKDTDmWz2","expanded_url":"https://twitter.com/WALregulatory/status/605690822101770241/photo/1","display_url":"pic.twitter.com/dRKDTDmWz2"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":56,"end":80,"tag":"antimicrobialresistance"}],"annotations":{},"cashtags":{}},"conversation_id":"605690822101770241","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_605690821833293824"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-01T13:46:00.000Z","possibly_sensitive":false,"text":"@EMA_News looks to clarify import requirements for finished products http://t.co/iSvIkH0DYa #pharma","source":"Hootsuite","author_id":"19642657","lang":"en","id":"605369709027069953","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/iSvIkH0DYa","expanded_url":"http://ow.ly/NHWcH","display_url":"ow.ly/NHWcH"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":92,"end":99,"tag":"pharma"}],"annotations":{},"cashtags":{}},"conversation_id":"605369709027069953","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-01T12:28:58.000Z","possibly_sensitive":false,"text":"@EMA_News Nice content. Glad to run across you.","source":"TweetDeck","author_id":"3172874427","lang":"en","id":"605350323591487488","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"605349848561385472","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"605349848561385472"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-06-01T10:01:59.000Z","possibly_sensitive":false,"text":"@EMA_News invites feedback on new draft #genetherapy guideline http://t.co/eHgJ7gGfIK http://t.co/cwBvi92b1g","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"605313332808183808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/eHgJ7gGfIK","expanded_url":"http://ow.ly/NHq0u","display_url":"ow.ly/NHq0u"},{"start":86,"end":108,"url":"http://t.co/cwBvi92b1g","expanded_url":"https://twitter.com/WALregulatory/status/605313332808183808/photo/1","display_url":"pic.twitter.com/cwBvi92b1g"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":40,"end":52,"tag":"genetherapy"}],"annotations":{},"cashtags":{}},"conversation_id":"605313332808183808","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_605313332413788160"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-29T13:45:57.000Z","possibly_sensitive":false,"text":"@EMA_News prepares to launch new service to improve safety monitoring of meds &amp; simplify pharmacovigilance activities http://t.co/W2iNaXiXAn","source":"Hootsuite","author_id":"19642657","lang":"en","id":"604282532671197186","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/W2iNaXiXAn","expanded_url":"http://ow.ly/NuBvh","display_url":"ow.ly/NuBvh"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"604282532671197186","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-28T18:15:10.000Z","possibly_sensitive":false,"text":"@EMA_News is launching a medical literature monitoring service to improve meds safety monitoring http://t.co/HphJKHsKjw RT @EAHPtweet","source":"Hootsuite","author_id":"2853363424","lang":"en","id":"603987895414870019","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/HphJKHsKjw","expanded_url":"http://www.pmlive.com/pharma_news/ema_prepares_to_launch_medical_literature_monitoring_service_742568#.VWbZIyo4bFU.twitter","display_url":"pmlive.com/pharma_news/em…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":123,"end":133,"username":"EAHPtweet","id":"203357203"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"603987895414870019","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-28T17:38:02.000Z","possibly_sensitive":false,"text":"@EMA_News Seek The Truth http://t.co/bzOAlHqk8F  -&gt; $PPHM case# 8:12-cv-01608 http://t.co/F7iOrQDoiN  FDA/Senators/FBI aware of sabotage","source":"Twitter Web Client","author_id":"2871888165","lang":"en","id":"603978551675789312","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":25,"end":47,"url":"http://t.co/bzOAlHqk8F","expanded_url":"http://bit.ly/1gGYThq","display_url":"bit.ly/1gGYThq"},{"start":81,"end":103,"url":"http://t.co/F7iOrQDoiN","expanded_url":"http://tinyurl.com/keokkgs","display_url":"tinyurl.com/keokkgs","status":200,"unwound_url":"https://investorshub.advfn.com/boards/read_msg.aspx?message_id=113108003"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":115,"end":117,"probability":0.9092,"type":"Organization","normalized_text":"FBI"}],"cashtags":[{"start":55,"end":60,"tag":"PPHM"}]},"conversation_id":"603978551675789312","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-28T13:45:33.000Z","possibly_sensitive":false,"text":"@EMA_News has released draft guidelines to aid the #GeneTherapy developers http://t.co/CnpjUXsIpc","source":"Hootsuite","author_id":"19642657","lang":"en","id":"603920045434085376","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/CnpjUXsIpc","expanded_url":"http://ow.ly/NuEVU","display_url":"ow.ly/NuEVU"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":51,"end":63,"tag":"GeneTherapy"}],"annotations":{},"cashtags":{}},"conversation_id":"603920045434085376","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-28T10:27:12.000Z","possibly_sensitive":false,"text":"@EMA_News is looking to recruit a Security Officer in our Infrastructure Services Department #EU #Jobs #London  https://t.co/cvPcy7L8T8","source":"Twitter Web Client","author_id":"17485749","lang":"en","id":"603870128929898496","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/cvPcy7L8T8","expanded_url":"https://www.linkedin.com/jobs2/view/51247040?trk=vsrp_jobs_res_name&trkInfo=VSRPsearchId%3A667550211432808734788%2CVSRPtargetId%3A51247040%2CVSRPcmpt%3Aprimary","display_url":"linkedin.com/jobs2/view/512…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":93,"end":96,"tag":"EU"},{"start":97,"end":102,"tag":"Jobs"},{"start":103,"end":110,"tag":"London"}],"annotations":{},"cashtags":{}},"conversation_id":"603870128929898496","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-27T15:44:35.000Z","possibly_sensitive":false,"text":"@EMA_news - Updated advice on use of high-dose ibuprofen - for prescribing #PrimaryCare professionals http://t.co/eQRBd2Lv0k","source":"Twitter Web Client","author_id":"164835748","lang":"en","id":"603587612775952384","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/eQRBd2Lv0k","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/05/news_detail_002337.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":75,"end":87,"tag":"PrimaryCare"}],"annotations":{},"cashtags":{}},"conversation_id":"603587612775952384","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-26T12:32:53.000Z","possibly_sensitive":false,"text":"@EMA_News Perfect and thanks a lot- will share!","source":"Twitter Web Client","author_id":"3225933441","lang":"en","id":"603176983292485632","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"602900073115197442","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"603124619130871808"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-25T20:37:40.000Z","possibly_sensitive":false,"text":"@EMA_News vet","source":"Twitter Web App","author_id":"229960979","lang":"und","id":"602936592815300608","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"601690868693782529","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"601690868693782529"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-25T18:12:33.000Z","possibly_sensitive":false,"text":"@EMA_News could you please fix the 'national authority' link in this document?http://t.co/HJ79Ul5eKx","source":"Twitter Web Client","author_id":"3225933441","lang":"en","id":"602900073115197442","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/HJ79Ul5eKx","expanded_url":"http://www.adrreports.eu/docs/ADR_reporting_FINAL_EN.pdf","display_url":"adrreports.eu/docs/ADR_repor…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"602900073115197442","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-22T14:05:54.000Z","possibly_sensitive":false,"text":"@EMA_News #FIS2015 'Tackling Infection Post 2015'-Glasgow 21-23 NOV. Registration &amp; abstract submission open. http://t.co/MuP3TnoWLD #AMR","source":"Twitter Web Client","author_id":"730263762","lang":"en","id":"601750839598968832","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/MuP3TnoWLD","expanded_url":"http://www.actiononinfection.com","display_url":"actiononinfection.com"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":18,"tag":"FIS2015"},{"start":137,"end":141,"tag":"AMR"}],"annotations":[{"start":50,"end":56,"probability":0.6655,"type":"Place","normalized_text":"Glasgow"}],"cashtags":{}},"conversation_id":"601750839598968832","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-22T13:01:07.000Z","possibly_sensitive":false,"text":".@EMA_News published minutes of orphan medicines committee meeting in April: http://t.co/0aWGCZUmuz #raredisease #OrphanDrug","source":"Hootsuite","author_id":"31353538","lang":"en","id":"601734533394862080","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/0aWGCZUmuz","expanded_url":"http://bit.ly/1R3efO8","display_url":"bit.ly/1R3efO8"}],"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":100,"end":112,"tag":"raredisease"},{"start":113,"end":124,"tag":"OrphanDrug"}],"annotations":{},"cashtags":{}},"conversation_id":"601026528865026049","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"601026528865026049"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-22T11:15:28.000Z","possibly_sensitive":false,"text":"@EMA_News backs 3 immunotherapies and Amgen PCSK9 inhibitor Repatha (evolocumab) for cholesterol http://t.co/Qk2c4gmnVC","source":"Twitter Web Client","author_id":"594516236","lang":"en","id":"601707949183078400","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/Qk2c4gmnVC","expanded_url":"http://bit.ly/1Enjhf6","display_url":"bit.ly/1Enjhf6"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"601707949183078400","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-19T21:40:18.000Z","possibly_sensitive":false,"text":"@EMA_News We've published our 2014 annual report: progress in science, medicines &amp; health: http://t.co/IOPJomJVo3 http://t.co/OIjL8Ccxmm”","source":"Twitter for iPad","author_id":"543802399","lang":"en","id":"600778027191140352","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/OIjL8Ccxmm","expanded_url":"http://ow.ly/My0of","display_url":"ow.ly/My0of"},{"start":95,"end":117,"url":"http://t.co/IOPJomJVo3","expanded_url":"https://twitter.com/EMA_News/status/595144721237934081/photo/1","display_url":"pic.twitter.com/IOPJomJVo3"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"600778027191140352","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_595144489129246720"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-18T09:36:36.000Z","possibly_sensitive":false,"text":"@EMA_News thank you. I followed your instrunctions","source":"Twitter Web Client","author_id":"3241683149","lang":"en","id":"600233515066761216","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"599120399205531648","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"600217325594378240"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-17T07:19:23.000Z","possibly_sensitive":false,"text":"@EMA_News cesará a cualquier evaluador q vaya a colaborar con la #industria #pharma http://t.co/0kXqoi9N4T Y ¿en @AEMPSGOB y comites CCAA?","source":"Twitter for iPad","author_id":"543802399","lang":"es","id":"599836597383737344","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/0kXqoi9N4T","expanded_url":"http://www.redaccionmedica.com/noticia/la-ema-refuerza-sus-medidas-contra-la-puerta-giratoria-con-la-industria-farmaceutica-82116","display_url":"redaccionmedica.com/noticia/la-ema…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":113,"end":122,"username":"AEMPSGOB","id":"326845755"}],"hashtags":[{"start":65,"end":75,"tag":"industria"},{"start":76,"end":83,"tag":"pharma"}],"annotations":{},"cashtags":{}},"conversation_id":"599836597383737344","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-15T11:40:57.000Z","possibly_sensitive":false,"text":"@EMA_News annual report shows progress in #science, #medicines and #health http://t.co/KNPQOUFG49","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"599177646111588352","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/KNPQOUFG49","expanded_url":"http://ow.ly/MZhDj","display_url":"ow.ly/MZhDj"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":42,"end":50,"tag":"science"},{"start":52,"end":62,"tag":"medicines"},{"start":67,"end":74,"tag":"health"}],"annotations":{},"cashtags":{}},"conversation_id":"599177646111588352","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-15T07:53:28.000Z","possibly_sensitive":false,"text":"@EMA_News is there an API library for medicines in europe? easy way to get info on updated SPCs, images etc?","source":"Twitter Web Client","author_id":"3241683149","lang":"en","id":"599120399205531648","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":51,"end":56,"probability":0.8238,"type":"Place","normalized_text":"europe"}],"cashtags":{}},"conversation_id":"599120399205531648","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-13T09:49:10.000Z","possibly_sensitive":false,"text":"@EMA_News I saw the post on G+ telling people you were on Twitter so I thought I would say hello and give you a follow!","source":"Twitter Web Client","author_id":"934642063","lang":"en","id":"598424739674255360","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":58,"end":64,"probability":0.6994,"type":"Product","normalized_text":"Twitter"}],"cashtags":{}},"conversation_id":"598091234448650240","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"598091234448650240"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-13T07:25:34.000Z","possibly_sensitive":false,"text":"@EMA_news Survey published whether children should be directly involved in activities of PDCO http://t.co/U1MLR6EpZm","source":"Twitter Web Client","author_id":"2194335170","lang":"en","id":"598388598250045440","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/U1MLR6EpZm","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Presentation/2015/05/WC500186710.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"598388598250045440","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-12T12:08:09.000Z","possibly_sensitive":false,"text":"@EMA_News CAT chair Paula Salmikangas says manufacturing cost of ATMPs is high so cost is high","source":"Twitter for iPhone","author_id":"59722141","lang":"en","id":"598097327195332608","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":20,"end":36,"probability":0.9891,"type":"Person","normalized_text":"Paula Salmikangas"},{"start":65,"end":69,"probability":0.3267,"type":"Organization","normalized_text":"ATMPs"}],"cashtags":{}},"conversation_id":"598097327195332608","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-12T12:06:21.000Z","possibly_sensitive":false,"text":"@EMA_News #COMP Chair Bruno Sepodes COMP should be more proactive and share responsibility for orphan assessment #OrphanDrug panel","source":"Twitter for iPhone","author_id":"59722141","lang":"en","id":"598096873610715136","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"COMP"},{"start":113,"end":124,"tag":"OrphanDrug"}],"annotations":[{"start":22,"end":34,"probability":0.7501,"type":"Person","normalized_text":"Bruno Sepodes"}],"cashtags":{}},"conversation_id":"598096873610715136","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-12T11:53:28.000Z","possibly_sensitive":false,"text":"@EMA_News Panel #OrphanDrug Ad Schuurman of CVZ says that without patients we won't get to the goal of price control and more access","source":"Twitter for iPhone","author_id":"59722141","lang":"en","id":"598093632709754880","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":16,"end":27,"tag":"OrphanDrug"}],"annotations":{},"cashtags":{}},"conversation_id":"598093632709754880","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-12T11:41:41.000Z","possibly_sensitive":false,"text":"@EMA_News panel debate on orphan medicines - an affordable public good? With patients @eurordis, regulators and payers","source":"Twitter for iPhone","author_id":"59722141","lang":"en","id":"598090667584331776","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":86,"end":95,"username":"eurordis","id":"26993786"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"598090667584331776","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-11T22:42:35.000Z","possibly_sensitive":false,"text":"@EMA_News #medicalwriting #clinicaltrial #EMWA #AMWA Video update CORE Reference project 06May15: https://t.co/ewZ23BvDSZ","source":"Twitter Web Client","author_id":"2407513628","lang":"en","id":"597894600217460737","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/ewZ23BvDSZ","expanded_url":"https://vimeo.com/127467647","display_url":"vimeo.com/127467647"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":25,"tag":"medicalwriting"},{"start":26,"end":40,"tag":"clinicaltrial"},{"start":41,"end":46,"tag":"EMWA"},{"start":47,"end":52,"tag":"AMWA"}],"annotations":{},"cashtags":{}},"conversation_id":"597894600217460737","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-09T00:36:51.000Z","possibly_sensitive":false,"text":"@EMA_News Hi EMA,how can I subscribe for news letters ?","source":"Twitter Web Client","author_id":"547973463","lang":"en","id":"596836192919920641","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":13,"end":15,"probability":0.6045,"type":"Person","normalized_text":"EMA"}],"cashtags":{}},"conversation_id":"596836192919920641","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-08T15:45:57.000Z","possibly_sensitive":false,"text":"@EMA_News Tightens Rules for Committee Members and Experts. Read more here.\n\nhttp://t.co/5GwGT91n90","source":"Hootsuite","author_id":"487664492","lang":"en","id":"596702586209722369","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/5GwGT91n90","expanded_url":"http://bit.ly/RulesofEMA","display_url":"bit.ly/RulesofEMA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"596702586209722369","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-08T09:21:17.000Z","possibly_sensitive":false,"text":"@EMA_News thanks for the info! Regards","source":"Twitter for iPhone","author_id":"77272175","lang":"en","id":"596605781388206080","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"596602918209454080","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"596605590861959169"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-08T09:09:54.000Z","possibly_sensitive":false,"text":"@EMA_News when the minutes of the last prac committee be available?","source":"Twitter for iPhone","author_id":"77272175","lang":"en","id":"596602918209454080","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"596602918209454080","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-07T02:27:19.000Z","possibly_sensitive":false,"text":"@EMA_News Seek The Truth http://t.co/bzOAlHqk8F -&gt; $PPHM case# 8:12-cv-01608 http://t.co/F7iOrQDoiN FDA &amp; Senators aware of sabotage","source":"Twitter Web Client","author_id":"2871888165","lang":"en","id":"596139217702539264","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":25,"end":47,"url":"http://t.co/bzOAlHqk8F","expanded_url":"http://bit.ly/1gGYThq","display_url":"bit.ly/1gGYThq"},{"start":80,"end":102,"url":"http://t.co/F7iOrQDoiN","expanded_url":"http://tinyurl.com/keokkgs","display_url":"tinyurl.com/keokkgs","status":200,"unwound_url":"https://investorshub.advfn.com/boards/read_msg.aspx?message_id=113108003"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":[{"start":54,"end":59,"tag":"PPHM"}]},"conversation_id":"596139217702539264","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-06T15:43:49.000Z","possibly_sensitive":false,"text":"@EMA_News rules on conflict of interest tightened. #EMA https://t.co/97tQRrffiq","source":"Twitter Web Client","author_id":"23823353","lang":"en","id":"595977274417111040","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":56,"end":79,"url":"https://t.co/97tQRrffiq","expanded_url":"https://twitter.com/Sasha_Terzieva/status/595883782026178560","display_url":"twitter.com/Sasha_Terzieva…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":51,"end":55,"tag":"EMA"}],"annotations":{},"cashtags":{}},"conversation_id":"595977274417111040","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"595883782026178560"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-06T13:42:36.000Z","possibly_sensitive":false,"text":"@EMA_News tightens rules on 'revolving door' for committee members and experts http://t.co/gZlbwejOmH","source":"Twitter Web Client","author_id":"1106659014","lang":"en","id":"595946769386774528","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/gZlbwejOmH","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/05/news_detail_002322.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"595946769386774528","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-06T09:46:30.000Z","possibly_sensitive":false,"text":"@EMA_News rende + stringenti le norme su #conflitti di #interesse. AIFA aggiorna Regolamento http://t.co/mILVLZdI2Y https://t.co/KpLv8F275T","source":"TweetDeck","author_id":"441940097","lang":"it","id":"595887352188383232","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/mILVLZdI2Y","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/ema-rende-pi%C3%B9-stringenti-le-norme-materia-di-conflitti-di-interesse-i-membri-dei-comitati-e-","display_url":"agenziafarmaco.gov.it/it/content/ema…"},{"start":116,"end":139,"url":"https://t.co/KpLv8F275T","expanded_url":"https://twitter.com/EMA_News/status/595881554443948032","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":41,"end":51,"tag":"conflitti"},{"start":55,"end":65,"tag":"interesse"}],"annotations":{},"cashtags":{}},"conversation_id":"595887352188383232","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"595881554443948032"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-06T09:14:05.000Z","possibly_sensitive":false,"text":"@EMA_News rende più stringenti le norme in materia di #conflitti di #interesse. Anche AIFA aggiorna suo regolamento http://t.co/mILVLZdI2Y","source":"TweetDeck","author_id":"441940097","lang":"it","id":"595879194304892928","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/mILVLZdI2Y","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/ema-rende-pi%C3%B9-stringenti-le-norme-materia-di-conflitti-di-interesse-i-membri-dei-comitati-e-","display_url":"agenziafarmaco.gov.it/it/content/ema…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":54,"end":64,"tag":"conflitti"},{"start":68,"end":78,"tag":"interesse"}],"annotations":{},"cashtags":{}},"conversation_id":"595879194304892928","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-06T09:13:46.000Z","possibly_sensitive":false,"text":"@EMA_News tightens rules on “revolving door” for committee members and experts","source":"Twitter Web Client","author_id":"459335626","lang":"en","id":"595879114680246272","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"595879114680246272","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-05T20:10:40.000Z","possibly_sensitive":false,"text":"@EMA_News 2014 in Review: more collab w/ #HTA bodies, early engagement impt for dev'lp new meds http://t.co/KcDP0ide8F via @CADTH_ACMTS","source":"Hootsuite","author_id":"1588972196","lang":"en","id":"595682042601447427","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/KcDP0ide8F","expanded_url":"http://bit.ly/1I3MTWl","display_url":"bit.ly/1I3MTWl"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":123,"end":135,"username":"CADTH_ACMTS","id":"431586713"}],"hashtags":[{"start":41,"end":45,"tag":"HTA"}],"annotations":{},"cashtags":{}},"conversation_id":"595682042601447427","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-04T15:35:29.000Z","possibly_sensitive":false,"text":"@EMA_News in 2014: A Landmark Year for Approvals, With Eyes on the Future http://t.co/PGHOGACI8f","source":"Hootsuite","author_id":"19642657","lang":"en","id":"595250402943246336","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/PGHOGACI8f","expanded_url":"http://ow.ly/MtsmX","display_url":"ow.ly/MtsmX"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"595250402943246336","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-04T11:06:07.000Z","possibly_sensitive":false,"text":"@EMA_News Thank you for the reply. Maybe the 'professionals' need to brush up on evidence @Jake135791","source":"Twitter for iPhone","author_id":"313427304","lang":"en","id":"595182613129736192","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":90,"end":101,"username":"Jake135791","id":"898474992"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"595144307016892416","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"595181043138834432"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-04T08:49:58.000Z","possibly_sensitive":false,"text":"@EMA_News Could you clarify your position on SSRIs inducing suicide in children -for an upcoming Prozac inquest (14 yr old child)?","source":"Twitter Web Client","author_id":"313427304","lang":"en","id":"595148347842912256","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"595144307016892416","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"595144307016892416"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-04T08:40:15.000Z","possibly_sensitive":false,"text":"@EMA_News Looks very promising. A collaboration with @RxISK where most people log adverse events would help enormously.","source":"Twitter Web Client","author_id":"313427304","lang":"en","id":"595145906103656448","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":53,"end":59,"username":"RxISK","id":"267634622"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"595144721237934081","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"595144721237934081"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-05-03T20:40:24.000Z","possibly_sensitive":false,"text":"@EMA_News Good news for #Melanoma Patients!","source":"Twitter Web Client","author_id":"810969654","lang":"en","id":"594964746245378049","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":24,"end":33,"tag":"Melanoma"}],"annotations":{},"cashtags":{}},"conversation_id":"592615323691569152","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"592615323691569152"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-30T13:31:15.000Z","possibly_sensitive":false,"text":"@EMA_News releases draft #goodpractice guides for reducing #medicationerrors in the EU http://t.co/7AWVzaEOuP http://t.co/26D3asSDmQ","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"593769584886476800","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/7AWVzaEOuP","expanded_url":"http://ow.ly/Mdgmc","display_url":"ow.ly/Mdgmc"},{"start":110,"end":132,"url":"http://t.co/26D3asSDmQ","expanded_url":"http://ow.ly/i/ayGhd","display_url":"ow.ly/i/ayGhd"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":25,"end":38,"tag":"goodpractice"},{"start":59,"end":76,"tag":"medicationerrors"}],"annotations":{},"cashtags":{}},"conversation_id":"593769584886476800","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-30T08:31:54.000Z","possibly_sensitive":false,"text":"@EMA_News @myESMO @_rarecancer initiative: joint workshop as a model for other #rarecancers today in London #rareCSM http://t.co/yvcNBBdghO","source":"Twitter Web Client","author_id":"2301430153","lang":"en","id":"593694252917497856","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/yvcNBBdghO","expanded_url":"http://bit.ly/1DY1E5O","display_url":"bit.ly/1DY1E5O"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"myESMO","id":"69232855"},{"start":18,"end":30,"username":"_rarecancer","id":"2301430153"}],"hashtags":[{"start":79,"end":91,"tag":"rarecancers"},{"start":108,"end":116,"tag":"rareCSM"}],"annotations":[{"start":101,"end":106,"probability":0.9909,"type":"Place","normalized_text":"London"}],"cashtags":{}},"conversation_id":"593694252917497856","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-29T14:33:55.000Z","possibly_sensitive":false,"text":"@EMA_News recommends new indication for Relistor for opioid-induced #constipation http://t.co/PXkYM3Pv64","source":"Twitter Web Client","author_id":"732952291","lang":"en","id":"593422969365487616","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/PXkYM3Pv64","expanded_url":"http://goo.gl/Zh1T0K","display_url":"goo.gl/Zh1T0K"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":68,"end":81,"tag":"constipation"}],"annotations":[{"start":40,"end":47,"probability":0.3016,"type":"Organization","normalized_text":"Relistor"}],"cashtags":{}},"conversation_id":"593422969365487616","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-29T11:28:59.000Z","possibly_sensitive":false,"text":"@EMA_News  @ispch","source":"Twitter Web Client","author_id":"3207682415","lang":"und","id":"593376429297016832","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":17,"username":"ispch","id":"256194381"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"592615385565962240","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"592615385565962240"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-29T11:15:29.000Z","possibly_sensitive":false,"text":"@EMA_News provides advice notes on #pharmacovigilance annual #fees http://t.co/z3oeJuCCn7 http://t.co/Jte0aiNLpc","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"593373029197025280","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/z3oeJuCCn7","expanded_url":"http://ow.ly/Mdgba","display_url":"ow.ly/Mdgba"},{"start":90,"end":112,"url":"http://t.co/Jte0aiNLpc","expanded_url":"http://ow.ly/i/ayGcX","display_url":"ow.ly/i/ayGcX"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":35,"end":53,"tag":"pharmacovigilance"},{"start":61,"end":66,"tag":"fees"}],"annotations":{},"cashtags":{}},"conversation_id":"593373029197025280","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-29T08:09:36.000Z","possibly_sensitive":false,"text":"@EMA_News says companies still need to report #SideEffects of donated #drugs reports @RAPSorg http://t.co/LugvQYDapq","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"593326250971762688","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/LugvQYDapq","expanded_url":"http://ow.ly/MgqVn","display_url":"ow.ly/MgqVn"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":85,"end":93,"username":"RAPSorg","id":"111425542"}],"hashtags":[{"start":46,"end":58,"tag":"SideEffects"},{"start":70,"end":76,"tag":"drugs"}],"annotations":{},"cashtags":{}},"conversation_id":"593326250971762688","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-28T17:22:56.000Z","possibly_sensitive":false,"text":"@EMA_News For more on this see the new @EASLnews 2015 #HCV treatment guidelines http://t.co/KNn9aUd16q @JHepatology @HepatitisEurope","source":"Twitter Web Client","author_id":"2401564993","lang":"en","id":"593103114040905729","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/KNn9aUd16q","expanded_url":"http://www.easl.eu/medias/cpg/HEPC-2015/Full-report.pdf","display_url":"easl.eu/medias/cpg/HEP…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":39,"end":48,"username":"EASLnews","id":"317662616"},{"start":103,"end":115,"username":"JHepatology","id":"862974992"}],"hashtags":[{"start":54,"end":58,"tag":"HCV"}],"annotations":{},"cashtags":{}},"conversation_id":"593103114040905729","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-28T12:09:45.000Z","possibly_sensitive":false,"text":"@EMA_News recommends refusal of marketing authorisation for dasiprotimut-T for treatment of non-Hodgkin’s #lymphoma http://t.co/PRAkBSLTjX","source":"Hootsuite","author_id":"69232855","lang":"en","id":"593024300531220480","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/PRAkBSLTjX","expanded_url":"http://ow.ly/MdGiQ","display_url":"ow.ly/MdGiQ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":106,"end":115,"tag":"lymphoma"}],"annotations":{},"cashtags":{}},"conversation_id":"593024300531220480","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-28T09:01:35.000Z","possibly_sensitive":false,"text":"@EMA_News #scientificadvice resulting in higher success rates http://t.co/WAVqax1Q7I","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"592976945832468481","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/WAVqax1Q7I","expanded_url":"http://ow.ly/Mddax","display_url":"ow.ly/Mddax"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":27,"tag":"scientificadvice"}],"annotations":{},"cashtags":{}},"conversation_id":"592976945832468481","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-27T09:38:24.000Z","possibly_sensitive":false,"text":"@EMA_News Please recommend outphasing animal experiments. A.D. 2015.","source":"Twitter Web Client","author_id":"1452235320","lang":"en","id":"592623821980606464","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"592615188567822336","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"592615188567822336"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-27T09:36:52.000Z","possibly_sensitive":false,"text":"@EMA_News How many animals were offered? Which kinds? Where to find this information? Please give the FULL picture.","source":"Twitter Web Client","author_id":"1452235320","lang":"en","id":"592623435987181568","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"592615323691569152","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"592615323691569152"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-27T09:28:46.000Z","possibly_sensitive":false,"text":"@EMA_News \"Geneesmiddel' van de markt gehaald: Duloxetine. After animal experiments. Another big shame (for mankind).\nhttp://t.co/7XQB3Fpcrx","source":"Twitter Web Client","author_id":"1452235320","lang":"en","id":"592621400831176704","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/7XQB3Fpcrx","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2015/04/WC500186169.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"592615764051546112","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"592615764051546112"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-27T09:20:20.000Z","possibly_sensitive":false,"text":"MT“@EMA_News: We've rec avoid certain #hepatitisC meds &amp; #amiodarone tog, risk of slow heart rate: http://t.co/aYPMYjMUAp”\n\nSeen? @iainbrew","source":"Twitter for iPad","author_id":"99747258","lang":"en","id":"592619278362345472","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/aYPMYjMUAp","expanded_url":"http://bit.ly/1FjFcJC","display_url":"bit.ly/1FjFcJC"}],"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"},{"start":134,"end":143,"username":"iainbrew","id":"32867239"}],"hashtags":[{"start":38,"end":49,"tag":"hepatitisC"},{"start":61,"end":72,"tag":"amiodarone"}],"annotations":{},"cashtags":{}},"conversation_id":"592615188567822336","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"592615188567822336"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-24T16:59:28.000Z","possibly_sensitive":false,"text":"@EMA_News : #codeine not to be used in #children below 12 years for cough and cold  http://t.co/kcsoBa4hjC","source":"Twitter Web Client","author_id":"2924203214","lang":"en","id":"591647655966560256","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/kcsoBa4hjC","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/04/news_detail_002316.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":12,"end":20,"tag":"codeine"},{"start":39,"end":48,"tag":"children"}],"annotations":{},"cashtags":{}},"conversation_id":"591647655966560256","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"place_id":"d9d978b087a92583","coordinates":{"coordinates":{}}}},{"created_at":"2015-04-24T16:30:44.000Z","possibly_sensitive":false,"text":"@EMA_News recommends granting a marketing authorisation for nivolumab for treatment of adv. #melanoma #MELSM http://t.co/3BZMsaoPpZ","source":"Hootsuite","author_id":"69232855","lang":"en","id":"591640426060374017","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/3BZMsaoPpZ","expanded_url":"http://ow.ly/M4CUW","display_url":"ow.ly/M4CUW"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":92,"end":101,"tag":"melanoma"},{"start":102,"end":108,"tag":"MELSM"}],"annotations":{},"cashtags":{}},"conversation_id":"591640426060374017","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-24T16:04:32.000Z","possibly_sensitive":false,"text":"@EMA_News @EU_Commission @IAPOtweets @EFCCAYouthGroup @biosimilarz @KathrinLudwig @Carmen_duro @angel189 @biosimilar_news #thanks #EBGBIOS15","source":"Twitter for iPhone","author_id":"2917826331","lang":"und","id":"591633835177156608","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"},{"start":25,"end":36,"username":"IAPOtweets","id":"14682411"},{"start":37,"end":53,"username":"EFCCAYouthGroup","id":"1234411952"},{"start":54,"end":66,"username":"biosimilarz","id":"239982538"},{"start":67,"end":81,"username":"KathrinLudwig","id":"376804644"},{"start":82,"end":94,"username":"Carmen_duro","id":"222192110"},{"start":95,"end":104,"username":"angel189","id":"17471096"},{"start":105,"end":121,"username":"biosimilar_news","id":"346385183"}],"hashtags":[{"start":122,"end":129,"tag":"thanks"},{"start":130,"end":140,"tag":"EBGBIOS15"}],"annotations":{},"cashtags":{}},"conversation_id":"591633835177156608","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-24T14:53:25.000Z","possibly_sensitive":false,"text":"@EMA_News said yes to @bmsnews #Opdivo for the first-line treatment of #melanoma! @Merck, CheckMate. http://t.co/FLWhMbyGf3","source":"Twitter Web Client","author_id":"2814602552","lang":"en","id":"591615937033412609","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/FLWhMbyGf3","expanded_url":"http://tinyurl.com/k4vryrw","display_url":"tinyurl.com/k4vryrw"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":22,"end":30,"username":"bmsnews","id":"34010976"},{"start":82,"end":88,"username":"Merck","id":"35961145"}],"hashtags":[{"start":31,"end":38,"tag":"Opdivo"},{"start":71,"end":80,"tag":"melanoma"}],"annotations":{},"cashtags":{}},"conversation_id":"591615937033412609","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-24T14:16:20.000Z","possibly_sensitive":false,"text":"@EMA_News You've been quoted in my #Storify story \"Top tweets from the European Biosimilars Group meeting \" http://t.co/crh078UsR5","source":"Storify","author_id":"18800238","lang":"en","id":"591606603977220098","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/crh078UsR5","expanded_url":"http://sfy.co/p0M8H","display_url":"sfy.co/p0M8H"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":35,"end":43,"tag":"Storify"}],"annotations":{},"cashtags":{}},"conversation_id":"591606603977220098","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-24T11:27:43.000Z","possibly_sensitive":false,"text":"@EMA_News backs 11 drugs, inc B-MS' Opdivo (melanoma) Daiichi Sankyo bloodthinner Lixiana, Vanda sleep drug http://t.co/F2LSSxs1Cc #pharma","source":"Twitter Web Client","author_id":"594516236","lang":"nl","id":"591564168714653696","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/F2LSSxs1Cc","expanded_url":"http://bit.ly/1HvQg8n","display_url":"bit.ly/1HvQg8n"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":131,"end":138,"tag":"pharma"}],"annotations":{},"cashtags":{}},"conversation_id":"591564168714653696","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-24T08:21:00.000Z","possibly_sensitive":false,"text":"@EMA_News Wasn't on Peter's slide, hence my tweet...interestingly enoxaparin was, and that was submitted after infliximab.","source":"Twitter Web Client","author_id":"239982538","lang":"en","id":"591517179268485120","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":20,"end":24,"probability":0.8961,"type":"Person","normalized_text":"Peter"}],"cashtags":{}},"conversation_id":"591514490379702273","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"591516859519934464"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-24T08:10:18.000Z","possibly_sensitive":false,"text":"@EMA_News expects an increase in #biosimilars submissions in 2015, says Richardson #EBGBIOS15","source":"Twitter Web Client","author_id":"239982538","lang":"en","id":"591514490379702273","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":33,"end":45,"tag":"biosimilars"},{"start":83,"end":93,"tag":"EBGBIOS15"}],"annotations":[{"start":72,"end":81,"probability":0.7713,"type":"Person","normalized_text":"Richardson"}],"cashtags":{}},"conversation_id":"591514490379702273","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-23T20:26:00.000Z","possibly_sensitive":false,"text":"@EMA_News #20thanniversary Patients at heart of innovation @eurordis http://t.co/xcqxg6l2V1","source":"Twitter Web Client","author_id":"59722141","lang":"en","id":"591337247045189632","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/xcqxg6l2V1","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/audience/alp_audiencetype_000001.jsp&mid=","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":59,"end":68,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":10,"end":26,"tag":"20thanniversary"}],"annotations":{},"cashtags":{}},"conversation_id":"591337247045189632","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-21T15:02:57.000Z","possibly_sensitive":false,"text":"@EMA_News says complying with its scientific advice raises likelihood of approval, fewer objection http://t.co/BvytcLgWiv #meds #SMEs","source":"Hootsuite","author_id":"19642657","lang":"en","id":"590531172565942273","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/BvytcLgWiv","expanded_url":"http://ow.ly/LTwuj","display_url":"ow.ly/LTwuj"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":122,"end":127,"tag":"meds"},{"start":128,"end":133,"tag":"SMEs"}],"annotations":{},"cashtags":{}},"conversation_id":"590531172565942273","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-20T20:37:56.000Z","possibly_sensitive":false,"text":"@EMA_News workshop on the importance of dose finding and dose selection for the successful R&amp;D of medicinal products http://t.co/9jSS2qYmUX","source":"Twitter Web Client","author_id":"2176193576","lang":"en","id":"590253083634053120","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/9jSS2qYmUX","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2014/06/event_detail_000993.jsp&mid=WC0b01ac058004d5c3","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"590253083634053120","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-20T14:12:45.000Z","possibly_sensitive":false,"text":"@EMA_News Thanks for the RT","source":"Twitter Web Client","author_id":"2917826331","lang":"en","id":"590156150080962561","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"590156150080962561","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-20T13:58:12.000Z","possibly_sensitive":false,"text":"@EMA_News Have published the #agenda of this week's human medicines committee (CHMP) meeting: http://t.co/TAx4Wf07hb","source":"Twitter for Android","author_id":"226603998","lang":"en","id":"590152487568551936","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/TAx4Wf07hb","expanded_url":"http://bit.ly/1O7M7ew","display_url":"bit.ly/1O7M7ew"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":29,"end":36,"tag":"agenda"}],"annotations":{},"cashtags":{}},"conversation_id":"590152487568551936","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-20T13:39:31.000Z","possibly_sensitive":false,"text":"@EMA_News withdraw harmful drugs for the safety of public","source":"Twitter for Android","author_id":"982666808","lang":"en","id":"590147786902999040","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"590146315956445184","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"590146315956445184"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-20T13:26:18.000Z","possibly_sensitive":false,"text":"@EMA_News @IMI_JU  #FLUCOP project launched today @sanofipasteur . Follow us @EuropeVaccine or @OdileLeroy","source":"Twitter Web Client","author_id":"895621416","lang":"en","id":"590144462992605184","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"imi_ju","id":"1473203261469790214"},{"start":77,"end":91,"username":"EuropeVaccine","id":"321861975"},{"start":95,"end":106,"username":"OdileLeroy","id":"895621416"}],"hashtags":[{"start":19,"end":26,"tag":"FLUCOP"}],"annotations":{},"cashtags":{}},"conversation_id":"590144462992605184","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-18T13:21:42.000Z","possibly_sensitive":false,"text":"@EMA_News #Pottscup #20thanniversary EBA winners and EMA3 for FairPlay - great day see you in May http://t.co/XbbAY9G1Hn","source":"Twitter for iPhone","author_id":"59722141","lang":"en","id":"589418526366130178","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/XbbAY9G1Hn","expanded_url":"https://twitter.com/kardamyla/status/589418526366130178/photo/1","display_url":"pic.twitter.com/XbbAY9G1Hn"},{"start":98,"end":120,"url":"http://t.co/XbbAY9G1Hn","expanded_url":"https://twitter.com/kardamyla/status/589418526366130178/photo/1","display_url":"pic.twitter.com/XbbAY9G1Hn"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"Pottscup"},{"start":20,"end":36,"tag":"20thanniversary"}],"annotations":{},"cashtags":{}},"conversation_id":"589418526366130178","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_589418512302678016","3_589418512373919745"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-18T12:08:13.000Z","possibly_sensitive":false,"text":"@EMA_News half way through #Pottscup #20thanniversary http://t.co/DzhXbULiKe","source":"Twitter for iPhone","author_id":"59722141","lang":"en","id":"589400035978280960","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/DzhXbULiKe","expanded_url":"https://twitter.com/kardamyla/status/589400035978280960/photo/1","display_url":"pic.twitter.com/DzhXbULiKe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":27,"end":36,"tag":"Pottscup"},{"start":37,"end":53,"tag":"20thanniversary"}],"annotations":{},"cashtags":{}},"conversation_id":"589400035978280960","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_589400024423014400"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-18T09:58:47.000Z","possibly_sensitive":false,"text":"@EMA_News after first round http://t.co/9TFfXIDegk","source":"Twitter for iPhone","author_id":"59722141","lang":"en","id":"589367460064813056","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":28,"end":50,"url":"http://t.co/9TFfXIDegk","expanded_url":"https://twitter.com/kardamyla/status/589367460064813056/photo/1","display_url":"pic.twitter.com/9TFfXIDegk"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"589367460064813056","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_589367450032074752"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-18T08:48:58.000Z","possibly_sensitive":false,"text":"@EMA_News #20thanniversary Pott's cup football tournament #London2015 kick off soon http://t.co/qp3DWLEqoz","source":"Twitter for iPhone","author_id":"59722141","lang":"en","id":"589349892272840704","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/qp3DWLEqoz","expanded_url":"https://twitter.com/kardamyla/status/589349892272840704/photo/1","display_url":"pic.twitter.com/qp3DWLEqoz"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":26,"tag":"20thanniversary"},{"start":58,"end":69,"tag":"London2015"}],"annotations":{},"cashtags":{}},"conversation_id":"589349892272840704","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_589349875575291904"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-17T16:02:58.000Z","possibly_sensitive":false,"text":"@EMA_News it is like the butcher judging its own meat. It would be interesting to know whether an independent panel would arrive at the same","source":"Twitter Web Client","author_id":"260396247","lang":"en","id":"589096723265560576","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"589090316671655936","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"589090316671655936"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-16T12:32:13.000Z","possibly_sensitive":false,"text":"@EMA_News - Preventing medication errors in the European Union - Public Consultation - deadline 14 June @EU_Health http://t.co/Wh2Llv5Ayx","source":"Twitter Web Client","author_id":"164835748","lang":"en","id":"588681300028055552","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Wh2Llv5Ayx","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/04/news_detail_002307.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":104,"end":114,"username":"EU_Health","id":"606325697"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"588681300028055552","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-16T10:08:25.000Z","possibly_sensitive":false,"text":"“@EMA_News: assessment report for #Mysimba (#naltrexone / #bupropion), a #medicine : http://t.co/4c5pxb24bK” excludes Psychiatic ADRs risk!","source":"Twitter for iPad","author_id":"205270115","lang":"en","id":"588645110683987968","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/4c5pxb24bK","expanded_url":"http://bit.ly/1EGm0FO","display_url":"bit.ly/1EGm0FO"}],"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":34,"end":42,"tag":"Mysimba"},{"start":44,"end":55,"tag":"naltrexone"},{"start":58,"end":68,"tag":"bupropion"},{"start":73,"end":82,"tag":"medicine"}],"annotations":{},"cashtags":{}},"conversation_id":"588616677476052992","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"588616677476052992"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-16T10:03:37.000Z","possibly_sensitive":false,"text":"@EMA_News suicide and use of alcohol risks for bupropion known yet not included in your summary for Mysimba See ADRs http://t.co/LkMA3MBHnR","source":"Twitter for iPad","author_id":"205270115","lang":"en","id":"588643904624394240","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/LkMA3MBHnR","expanded_url":"http://www.mhra.gov.uk/drug-analysis-prints","display_url":"mhra.gov.uk/drug-analysis-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":100,"end":115,"probability":0.2842,"type":"Other","normalized_text":"Mysimba See ADRs"}],"cashtags":{}},"conversation_id":"588616677476052992","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"588616677476052992"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-14T16:57:57.000Z","possibly_sensitive":false,"text":"@EMA_News COMP celebrates 15 years! Congratulations! more than 100 authorised orphans and more to come.. http://t.co/pDw1bmPPXp","source":"Twitter Web Client","author_id":"59722141","lang":"en","id":"588023396589510659","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/pDw1bmPPXp","expanded_url":"https://twitter.com/kardamyla/status/588023396589510659/photo/1","display_url":"pic.twitter.com/pDw1bmPPXp"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"588023396589510659","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_588023395318661120"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-14T14:26:36.000Z","possibly_sensitive":false,"text":"@EMA_News Preventing medication errors in the European Union: #consultation on draft good practice guides: http://t.co/4VgMwjBjod","source":"Twitter Web Client","author_id":"529139447","lang":"en","id":"587985308320301057","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/4VgMwjBjod","expanded_url":"http://bit.ly/1aZCE7G","display_url":"bit.ly/1aZCE7G"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":62,"end":75,"tag":"consultation"}],"annotations":{},"cashtags":{}},"conversation_id":"587985308320301057","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-13T16:11:31.000Z","possibly_sensitive":false,"text":"@EMA_News Good to know. Just as well I don't prescribe more than 1200mg daily then.","source":"Twitter for Android","author_id":"580755493","lang":"en","id":"587649324391260163","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":65,"end":70,"probability":0.5729,"type":"Person","normalized_text":"1200mg"}],"cashtags":{}},"conversation_id":"587648354131259392","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"587648354131259392"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-13T16:05:28.000Z","possibly_sensitive":false,"text":"“@EMA_News: Updated guidance on the use of high doses of ibuprofen https://t.co/qX4q77IFrx”","source":"Twitter for iPad","author_id":"555970431","lang":"en","id":"587647799820431360","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/qX4q77IFrx","expanded_url":"https://twitter.com/LV_MPA/status/587616368071024640","display_url":"twitter.com/LV_MPA/status/…"}],"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"587645827100868609","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"quoted","id":"587616368071024640"},{"type":"replied_to","id":"587645827100868609"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-13T15:54:39.000Z","possibly_sensitive":false,"text":"@EMA_News  lo sabemos, pero no lo hacemos. La mayoría de las veces es suficiente con la dosis baja.","source":"Twitter Web App","author_id":"1448250104","lang":"es","id":"587645080674119682","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"587644276965793792","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"587644276965793792"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-13T09:03:52.000Z","possibly_sensitive":false,"text":"@EMA_News Can you please help? http://t.co/U8fhSbLlCZ\nhttps://t.co/eNryM7zXPd","source":"Twitter Web Client","author_id":"51240014","lang":"en","id":"587541703382462464","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":31,"end":53,"url":"http://t.co/U8fhSbLlCZ","expanded_url":"http://www.gofundme.com/rg87wrg8","display_url":"gofundme.com/rg87wrg8"},{"start":54,"end":77,"url":"https://t.co/eNryM7zXPd","expanded_url":"https://www.giveforward.com/fundraiser/5lf8/angelina-s-medical-fund","display_url":"giveforward.com/fundraiser/5lf…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"587541703382462464","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-11T10:22:40.000Z","possibly_sensitive":false,"text":"@EMA_News CYSTIC FIBROSIS SPAIN-22thApril-PROTEST SocialMobilisation ApprovalVERTEXmedicines #mifuturoyaesposible RT http://t.co/dizJniMrUB","source":"Twitter Web Client","author_id":"2789795314","lang":"en","id":"586836756143726592","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/dizJniMrUB","expanded_url":"https://twitter.com/LuchaFQ/status/586836756143726592/photo/1","display_url":"pic.twitter.com/dizJniMrUB"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":93,"end":113,"tag":"mifuturoyaesposible"}],"annotations":[{"start":26,"end":30,"probability":0.4451,"type":"Place","normalized_text":"SPAIN"}],"cashtags":{}},"conversation_id":"586836756143726592","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_586836755296493568"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-10T15:19:30.000Z","possibly_sensitive":false,"text":"@EMA_News hat neues #Antibiotikum von #MSD gegen #Infektionskrankheiten in der #EU zugela... http://t.co/koyNDzFFp3 via @DieSchwenninger","source":"twitterfeed","author_id":"2902746586","lang":"de","id":"586549069788479490","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/koyNDzFFp3","expanded_url":"http://bit.ly/1D3bxBT","display_url":"bit.ly/1D3bxBT"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":20,"end":33,"tag":"Antibiotikum"},{"start":38,"end":42,"tag":"MSD"},{"start":49,"end":71,"tag":"Infektionskrankheiten"},{"start":79,"end":82,"tag":"EU"}],"annotations":{},"cashtags":{}},"conversation_id":"586549069788479490","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-10T14:06:44.000Z","possibly_sensitive":false,"text":"@EMA_News hat neues #Antibiotikum von #MSD gegen #Infektionskrankheiten in der #EU zugelassen. http://t.co/yZHxdXqF2m","source":"Twitter Web Client","author_id":"36675688","lang":"de","id":"586530759583870976","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/yZHxdXqF2m","expanded_url":"http://bit.ly/1D2lwaH","display_url":"bit.ly/1D2lwaH"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":20,"end":33,"tag":"Antibiotikum"},{"start":38,"end":42,"tag":"MSD"},{"start":49,"end":71,"tag":"Infektionskrankheiten"},{"start":79,"end":82,"tag":"EU"}],"annotations":{},"cashtags":{}},"conversation_id":"586530759583870976","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-09T12:24:31.000Z","possibly_sensitive":false,"text":"@EMA_News Thanks for the RT","source":"Twitter Web Client","author_id":"2315763655","lang":"en","id":"586142647414304770","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"586142647414304770","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-08T09:35:00.000Z","possibly_sensitive":false,"text":"@EMA_News \nMALATTIE RARE FARMACI ORFANI\nCNMR","source":"Twitter Web Client","author_id":"613251313","lang":"ro","id":"585737598942969856","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"585737598942969856","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-07T12:14:58.000Z","possibly_sensitive":false,"text":"@EMA_News Our customers tell us how they have increased their income thanks to KulaHub. Call 0845 299 3749 to find out more","source":"TweetAdder v4","author_id":"2229647095","lang":"en","id":"585415465289252864","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"585415465289252864","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-07T06:26:00.000Z","possibly_sensitive":false,"text":"@EMA_News #yellowfever #vaccine #psychosis new sufferer steps forward  #justiceformyhusband http://t.co/vm2RXmooN4","source":"Twitter Web Client","author_id":"17966242","lang":"en","id":"585327646210404352","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/vm2RXmooN4","expanded_url":"http://www.dailymail.co.uk/health/article-3027941/Can-routine-holiday-jab-send-mad-s-BBC-reporter-Malcolm-Brabant-says-happened-s-not-alone.html","display_url":"dailymail.co.uk/health/article…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":22,"tag":"yellowfever"},{"start":23,"end":31,"tag":"vaccine"},{"start":32,"end":42,"tag":"psychosis"},{"start":71,"end":91,"tag":"justiceformyhusband"}],"annotations":{},"cashtags":{}},"conversation_id":"585327646210404352","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-06T13:16:51.000Z","possibly_sensitive":false,"text":"@EMA_News and @US_FDA identify mobile apps as promising tools to report drug adverse events read http://t.co/UUttjrOECp","source":"Twitter Web Client","author_id":"163225697","lang":"en","id":"585068652715577345","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/UUttjrOECp","expanded_url":"http://bit.ly/1Jf42tD","display_url":"bit.ly/1Jf42tD"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":21,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"585068652715577345","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-01T12:20:08.000Z","possibly_sensitive":false,"text":"@EMA_News @healthhashtags @rteston You've been quoted in my #Storify story \"What happened at @EGAgenerics?\" http://t.co/uK9VWKe0Yd","source":"Storify","author_id":"2315763655","lang":"en","id":"583242441710571520","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/uK9VWKe0Yd","expanded_url":"http://sfy.co/f0TCn","display_url":"sfy.co/f0TCn"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"healthhashtags","id":"202011626"},{"start":26,"end":34,"username":"rteston","id":"78254220"},{"start":93,"end":105,"username":"egagenerics","id":"1229029034"}],"hashtags":[{"start":60,"end":68,"tag":"Storify"}],"annotations":{},"cashtags":{}},"conversation_id":"583242441710571520","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-04-01T11:38:34.000Z","possibly_sensitive":false,"text":"@EMA_News pledges to review paediatric investigation plans for Ebola treatments in \"shortest possible time\" ($) http://t.co/LH6VuWDYLM","source":"Twitter Web Client","author_id":"459335626","lang":"en","id":"583231981196058624","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/LH6VuWDYLM","expanded_url":"http://bit.ly/1NIp06X","display_url":"bit.ly/1NIp06X"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"583231981196058624","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-31T18:17:38.000Z","possibly_sensitive":false,"text":"@EMA_News and Heads of Medicines Agencies unveil high-level strategy for 2020 - read about it here: http://t.co/sy6QvruHIG","source":"Twitter Web Client","author_id":"1195040281","lang":"en","id":"582970020482912256","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/sy6QvruHIG","expanded_url":"http://ow.ly/L2HRi","display_url":"ow.ly/L2HRi"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":14,"end":40,"probability":0.6969,"type":"Organization","normalized_text":"Heads of Medicines Agencies"}],"cashtags":{}},"conversation_id":"582970020482912256","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-31T14:16:29.000Z","possibly_sensitive":false,"text":"Nueva Guía para la investigación clínica para el tratamiento de #esclerosismultiple  publicada por la “@EMA_News : http://t.co/bI8wqZuPhh”","source":"Twitter for iPad","author_id":"1221603110","lang":"es","id":"582909334344044545","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/bI8wqZuPhh","expanded_url":"http://bit.ly/1Dl7geP","display_url":"bit.ly/1Dl7geP"}],"mentions":[{"start":103,"end":112,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":64,"end":83,"tag":"esclerosismultiple"}],"annotations":{},"cashtags":{}},"conversation_id":"582885182266585088","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"582885182266585088"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-30T16:53:38.000Z","possibly_sensitive":false,"text":"@EMA_News : dal 1 luglio 2015 nuove regole per la presentazione di domande, rinnovi e variazioni di AIC | AIFA http://t.co/LmfZgPKqh3","source":"Twitter Web Client","author_id":"2176193576","lang":"it","id":"582586492301811712","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/LmfZgPKqh3","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/ema-dal-1-luglio-2015-nuove-regole-la-presentazione-di-domande-rinnovi-e-variazioni-di-aic#.VRl_dMQHM00.twitter","display_url":"agenziafarmaco.gov.it/it/content/ema…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"582586492301811712","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-30T07:44:29.000Z","possibly_sensitive":false,"text":"@EMA_News reviews @biogen and Samsung's  biosimilar of Remicade http://t.co/Sp81M9Hjni","source":"Twitter Web Client","author_id":"594516236","lang":"en","id":"582448295072673792","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/Sp81M9Hjni","expanded_url":"http://bit.ly/1bImQpW","display_url":"bit.ly/1bImQpW"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":18,"end":25,"username":"biogen","id":"155650832"}],"hashtags":{},"annotations":[{"start":30,"end":36,"probability":0.6651,"type":"Organization","normalized_text":"Samsung"}],"cashtags":{}},"conversation_id":"582448295072673792","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-28T18:20:07.000Z","possibly_sensitive":false,"text":"@EMA_News  @OACSinIreland @Karen keely @oacscharity","source":"Twitter Web App","author_id":"297306966","lang":"en","id":"581883481136959488","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":26,"end":32,"username":"Karen","id":"190906595"},{"start":39,"end":51,"username":"OACSCharity","id":"2836109170"}],"hashtags":{},"annotations":[{"start":33,"end":37,"probability":0.6784,"type":"Person","normalized_text":"keely"}],"cashtags":{}},"conversation_id":"536822673704505344","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"536822673704505344"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-27T13:11:18.000Z","possibly_sensitive":false,"text":"@EMA_news New restrictions to minimise the risks of effects on heart rhythm with hydroxyzine-containing medicines http://t.co/4UFwKpCnjR","source":"Twitter Web Client","author_id":"164835748","lang":"en","id":"581443378358927360","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/4UFwKpCnjR","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/03/news_detail_002296.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"581443378358927360","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-27T12:19:01.000Z","possibly_sensitive":false,"text":"@EMA_News backs five new meds, inc #Eisai Lenvima for thyroid cancer and @Boehringer diabetes combo Synjardy http://t.co/liBQki2ScE #pharma","source":"Twitter Web Client","author_id":"594516236","lang":"en","id":"581430220730814464","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/liBQki2ScE","expanded_url":"http://bit.ly/1EIGcT4","display_url":"bit.ly/1EIGcT4"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":73,"end":84,"username":"Boehringer","id":"17437735"}],"hashtags":[{"start":35,"end":41,"tag":"Eisai"},{"start":132,"end":139,"tag":"pharma"}],"annotations":{},"cashtags":{}},"conversation_id":"581430220730814464","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-24T17:10:17.000Z","possibly_sensitive":false,"text":"@EMA_News Thank you","source":"Twitter Web Client","author_id":"358759878","lang":"en","id":"580416355763130368","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"580373449719341056","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"580413338443735040"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-24T16:06:54.000Z","possibly_sensitive":false,"text":"@EMA_News re: 2.5 Products in the Decision Making Phase. Does the CHMP plan discussion on these items?","source":"Twitter Web Client","author_id":"358759878","lang":"en","id":"580400406473412608","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"580373449719341056","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"580373449719341056"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-24T13:13:06.000Z","possibly_sensitive":false,"text":"@EMA_News ofrece ayuda a pymes del sector biomédico / biotecnológico http://t.co/Wf6kaVQVgU","source":"Twitter for iPad","author_id":"317777498","lang":"es","id":"580356667176591360","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/Wf6kaVQVgU","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/landing/human_medicines_regulatory.jsp&mid=","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"580356667176591360","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-23T11:42:18.000Z","possibly_sensitive":false,"text":"@EMA_News turns 20! http://t.co/BgVDgWtiQB http://t.co/KbwQCFWYda","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"579971426620477440","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":20,"end":42,"url":"http://t.co/BgVDgWtiQB","expanded_url":"http://ow.ly/KFO59","display_url":"ow.ly/KFO59"},{"start":43,"end":65,"url":"http://t.co/KbwQCFWYda","expanded_url":"http://ow.ly/i/a3kDR","display_url":"ow.ly/i/a3kDR"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"579971426620477440","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-22T15:01:21.000Z","possibly_sensitive":false,"text":"@EMA_News Have you seen these 6 amazing ways to create a great annual report? http://t.co/ZhNInZXEVX","source":"Hootsuite","author_id":"2585578386","lang":"en","id":"579659134062198784","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/ZhNInZXEVX","expanded_url":"http://ht.ly/Kr46Y","display_url":"ht.ly/Kr46Y"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"579659134062198784","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-22T15:00:24.000Z","possibly_sensitive":false,"text":"@EMA_News recommends restrictions on codeine for children http://t.co/2ZwNwUn4oF","source":"TweetDeck","author_id":"43070633","lang":"en","id":"579658895821385728","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/2ZwNwUn4oF","expanded_url":"http://bit.ly/1FBgMLo","display_url":"bit.ly/1FBgMLo"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"579658895821385728","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-21T07:30:04.000Z","possibly_sensitive":false,"text":"@EMA_News looks at improving #veterinary #pharmacovigilance; plans to engage with @industry bodies &amp; #EU #Regulators! http://t.co/xmjxpq4Tw8","source":"Twitter for Android","author_id":"18665825","lang":"en","id":"579183174221049856","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":4,"quote_count":0},"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/xmjxpq4Tw8","expanded_url":"http://shar.es/1fOdbY","display_url":"shar.es/1fOdbY"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":82,"end":91,"username":"industry","id":"403581724"}],"hashtags":[{"start":29,"end":40,"tag":"veterinary"},{"start":41,"end":59,"tag":"pharmacovigilance"},{"start":105,"end":108,"tag":"EU"},{"start":109,"end":120,"tag":"Regulators"}],"annotations":{},"cashtags":{}},"conversation_id":"579183174221049856","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-20T10:37:40.000Z","possibly_sensitive":false,"text":"@EMA_News Congratulations on 20 years of protecting public and animal health through scientific evaluation and supervision of medicines!","source":"Twitter Web Client","author_id":"2242197968","lang":"en","id":"578868000792698880","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"578868000792698880","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-20T09:47:50.000Z","possibly_sensitive":false,"text":"@EMA_News publica cuestionario para conocer opinión de menores sobre fármacos http://t.co/7RkgHvUKlC","source":"TweetDeck","author_id":"152983899","lang":"es","id":"578855458817077248","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/7RkgHvUKlC","expanded_url":"http://www.pmfarma.es/noticias/20475-ema-publica-cuestionario-para-conocer-opinion-de-menores-sobre-farmacos.html?utm_source=twitter&utm_medium=manual","display_url":"pmfarma.es/noticias/20475…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"578855458817077248","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-19T11:53:52.000Z","possibly_sensitive":false,"text":"@EMA_News Congratulations on 20 years. \nSorry to see that 'watching live' means only the first two minutes.","source":"Twitter for iPad","author_id":"14327238","lang":"en","id":"578524787116535808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"578524787116535808","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-19T10:26:58.000Z","possibly_sensitive":false,"text":"@EMA_News meet #PRAC at #Pharmacovigilance, #DrugSafety &amp; #riskmanagement 2015 | Visit http://t.co/n4ICIOIBxp http://t.co/5hpzklscbR","source":"Twitter Web Client","author_id":"394086873","lang":"en","id":"578502919265320960","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/n4ICIOIBxp","expanded_url":"http://bit.ly/1zWLNqV","display_url":"bit.ly/1zWLNqV","status":200,"unwound_url":"https://www.smi-online.co.uk/pharmaceuticals/uk/conference/pharmacovigilance?utm_source=P-137&utm_medium=2015pharmacovigilance27.asp&utm_campaign=GOTO"},{"start":114,"end":136,"url":"http://t.co/5hpzklscbR","expanded_url":"https://twitter.com/SMIpharm/status/578502919265320960/photo/1","display_url":"pic.twitter.com/5hpzklscbR"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":15,"end":20,"tag":"PRAC"},{"start":24,"end":42,"tag":"Pharmacovigilance"},{"start":44,"end":55,"tag":"DrugSafety"},{"start":62,"end":77,"tag":"riskmanagement"}],"annotations":{},"cashtags":{}},"conversation_id":"577493093118783488","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"577493093118783488"}],"attachments":{"media_keys":["3_578502918686580736"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T18:52:08.000Z","possibly_sensitive":false,"text":"@EMA_News is celebrating 20th anniversary with one eye to increased complexity in drug development","source":"TweetDeck","author_id":"32492934","lang":"en","id":"578267658128375808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"578267658128375808","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T18:17:21.000Z","possibly_sensitive":false,"text":"@EMA_News Thanks for the RT!","source":"Twitter Web Client","author_id":"111425542","lang":"en","id":"578258907015090176","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"578258907015090176","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T18:00:09.000Z","possibly_sensitive":false,"text":"@EMA_News Role of Patients in Scientific Advice and Scientific Advisory Groups at EMA: New Video! https://t.co/8MyMi7uzRG","source":"Twitter Web Client","author_id":"59722141","lang":"en","id":"578254576400359424","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/8MyMi7uzRG","expanded_url":"https://youtu.be/pzrTwxLesEk","display_url":"youtu.be/pzrTwxLesEk"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"578254576400359424","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T16:35:29.000Z","possibly_sensitive":false,"text":"@EMA_News updated Patients and consumers pages - more to come http://t.co/lI0zzP2g3U","source":"Twitter Web Client","author_id":"59722141","lang":"en","id":"578233269981970432","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/lI0zzP2g3U","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/partners_and_networks/general/general_content_000317.jsp&mid=WC0b01ac058003500c","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"578233269981970432","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T15:15:37.000Z","possibly_sensitive":false,"text":"@ema_news y @AempsGob se interesan por la opinión de los niños en el uso de medicamentos e investigación clínica |  http://t.co/7RBNUFcke7","source":"Hootsuite","author_id":"2976191537","lang":"es","id":"578213172546502656","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/7RBNUFcke7","expanded_url":"http://ow.ly/KuEp8","display_url":"ow.ly/KuEp8"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":21,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"578213172546502656","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T12:52:48.000Z","possibly_sensitive":false,"text":"@EMA_news ‘only one thing worse than fighting with allies, is fighting without them’ Winston Churchill – Margaret Hamburg, FDA Commissioner","source":"Hootsuite","author_id":"36317302","lang":"en","id":"578177230892838912","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":85,"end":101,"probability":0.9813,"type":"Person","normalized_text":"Winston Churchill"},{"start":105,"end":120,"probability":0.7506,"type":"Person","normalized_text":"Margaret Hamburg"},{"start":123,"end":125,"probability":0.7759,"type":"Organization","normalized_text":"FDA"}],"cashtags":{}},"conversation_id":"578177230892838912","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T12:50:17.000Z","possibly_sensitive":false,"text":"@EMA_news 'networks of co-operation will be the modes of success in the future’, Bill Clinton – Margaret Hamburg, FDA Commissioner","source":"Hootsuite","author_id":"36317302","lang":"en","id":"578176597464854528","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":81,"end":92,"probability":0.9897,"type":"Person","normalized_text":"Bill Clinton"},{"start":96,"end":111,"probability":0.5853,"type":"Person","normalized_text":"Margaret Hamburg"},{"start":114,"end":116,"probability":0.7235,"type":"Organization","normalized_text":"FDA"}],"cashtags":{}},"conversation_id":"578176597464854528","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T12:48:02.000Z","possibly_sensitive":false,"text":"@EMA_News ‘Great to see a patient focused approach for the 20th anniversary’, Guido Rasi – Principal Adviser in charge of strategy.","source":"Hootsuite","author_id":"36317302","lang":"en","id":"578176029820366848","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":78,"end":87,"probability":0.9848,"type":"Person","normalized_text":"Guido Rasi"}],"cashtags":{}},"conversation_id":"578176029820366848","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T12:46:53.000Z","possibly_sensitive":false,"text":"@EMA_News 'EMA is looking to learn from patients the real value of the Therapeutic Area approach' - Guido Rasi, Principal Adviser","source":"Hootsuite","author_id":"36317302","lang":"en","id":"578175740342042624","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":100,"end":109,"probability":0.9869,"type":"Person","normalized_text":"Guido Rasi"}],"cashtags":{}},"conversation_id":"578175740342042624","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T12:31:31.000Z","possibly_sensitive":false,"text":"@EMA_News 20th annivers Sir Walport: Need for seamless care: #PrimaryCare - #socialcare - #secondarycare without obstacles: #integratedcare","source":"Twitter for Android","author_id":"164835748","lang":"en","id":"578171875982983168","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":61,"end":73,"tag":"PrimaryCare"},{"start":76,"end":87,"tag":"socialcare"},{"start":90,"end":104,"tag":"secondarycare"},{"start":124,"end":139,"tag":"integratedcare"}],"annotations":[{"start":24,"end":34,"probability":0.5112,"type":"Person","normalized_text":"Sir Walport"}],"cashtags":{}},"conversation_id":"578171875982983168","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T11:52:07.000Z","possibly_sensitive":false,"text":"@EMA_News 20th anniversary Elias Zerhouni: #PrimaryCare drugs are at risk as investments are concentrated on only 20% of diseases","source":"Twitter for Android","author_id":"164835748","lang":"en","id":"578161959322910720","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":43,"end":55,"tag":"PrimaryCare"}],"annotations":[{"start":27,"end":40,"probability":0.9529,"type":"Person","normalized_text":"Elias Zerhouni"}],"cashtags":{}},"conversation_id":"578161959322910720","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-18T10:30:55.000Z","possibly_sensitive":false,"text":"Congratulations to @EMA_News on 20 years of \"Patients at the heart of future innovation!\" http://t.co/hjYqmBrnQZ","source":"Twitter for iPhone","author_id":"188882079","lang":"en","id":"578141524569022464","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/hjYqmBrnQZ","expanded_url":"http://bit.ly/1BLYeVJ","display_url":"bit.ly/1BLYeVJ"}],"mentions":[{"start":19,"end":28,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"577911349373702144","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"577911349373702144"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-17T22:11:21.000Z","possibly_sensitive":false,"text":"Watch the live broadcast of @EMA_News 20th anniversary conference, tomorrow from 11:00-16:00 UK time: http://t.co/rfHw6OfttL","source":"Twitter for iPhone","author_id":"113148426","lang":"en","id":"577955407492227073","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/rfHw6OfttL","expanded_url":"http://bit.ly/1BLYeVJ","display_url":"bit.ly/1BLYeVJ"}],"mentions":[{"start":28,"end":37,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":93,"end":94,"probability":0.7835,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"conversation_id":"577911349373702144","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"577911349373702144"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-17T19:19:17.000Z","possibly_sensitive":false,"text":"RT @EMA_News: Watch the live broadcast of our 20th anniversary conference, tomorrow from 11:00-16:00 UK time: http://t.co/DjUF1W2egH #pharma","source":"Hootsuite","author_id":"15536425","lang":"en","id":"577912106596564992","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/DjUF1W2egH","expanded_url":"http://bit.ly/1BLYeVJ","display_url":"bit.ly/1BLYeVJ"}],"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":133,"end":140,"tag":"pharma"}],"annotations":[{"start":101,"end":102,"probability":0.7564,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"conversation_id":"577911349373702144","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"577911349373702144"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-17T13:45:38.000Z","possibly_sensitive":false,"text":"@EMA_News publishes details of its #pharmacovigilance fees http://t.co/WlAc5RjS9V","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"577828139751051264","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/WlAc5RjS9V","expanded_url":"http://ow.ly/KikqL","display_url":"ow.ly/KikqL"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":35,"end":53,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"conversation_id":"577828139751051264","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-17T10:18:31.000Z","possibly_sensitive":false,"text":"@EMA_News: Le comité de pharmacovigilance pour une contre-indication totale de la #codéine chez les moins de 12 ans : http://t.co/GAo12nonVS","source":"TweetDeck","author_id":"1339508364","lang":"fr","id":"577776014367019008","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/GAo12nonVS","expanded_url":"http://bit.ly/1GMqc8g","display_url":"bit.ly/1GMqc8g"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":82,"end":90,"tag":"codéine"}],"annotations":{},"cashtags":{}},"conversation_id":"577776014367019008","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-11T14:15:55.000Z","possibly_sensitive":false,"text":"@EMA_news @EU_Commission speak on comp. law, transparency of clinical trial data, adaptive licensing at #pharmalaw http://t.co/5sGDJet5Z8","source":"Hootsuite","author_id":"522169620","lang":"en","id":"575661431133192192","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/5sGDJet5Z8","expanded_url":"http://ow.ly/JuB8c","display_url":"ow.ly/JuB8c"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":104,"end":114,"tag":"pharmalaw"}],"annotations":{},"cashtags":{}},"conversation_id":"575661431133192192","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-10T16:03:47.000Z","possibly_sensitive":false,"text":"@EMA_News @AEMPSGOB just to note that it is on the SPC of Onglyza. Here is the crop http://t.co/k22H00y0dU","source":"Twitter Web Client","author_id":"525798275","lang":"en","id":"575326188962496512","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/k22H00y0dU","expanded_url":"https://twitter.com/fararod/status/575326188962496512/photo/1","display_url":"pic.twitter.com/k22H00y0dU"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":[{"start":51,"end":64,"probability":0.1949,"type":"Organization","normalized_text":"SPC of Onglyza"}],"cashtags":{}},"conversation_id":"575075156994957314","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"575271212093435907"}],"attachments":{"media_keys":["3_575326188060741632"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-09T23:26:16.000Z","possibly_sensitive":false,"text":"@EMA_News @AEMPSGOB When the review risk of heart failure for saxaglitpin following results from SAVOR-TIMI 53 trial, and the summary sheet","source":"Twitter Web Client","author_id":"525798275","lang":"en","id":"575075156994957314","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"575075156994957314","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-07T10:05:15.000Z","possibly_sensitive":false,"text":"RT @EMA_News: #Consultation on #guidelines to reduce antimicrobial #resistance in animals &amp; prevent transm. to people http://t.co/5wucixDhxE","source":"Hootsuite","author_id":"1608295104","lang":"en","id":"574148798726938624","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/5wucixDhxE","expanded_url":"http://bit.ly/1DZMIac","display_url":"bit.ly/1DZMIac"}],"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":14,"end":27,"tag":"Consultation"},{"start":31,"end":42,"tag":"guidelines"},{"start":67,"end":78,"tag":"resistance"}],"annotations":{},"cashtags":{}},"conversation_id":"573893511839358976","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"573893511839358976"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-05T21:10:04.000Z","possibly_sensitive":false,"text":"@EMA_News great and informative day discussing bio similars really useful resources @IAPOtweets http://t.co/GDUMilaKgx","source":"Twitter for iPhone","author_id":"1622831072","lang":"en","id":"573591331404128257","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/GDUMilaKgx","expanded_url":"https://twitter.com/clarenras/status/573591331404128257/photo/1","display_url":"pic.twitter.com/GDUMilaKgx"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":84,"end":95,"username":"IAPOtweets","id":"14682411"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"573591331404128257","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_573591330019999745"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-04T19:20:42.000Z","possibly_sensitive":false,"text":"@EMA_News Hi any idea when the PROTECT Symposium Video will be posted?","source":"Twitter Web Client","author_id":"3722601","lang":"en","id":"573201420104667136","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":31,"end":53,"probability":0.4208,"type":"Other","normalized_text":"PROTECT Symposium Video"}],"cashtags":{}},"conversation_id":"573201420104667136","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-04T09:54:31.000Z","possibly_sensitive":false,"text":"@EMA_News @EFA_Patients @Suecos helps regarding back and knee pain. You could retweet this.","source":"Twitter Web Client","author_id":"2166888937","lang":"en","id":"573058934476562432","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"EFA_Patients","id":"1299643704"},{"start":24,"end":31,"username":"SueCos","id":"711888939620114432"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"573047043381436416","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"573058509740371968"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-04T09:01:07.000Z","possibly_sensitive":false,"text":"@EMA_News award of one million euro awaits if you will develop a safe test that decides if antibiotics are needed for a certain treatment","source":"Twitter Web Client","author_id":"110945817","lang":"en","id":"573045497184821249","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"573045497184821249","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-04T09:00:01.000Z","possibly_sensitive":false,"text":"@EMA_news /@US_FDA #PatientEngagement fellowship: a time to learn and share http://t.co/YIcP4BJEYM","source":"Sprout Social","author_id":"2315763655","lang":"en","id":"573045217785335808","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/YIcP4BJEYM","expanded_url":"http://1.usa.gov/1Lyz0wB","display_url":"1.usa.gov/1Lyz0wB"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":18,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":19,"end":37,"tag":"PatientEngagement"}],"annotations":{},"cashtags":{}},"conversation_id":"573045217785335808","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-03T13:38:46.000Z","possibly_sensitive":false,"text":"@EMA_News Hello,http://t.co/g7giYrE3Sf","source":"Twitter Web Client","author_id":"2816632128","lang":"en","id":"572752982611247104","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":16,"end":38,"url":"http://t.co/g7giYrE3Sf","expanded_url":"http://www.leadergroupint.com/","display_url":"leadergroupint.com"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"572752982611247104","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-02T12:00:04.000Z","possibly_sensitive":false,"text":"“@EMA_News: Risk of allergy and skin reactions to be included in safety information for #ambroxol and #bromhexine: http://t.co/eujGGj8cgY”","source":"Twitter for iPhone","author_id":"140587674","lang":"en","id":"572365752835153922","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/eujGGj8cgY","expanded_url":"http://bit.ly/1JUXiFq","display_url":"bit.ly/1JUXiFq"}],"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":88,"end":97,"tag":"ambroxol"},{"start":102,"end":113,"tag":"bromhexine"}],"annotations":{},"cashtags":{}},"conversation_id":"572362361719431168","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"572362361719431168"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-02T10:45:27.000Z","possibly_sensitive":false,"text":"@EMA_News #yellowfever #vaccine  can cause  severe #psychosis.","source":"Twitter Web Client","author_id":"17966242","lang":"en","id":"572346977188507648","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":22,"tag":"yellowfever"},{"start":23,"end":31,"tag":"vaccine"},{"start":51,"end":61,"tag":"psychosis"}],"annotations":{},"cashtags":{}},"conversation_id":"571979908345405441","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"572328267732160513"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-02T08:52:15.000Z","possibly_sensitive":false,"text":"@EMA_News accepts #Santen #MAA filing for intravitreal sirolimus to treat noninfectious uveitis of posterior segment http://t.co/3DOBPj79Im","source":"Twitter for iPad","author_id":"243228907","lang":"en","id":"572318486548119552","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/3DOBPj79Im","expanded_url":"http://shar.es/1WOf3T","display_url":"shar.es/1WOf3T"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":18,"end":25,"tag":"Santen"},{"start":26,"end":30,"tag":"MAA"}],"annotations":{},"cashtags":{}},"conversation_id":"572318486548119552","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-03-01T10:26:51.000Z","possibly_sensitive":false,"text":"@EMA_News why is #yellowfever #vaccine not withdrawn and investigated? #bbc #SanofiPasteur #psychosis http://t.co/f6G47lHBCo","source":"Twitter Web Client","author_id":"17966242","lang":"en","id":"571979908345405441","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/f6G47lHBCo","expanded_url":"http://www.telegraph.co.uk/news/worldnews/europe/11439622/How-a-jab-plunged-my-life-into-madness.html","display_url":"telegraph.co.uk/news/worldnews…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":17,"end":29,"tag":"yellowfever"},{"start":30,"end":38,"tag":"vaccine"},{"start":71,"end":75,"tag":"bbc"},{"start":76,"end":90,"tag":"SanofiPasteur"},{"start":91,"end":101,"tag":"psychosis"}],"annotations":{},"cashtags":{}},"conversation_id":"571979908345405441","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-28T16:29:31.000Z","possibly_sensitive":false,"text":"@EMA_News Accepts MAA for #Kyprolis. Grants Accelerated Assessment @Amgen  http://t.co/PwT087Tj07","source":"Safari on iOS","author_id":"633978297","lang":"en","id":"571708788090281984","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/PwT087Tj07","expanded_url":"http://www.amgen.com/media/media_pr_detail.jsp?releaseID=2020786","display_url":"amgen.com/media/media_pr…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":67,"end":73,"username":"Amgen","id":"28436760"}],"hashtags":[{"start":26,"end":35,"tag":"Kyprolis"}],"annotations":{},"cashtags":{}},"conversation_id":"571708788090281984","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-27T10:19:43.000Z","possibly_sensitive":false,"text":"@EMA_News \n : Minister @lesley4wrexham  taking a selfie- hands in the air to support #RareDisease Day #C20Conf http://t.co/U8tk5o83Rg\"\"\"","source":"Twitter for Android","author_id":"226603998","lang":"en","id":"571253335132676097","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/U8tk5o83Rg","expanded_url":"https://twitter.com/Communities2_0/status/570548151838486530/photo/1","display_url":"pic.twitter.com/U8tk5o83Rg"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":23,"end":38,"username":"lesley4wrexham","id":"201258574"}],"hashtags":[{"start":85,"end":97,"tag":"RareDisease"},{"start":102,"end":110,"tag":"C20Conf"}],"annotations":{},"cashtags":{}},"conversation_id":"571253335132676097","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_570548121924558849"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-27T10:01:39.000Z","possibly_sensitive":false,"text":"@EMA_News conoce y valora los mejores restaurantes desde tu móvil con la app gratuita RankEating: http://t.co/SytIkRtpMX","source":"asdasdasdqwdqwcasczxqwdawd","author_id":"3058472477","lang":"es","id":"571248792038727680","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/SytIkRtpMX","expanded_url":"http://www.goo.gl/X8xmkN","display_url":"goo.gl/X8xmkN"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"571248792038727680","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-27T09:36:03.000Z","possibly_sensitive":false,"text":"@EMA_News EMA supports Rare Disease Day 2015 http://t.co/Z9g9SMgnqh @eurordis @rarediseaseday","source":"Twitter for iPhone","author_id":"59722141","lang":"en","id":"571242347834580992","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":45,"end":67,"url":"http://t.co/Z9g9SMgnqh","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/02/news_detail_002277.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":68,"end":77,"username":"eurordis","id":"26993786"},{"start":78,"end":93,"username":"rarediseaseday","id":"19982434"}],"hashtags":{},"annotations":[{"start":23,"end":43,"probability":0.2984,"type":"Other","normalized_text":"Rare Disease Day 2015"}],"cashtags":{}},"conversation_id":"571242347834580992","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-26T10:33:59.000Z","possibly_sensitive":false,"text":"@EMA_News @EU_Health We have an election coming in the UK &amp; I remain to be convinced about some of this centralization its getting too much","source":"Twitter Web Client","author_id":"32528318","lang":"en","id":"570894537935196161","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":{},"annotations":[{"start":55,"end":56,"probability":0.9801,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"conversation_id":"570888982256586752","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"570893062563602432"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-26T10:28:07.000Z","possibly_sensitive":false,"text":"@EMA_News @EU_Health sorry I'm feeling rather anti the EU at the moment which is very unlike me but there is too much control","source":"Twitter Web Client","author_id":"32528318","lang":"en","id":"570893064413290496","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"570888982256586752","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"570892618986610688"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-26T10:27:00.000Z","possibly_sensitive":false,"text":"@EMA_News @EU_Health whatproducts services is a marketing authorization for? Is this for new drugs or all appliances?","source":"Twitter Web Client","author_id":"32528318","lang":"en","id":"570892780324712448","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"570888982256586752","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"570892179603906560"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-26T10:26:21.000Z","possibly_sensitive":false,"text":"@wigmore_welsh @EU_Health You can read more about what marketing authorisations are here: http://t.co/Z7GrvcfhaG","source":"TweetDeck","author_id":"116716199","lang":"en","id":"570892618986610688","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/Z7GrvcfhaG","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"mentions":[{"start":0,"end":14,"username":"wigmore_welsh","id":"32528318"},{"start":15,"end":25,"username":"EU_Health","id":"606325697"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"570888982256586752","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"570892330074578944"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-26T10:25:12.000Z","possibly_sensitive":false,"text":"@wigmore_welsh @EU_Health But from July they will have to use an online electronic application form instead.","source":"TweetDeck","author_id":"116716199","lang":"en","id":"570892330074578944","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":14,"username":"wigmore_welsh","id":"32528318"},{"start":15,"end":25,"username":"EU_Health","id":"606325697"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"570888982256586752","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"570892179603906560"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-26T10:19:55.000Z","possibly_sensitive":false,"text":"@EMA_News @EU_Health I dont even understand what this means. Can you put this in #simplecitizen #speak #orwell #1984 http://t.co/5B5Gf2EsQ8","source":"Twitter Web Client","author_id":"32528318","lang":"en","id":"570890997766467585","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/5B5Gf2EsQ8","expanded_url":"http://esubmission.ema.europa.eu/eaf/index.html","display_url":"esubmission.ema.europa.eu/eaf/index.html"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":81,"end":95,"tag":"simplecitizen"},{"start":96,"end":102,"tag":"speak"},{"start":103,"end":110,"tag":"orwell"}],"annotations":{},"cashtags":{}},"conversation_id":"570888982256586752","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"570888982256586752"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-26T08:20:29.000Z","possibly_sensitive":false,"text":"@EMA_News Good morning! Thanks for the RT","source":"Twitter Web Client","author_id":"2917826331","lang":"en","id":"570860941593718785","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"570860941593718785","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-25T20:55:22.000Z","possibly_sensitive":false,"text":"@EMA_News #Regulatory information: electronic application forms become mandatory for centralised procedures from July http://t.co/SyIEqWOFqX","source":"Tweetbot for iΟS","author_id":"2834291205","lang":"en","id":"570688528465727488","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/SyIEqWOFqX","expanded_url":"http://bit.ly/1wopBGA","display_url":"bit.ly/1wopBGA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":21,"tag":"Regulatory"}],"annotations":{},"cashtags":{}},"conversation_id":"570688528465727488","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-25T19:59:56.000Z","possibly_sensitive":false,"text":"@EMA_News Have you heard the news about Lisbon? #medicaltourism #http://bit.ly/1BnEDhy","source":"Twitter Web Client","author_id":"130591942","lang":"en","id":"570674576046354434","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":48,"end":63,"tag":"medicaltourism"}],"annotations":[{"start":40,"end":45,"probability":0.9023,"type":"Place","normalized_text":"Lisbon"}],"cashtags":{}},"conversation_id":"570674576046354434","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-25T13:52:15.000Z","possibly_sensitive":false,"text":"@EMA_News Only one update in 2015 to the Rare disease designations page on your website, although the EC Community Register has more?","source":"Twitter Web Client","author_id":"2360127492","lang":"en","id":"570582046428545024","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":102,"end":122,"probability":0.7819,"type":"Organization","normalized_text":"EC Community Register"}],"cashtags":{}},"conversation_id":"570582046428545024","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-24T16:49:22.000Z","possibly_sensitive":false,"text":"@EMA_News @PROTECT_BR Hi, is the video for last week's PROTECT Symposium available yet?","source":"Twitter Web Client","author_id":"3722601","lang":"en","id":"570264229808353281","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":21,"username":"PROTECT_BR","id":"2354960784"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"570264229808353281","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-23T16:10:48.000Z","possibly_sensitive":false,"text":"@EMA_News TY! Look forward to that.","source":"Twitter Web Client","author_id":"610847692","lang":"en","id":"569892136222662656","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"569884820207239170","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"569891322531864576"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-23T15:55:33.000Z","possibly_sensitive":false,"text":"@EMA_News This is the link to the CVMP, could you please put up the link to the CHMP? :)","source":"Twitter Web Client","author_id":"610847692","lang":"en","id":"569888299818586112","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"569884820207239170","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"569884820207239170"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-22T09:53:20.000Z","possibly_sensitive":false,"text":"@EMA_News Baryta Carbonica &amp; Anacardium Orientale(homeopathic), have no composition information ,are sold at Faro airport pharmacy, Portugal","source":"Twitter Web Client","author_id":"1744449541","lang":"en","id":"569434758477778944","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":109,"end":112,"probability":0.8129,"type":"Place","normalized_text":"Faro"},{"start":132,"end":139,"probability":0.9312,"type":"Place","normalized_text":"Portugal"}],"cashtags":{}},"conversation_id":"569434758477778944","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-20T18:25:24.000Z","possibly_sensitive":false,"text":"@EMA_News Hi When will vid of that last two day's PROTECT Symposium be up? Will it be on EMA's YouTube site?","source":"Twitter Web Client","author_id":"3722601","lang":"en","id":"568838848689668096","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":95,"end":101,"probability":0.4816,"type":"Product","normalized_text":"YouTube"}],"cashtags":{}},"conversation_id":"568838848689668096","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-19T18:45:14.000Z","possibly_sensitive":false,"text":"@EMA_News B&amp;S and Waymade amalgamate different batches of the same product and give them a new batch number.","source":"Twitter for iPad","author_id":"2882895538","lang":"en","id":"568481450162556928","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":18,"end":24,"probability":0.3444,"type":"Organization","normalized_text":"Waymade"}],"cashtags":{}},"conversation_id":"568481450162556928","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-19T11:47:38.000Z","possibly_sensitive":false,"text":"@EMA_News traduce nelle lingue UE modifiche raccomandate a Riassunti Caratteristiche Prodotto e Fogli Illustrativi http://t.co/NXXZNmUMNA","source":"TweetDeck","author_id":"441940097","lang":"it","id":"568376360504336384","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/NXXZNmUMNA","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/sicurezza-farmaci-ema-traduce-nelle-lingue-ue-modifiche-raccomandate-riassunti-caratteristic","display_url":"agenziafarmaco.gov.it/it/content/sic…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"568376360504336384","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-18T20:33:12.000Z","possibly_sensitive":false,"text":"@EMA_News waters down #transparency policy. Many exceptions to access to safety and efficacy data. http://t.co/StwR09Leb5 #AllTrials","source":"Twitter for Android","author_id":"18483956","lang":"en","id":"568146235175120896","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":4,"quote_count":0},"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/StwR09Leb5","expanded_url":"http://haieurope.org/wp-content/uploads/2015/02/PR-EMA-steers-away-from-transparency.pdf","display_url":"haieurope.org/wp-content/upl…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":22,"end":35,"tag":"transparency"},{"start":122,"end":132,"tag":"AllTrials"}],"annotations":{},"cashtags":{}},"conversation_id":"568146235175120896","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-16T16:37:12.000Z","possibly_sensitive":false,"text":"@EMA_News Thank you","source":"Twitter Web Client","author_id":"358759878","lang":"en","id":"567362068178018305","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"566308262027739137","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"567263719328325632"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-13T18:49:45.000Z","possibly_sensitive":false,"text":"@EMA_News Date of March meeting re: Mysimba? Orexigen said EC Standing Committee for Medicinal Products http://t.co/KiBbXJlx55","source":"Twitter Web Client","author_id":"358759878","lang":"en","id":"566308262027739137","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/KiBbXJlx55","expanded_url":"http://ir.orexigen.com/phoenix.zhtml?c=207034&p=irol-newsArticle&ID=2014720","display_url":"ir.orexigen.com/phoenix.zhtml?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"566308262027739137","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-13T13:47:47.000Z","possibly_sensitive":false,"text":"@EMA_News published the assessment report for #Cerdelga (#eliglustat), a #medicine to treat type-1 #Gaucher #disease http://t.co/XKLPGI1JU6","source":"Twitter for Mac","author_id":"98932140","lang":"en","id":"566232268084379648","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/XKLPGI1JU6","expanded_url":"http://bit.ly/1KRXPow","display_url":"bit.ly/1KRXPow"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":46,"end":55,"tag":"Cerdelga"},{"start":57,"end":68,"tag":"eliglustat"},{"start":73,"end":82,"tag":"medicine"},{"start":99,"end":107,"tag":"Gaucher"},{"start":108,"end":116,"tag":"disease"}],"annotations":{},"cashtags":{}},"conversation_id":"566206897985175554","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"566206897985175554"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-13T09:42:43.000Z","possibly_sensitive":false,"text":"@EMA_News to go extra mile to facilitate joint safety study for valproate ($) http://t.co/R3jpyIGt71 #pharmacovigilance","source":"Twitter Web Client","author_id":"459335626","lang":"en","id":"566170594463744000","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/R3jpyIGt71","expanded_url":"http://bit.ly/1D2QDow","display_url":"bit.ly/1D2QDow"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":101,"end":119,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"conversation_id":"566170594463744000","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-11T16:50:06.000Z","possibly_sensitive":false,"text":"@EMA_News Committee for Orphan Medicinal Products (COMP) raises hands for Rare Disease Day @rarediseaseday @eurordis http://t.co/mfdSnfxrbu","source":"Twitter Web Client","author_id":"59722141","lang":"en","id":"565553371948789760","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":8,"quote_count":0},"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/mfdSnfxrbu","expanded_url":"https://twitter.com/kardamyla/status/565553371948789760/photo/1","display_url":"pic.twitter.com/mfdSnfxrbu"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":91,"end":106,"username":"rarediseaseday","id":"19982434"},{"start":107,"end":116,"username":"eurordis","id":"26993786"}],"hashtags":{},"annotations":[{"start":24,"end":48,"probability":0.3052,"type":"Organization","normalized_text":"Orphan Medicinal Products"},{"start":74,"end":89,"probability":0.4994,"type":"Other","normalized_text":"Rare Disease Day"}],"cashtags":{}},"conversation_id":"565553371948789760","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_565553371160268800"]},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-11T11:21:49.000Z","possibly_sensitive":false,"text":"@EMA_News tries to defend redactions/censoring of clinical trial data in response to @EUombudsman inquiry  http://t.co/WSx5JwS3q4 #alltrials","source":"TweetDeck","author_id":"18483956","lang":"en","id":"565470756826800128","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/WSx5JwS3q4","expanded_url":"http://www.ombudsman.europa.eu/en/cases/correspondence.faces/en/58946/html.bookmark","display_url":"ombudsman.europa.eu/en/cases/corre…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":85,"end":97,"username":"EUombudsman","id":"873777758"}],"hashtags":[{"start":130,"end":140,"tag":"alltrials"}],"annotations":{},"cashtags":{}},"conversation_id":"565470756826800128","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-09T23:15:08.000Z","possibly_sensitive":false,"text":"@EMA_News Thank you.  But i thought it already was under evaluation but melanoma is not on the list.","source":"Twitter Web Client","author_id":"284748226","lang":"en","id":"564925497109671938","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"564838913210990592","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"564841819536891904"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-09T17:42:38.000Z","possibly_sensitive":false,"text":"@byzondereekster And you can follow the meetings of our human medicine committee here: http://t.co/dwC0S8CPbW","source":"TweetDeck","author_id":"116716199","lang":"en","id":"564841819536891904","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/dwC0S8CPbW","expanded_url":"http://bit.ly/1eSRmZC","display_url":"bit.ly/1eSRmZC"}],"mentions":[{"start":0,"end":16,"username":"byzondereekster","id":"284748226"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"564838913210990592","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"564840979673276416"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-09T17:31:05.000Z","possibly_sensitive":false,"text":"@EMA_News is there any news or predictions about the approval of immunotherapy for melanoma?!","source":"Twitter Web Client","author_id":"284748226","lang":"en","id":"564838913210990592","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"564838913210990592","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-09T15:19:28.000Z","possibly_sensitive":false,"text":"@EMA_News - Patients and carers updated webpages http://t.co/VhfOoiflGl ...more updates to come.... watch this space!!","source":"Twitter Web Client","author_id":"59722141","lang":"en","id":"564805791560241152","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/VhfOoiflGl","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/audience/alp_audiencetype_000001.jsp&mid","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"564805791560241152","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-07T06:27:17.000Z","possibly_sensitive":false,"text":"@EMA_News' guide to help IT teams with its new #pharmacovigilance #database http://t.co/SpMBmrVi37\n\n#DrugSafety #Prevention #AdverseEvents","source":"Twitter Web Client","author_id":"529274483","lang":"en","id":"563947087361232896","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":5,"quote_count":0},"entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/SpMBmrVi37","expanded_url":"http://www.fiercebiotechit.com/story/ema-posts-guide-help-it-teams-its-new-pharmacovigilance-database/2015-01-26","display_url":"fiercebiotechit.com/story/ema-post…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":47,"end":65,"tag":"pharmacovigilance"},{"start":66,"end":75,"tag":"database"},{"start":100,"end":111,"tag":"DrugSafety"},{"start":112,"end":123,"tag":"Prevention"},{"start":124,"end":138,"tag":"AdverseEvents"}],"annotations":{},"cashtags":{}},"conversation_id":"563947087361232896","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-04T15:21:21.000Z","possibly_sensitive":false,"text":"@EMA_News @AEMPSGOB Pomalidomide Italia registrato ma non ancora in SSNRelazione CTS AIFA 326/2003 per eventuale rimborso SSN #registriaifa","source":"Twitter for iPhone","author_id":"464709093","lang":"it","id":"562994324267626496","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"AEMPSGOB","id":"326845755"}],"hashtags":[{"start":126,"end":139,"tag":"registriaifa"}],"annotations":{},"cashtags":{}},"conversation_id":"562987216449052673","in_reply_to_user_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"562987216449052673"}],"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-03T12:00:58.000Z","possibly_sensitive":false,"text":"@EMA_News #biosimilar guidelines given an overhaul http://t.co/tbrSEocGhV","source":"Hootsuite","author_id":"1965354864","lang":"en","id":"562581506976415744","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"urls":[{"start":51,"end":73,"url":"http://t.co/tbrSEocGhV","expanded_url":"http://ow.ly/IkbHs","display_url":"ow.ly/IkbHs"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":21,"tag":"biosimilar"}],"annotations":{},"cashtags":{}},"conversation_id":"562581506976415744","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"created_at":"2015-02-03T05:45:28.000Z","possibly_sensitive":false,"text":"@EMA_News y la guerra de las farmaceuticas contra los medicamentos genéricos. http://t.co/RfZnhbA1f9","source":"TweetDeck","author_id":"18483956","lang":"es","id":"562487010641055744","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/RfZnhbA1f9","expanded_url":"http://www.nuevatribuna.es/articulo/sanidad/guerras-multinacionales-farmaceuticas-paga-ciudadania/20150131165419111941.html","display_url":"nuevatribuna.es/articulo/sanid…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"conversation_id":"562487010641055744","in_reply_to_user_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}}]
